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Summary 
 
The ribosome is a multifunctional ribonucleoprotein complex responsible for the 
translation of the genetic code into proteins. It consists of two subunits, the small 
ribosomal subunit and the large ribosomal subunit. During initiation of translation, both 
subunits join and form a functional 70S ribosome that is capable of protein synthesis. 
In the course of elongation, the ribosome synthesizes proteins according to the codons 
on the mRNA until it encounters a stop codon leading to the recruitment of release 
factors 1 or 2 followed by release of the nascent chain. Upon release of the polypeptide 
chain the subunits dissociate from each other and can be recruited for another round 
of translation. 
 There are two scenarios that interfere with active translation, namely the 
formation of so called ‘non-stop’ or ‘no-go’ complexes. In both cases, ribosomes pause 
translation and without interference of additional factors, they would become stalled. 
Accumulation of such events leads to a decrease of ribosomal subunits that can be 
recruited for translation, ultimately resulting in the death of the cell. Using cryo-electron 
microscopy (cryo-EM), we obtained the structure of alternative rescue factor A (ArfA) 
together with release factor 2 bound to a ‘non-stop’ complex. Our reconstructions 
showed that the C-terminal domain of ArfA occupies the empty mRNA channel on the 
SSU, whereas the N-terminal domain provides a platform for recruiting RF2 in a stop 
codon-independent way. Thereby, ArfA stabilizes a unique conformation of the switch 
loop of RF2, responsible for directing the catalytically important GGQ motif towards the 
PTC. The high-resolution structure of ArfA allowed us to compare its mode of action 
with trans-translation and alternative rescue factor B, two other factors operating on 
‘non-stop’ complexes. A second project focused on elongation factor P (EF-P), a factor 
that alleviates stalling on polyproline stalled ribosomes. Applying cryo-EM, we were 
able to show that in the absence of EF-P, the nascent chain is destabilized as the 
polyproline moiety attached to the P-tRNA is not able to accommodate within the 
ribosomal tunnel. Binding of modified EF-P to the polyproline stalled complex stabilizes 
the P-site tRNA and especially the CCA, thereby forcing the nascent chain to adopt an 
alternative conformation that is favorable for translation to proceed. 
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1 Introduction 
1.1 Central Dogma of molecular biology 
 
Conservation of the genome, its transfer and faithful implementation of the information 
stored within, are fundamentally important steps in every cell. About 50 to 60 years 
ago the central dogma of molecular biology gained prominence for establishing the 
sequential occurrence of these vital events and their interconnectedness (Crick, 1958, 
1970). The classical view describes a consecutive order of events, in which 
deoxyribonucleic acid (DNA) can either replicate itself to maintain the genomic integrity 
(Replication) or transfer its information onto ribonucleic acid (RNA) molecules 
(Transcription), which in turn serve as templates for the synthesis of proteins 
(Translation). Together replication, transcription and translation form the three 
founding pillars of the dogma of molecular biology. This model is valid to this day, 
however extensive studies over the decades have broadened our understanding of the 
molecular mechanisms behind it. Both replication and transcription require the 
recruitment of macromolecular machines. While replication of the genome requires the 
action of DNA polymerases, transcription of information from DNA to RNA is mediated 
by RNA polymerases. RNA molecules are a heterogeneous population that fulfill 
various roles in a cell and can be divided into two major classes, namely non-coding 
RNA (ncRNA) and messenger RNA (mRNA). Recent studies have shown that ncRNAs 
pursue different functions such as catalysis of chemical reactions (e.g. ribosomal RNA, 
rRNA), serving as adaptor molecules (e.g. transfer RNA, tRNA) or structural scaffolds 
(e.g. rRNA) and regulating gene expression (e.g. micro RNA, miRNA)(Dogini et al., 
2014; Hüttenhofer et al., 2005). On the other hand, mRNAs contain the information of 
genes, which can be decoded and translated into proteins. This process is called 
translation and is mediated by ribosomes. In contrast to the other two molecular 
machines, the ribosome mainly consists predominantly of rRNA and the structural and 
mechanistic themes of the core components are conserved among the three 
phylogenetic kingdoms of life. However, there are certain differences between and as 
well as within each kingdom concerning size, regulation and composition to name a 
few (Graf et al., 2017; Melnikov et al., 2012). My work is focused exclusively on the 
prokaryotic ribosomal machinery of Escherichia Coli (E. coli). Unless mentioned 
otherwise, all ribosomes within this thesis refer to the E. coli ribosome. 
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1.2 Structure of the E. coli ribosome 
 
The ribosome is a multifunctional cellular complex with an approximately molecular 
mass of 2.3 MDa. It consists out of two separate subunits, namely the large subunit 
(50S, LSU) and the small subunit (SSU, 30S), together forming a complete 70S 
ribosome. Both of the subunits are made out of rRNA and proteins.  
 
 
Figure 1. Structural overview of the bacterial ribosome. (A)  View of the structure of 
the SSU from the solvent side. The 16S rRNA (gold), rProteins (green) of the SSU and 
mRNA (cyan) are indicated. The major subdivision are indicated: H, head; N, neck; B, 
body; P, platform; S, shoulder; F, foot and T, toe (also known as spur). (B) View of the 
structure of the LSU from the solvent side. 23S rRNA (grey), 5S rRNA (salmon) and the 
rProteins (blue) are indicated. (C) Overview of a vacant 70S ribosome with the 
intersubunit space indicated. (D) View of the structure of the SSU from the interface with 
A-, P- and E-tRNAs (red, blue, purple). (E) View of the structure of the LSU from the 
interface with A-, P- and E-tRNAs bound (red, blue, purple). (F) Schematic representation 
of the 70S ribosome showing the 50S (grey), 30S (yellow), A-, P- and E-tRNAs (red, blue, 
purple) and mRNA (black). The side of the decoding center (DC) on the SSU, the peptidyl-
transferase center (PTC) as well as the ribosomal exit tunnel on the LSU are depicted as 
dashed-lined. 
 
The 30S is composed of the 16S rRNA and 21 ribosomal proteins (rProteins) forming 
the typical morphological shape of the SSU, which can be divided into Head, Neck and 
Body. The body itself can be further segmented into Shoulder, Platform, Foot and Toe 
(also known as spur) (Figure 1A) (Schluenzen et al., 2000). 
Introduction 
12 
 
The LSU includes the 23S rRNA, 5S rRNA and 33 rProteins. It forms a rounded base 
with three protuberances called the L1 stalk, the central protuberance and the L7/L12 
stalk (Figure 1B) (Yusupov et al., 2001).  
Both subunits join by forming intermolecular bridges providing an intersubunit 
space important for the accommodation of tRNAs (Figure 1C). The ribosome 
possesses three binding sites for tRNAs, namely the acceptor site (A-site), the peptidyl 
site (P-site) and the exit site (E-site) (Yusupov et al., 2001). All three tRNAs associate 
with the ribosome by forming contacts with the 30S as well as 50S (Figure 1D-F).  
Each of the subunits harbors a crucial functional core. The SSU comprises the 
decoding center (DC), where the correct tRNA is selected according to the information 
stored within the mRNA (Figure 1D,F) (Rozov et al., 2016a). The LSU contains the 
peptidyl transferase center (PTC), which links amino acids (aa) to a nascent 
polypeptide chain (NC) which passes through the ribosomal exit tunnel (Figure 1E,F) 
(Polacek and Mankin, 2005; Rodnina et al., 2007). High resolution structures revealed 
that both functional cores are made of rRNA with the closest ribosomal proteins being 
too far-off to participate in their respective enzymatic reaction, leading to the 
suggestion that the ribosome is a ribozyme (Ban et al., 2000; Demeshkina et al., 2012; 
Hansen et al., 2002a; Harms et al., 2001; Loveland et al., 2017; Ogle et al., 2001, 2002; 
Polikanov et al., 2014; Schluenzen et al., 2000; Schlünzen et al., 2001; Voorhees et 
al., 2009a). This is supported by a vast amount of biochemical data, revealing that 
translation can occur in the absence of translation factors as well as many ribosomal 
proteins (Dabbs, 1986; Gavrilova et al., 1976; Leder and Nirenberg, 1964; Lill et al., 
1986; Nomura et al., 1969). While mutations in rProteins are widely tolerated, 
manipulation of highly conserved rRNA residues, in contrast, results in inactivation of 
ribosomes (Dabbs, 1986; Lind et al., 2010)–33. Therefore, the ribosome should be 
indeed considered as a classical ribozyme (Noller, 2012). The role of the rProteins, on 
the other hand, is to improve efficiency and accuracy of translation, binding of tRNAs 
and translation factors as well as folding the rRNA in its functional state (Davies and 
Nomura, 1972; Hoang et al., 2004; Nomura et al., 1969).  
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1.3  Translation cycle 
 
  
 
Figure 2. The translation cycle. During Init iation (green) the 30S subunit incorporates 
the mRNA together with init iation factor (IF) 1,2 and 3 followed by the binding of 50S 
subunit and posit ioning of the initiator tRNA by IF2 to form the 70S Init iation complex 
(70SIC). This step is followed by Elongation (red), during which tRNAs are delivered to 
the A-site of the ribosome. After establishing a correct interaction between the anticodon 
of the tRNA and the codon on the mRNA (decoding), the r ibosome catalyzes the transfer 
of the peptide from the P-site tRNA onto the A-site tRNA, (peptide bond formation), 
prolonging the NC by an addit ional aa. Subsequently, elongation-factor G (EF-G) binds 
and translocates the tRNAs from the A- to the P-site and P- to the E-site, respectively. 
This leads to an empty A-site, allowing another round of elongation until the appearance 
of a stop codon in the A-site of the ribosome (termination, beige). Stop codons are either 
recognized by RF1 or RF2 (release factor), which hydrolyze the ester bond between the 
tRNA and the nascent chain, allowing the polypeptide chain to be released. RF3 mediates 
the release of the RF1/2 and allow EF-G and RRF (ribosomal recycling factor) to split the 
ribosome (recycling, cyan). After dissociation of the subunits from each other, they can 
participate in another round of translation. 
 
Translation is the most energy-consuming pathway in a growing E.coli cell. 
Approximately 50% of the energy in form of ATP and GTP are consumed during protein 
synthesis (Buttgereit and Brand, 1995; Russell and Cook, 1995). Due to the enormous 
energy costs, translation is a tightly regulated and monitored process as errors during 
protein synthesis would have devastating effects. Therefore, ribosomes not only 
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interact with mRNAs or tRNAs but also with many different protein factors like 
elongation factors or rescuing factors, which ensure fast and accurate translation. The 
order, in which ribosomes interact with these different factors is dictated by the four 
steps of translation. These steps are: (i) Initiation, (ii) Elongation, which can be further 
subdivided into Decoding, Peptide bond formation and Translocation, (iii) Termination 
as well as (iv) Recycling (Figure 2). It is worth noting that the last step, recycling, and 
the first step, initiation, are connected, as the dissociation of both subunits from each 
other allows them to participate in another round of initiation. Hence, translation should 
be imagined as a circular process and the order of events is often described as the 
translation cycle. Each single step and the corresponding sub-steps will be described 
in more detail in the following sections. 
 
1.3.1 Initiation 
 
Initiation of translation in bacteria starts either during transcription of mRNA or primarily 
on full length transcripts (Passalacqua et al., 2009). It involves the formation of the 30S 
preinitiation complex (30PIC) (i), during which the mRNA, the initiator-tRNA and the 
initiation factors (IF) 1, 2 and 3 bind to the small subunit. After establishing a correct 
interaction between the anticodon of the initiator-tRNA and the start codon on the 
mRNA, the 30PIC gets converted to a functional 30S initiation complex (30SIC) (ii), 
capable of recruiting the 50S subunit. The newly formed 70S initiation complex (70SIC) 
(iii) allows peptide bond formation between the initiator-tRNA and the incoming tRNA 
in the A-site. Although having a limited set of factors involved, initiation is a slow 
process. The assembly of ribosomes on the mRNA can last for several seconds, 
whereas elongation repeats itself 20 times per second (Fluitt et al., 2007; Young and 
Bremer, 1976). Therefore initiation is the rate-limiting step of translation (Gualerzi and 
Pon, 1990; Laursen et al., 2005). 
Formation of the 30PIC. After dissociation of the two subunits during recycling, IF3 
binds the 30S subunit either before or after release of the mRNA and tRNA (Milón et 
al., 2012). IF3 binds at the platform of the small subunit and adopts an open 
conformation (Carter et al., 2001; Milón et al., 2012). The N-terminal domain (NTD) is 
located close to the binding site of the initiator-tRNA, whereas the C-terminal domain 
(CTD) interacts with loop 790 (h24) (Figure 3A) (Hussain et al., 2016; Milón et al., 
2012). Binding of IF3 prevents re-association of the 50S subunit before binding of the 
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remaining IFs, mRNA and initiator-tRNA (Dallas and Noller, 2001; Karimi et al., 1999). 
Subsequently, IF2 binds and forms a short-lived complex together with IF3 and the 
SSU, which becomes stabilized by the binding of IF1. IF2 consists of three major parts, 
namely the N-terminal region, the central “G-domain” and the C-terminal part. On the 
30S subunit the NTD of IF2 contacts IF1 and S12 and is thought to be in charge for 
the binding of IF2 to the small subunit (Julián et al., 2011; Moreno et al., 1998, 1999). 
The C-terminal part of IF2 is responsible for the interaction with the 3’ end of the 
initiator-tRNA as well as with its fMet moiety (Figure 3A) (Caban et al., 2017; 
Guenneugues et al., 2000; Hussain et al., 2016). The GTP-binding domain or G-
domain contains the structural elements for binding and hydrolysis of GTP (Gualerzi 
et al., 1991; Wienk et al., 2012). IF1 is a small protein that binds to the ribosomal A-
site in vicinity to h44 and the 530 loop and stabilizes IF2 and IF3 on the small subunit 
(Figure 3A) (Hussain et al., 2016). After the initial binding of the IFs on the 30S, IF1 
and 3 synergistically induce conformational changes within the small subunit, 
reminiscent of the conformation of a rotated ribosome (Figure 3B) (Julián et al., 2011; 
Simonetti et al., 2008). 30S bound IF2 is responsible for recruiting the initiator-tRNA, 
which is a tRNA different from the bulk of elongating tRNAs. The initiator-tRNA is 
aminoacylated with methionine, whose αNH2-group gets formylated by formyl-methyl-
transferase (FMT). The modification of the αNH2-group leads to a specificity for the 
initiator-tRNA towards IF2 and discrimination against EF-Tu (Antoun et al., 2006; 
Boelens and Gualerzi, 2002).  
Recruitment of the mRNA. Binding of the mRNA to the 30S subunit can happen any 
time during 30PIC formation and is therefore independent of the composition of the 
complex (Milón et al., 2012; Studer and Joseph, 2006). The recruitment rather depends 
on inherited features of the mRNA itself, which are (i) the secondary structure of the 
translation initiation region (TIR), (ii) the ability of the TIR to interact with the ribosomal 
protein S1 and (iii) the presence of a Shine-Dalgarno sequence (SD-sequence) (Boni 
et al., 1991; Shine and Dalgarno, 1974; Skorski et al., 2006; Sørensen et al., 1998; 
Studer and Joseph, 2006).  
The docking site or “entrance” of the mRNA is located around the platform of 
the 30S (h26, h28, h40) and is made up of several positively charged ribosomal 
proteins, that are able to interact with differently folded mRNAs (Figure 3C) (Allen et 
al., 2005; Jenner et al., 2005; Kaminishi et al., 2007; Marzi et al., 2007). It was shown 
that weak secondary structures favor translation initiation, however also highly 
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structured mRNAs are able to be recruited to the docking site (Allert et al., 2010; Kudla 
et al., 2009; Nakamoto, 2006). This suggests, although all mRNAs have the same 
docking site, that the strength of folding influences the details of recruitment (Milón and 
Rodnina, 2012). Recruitment of the mRNA to the 30S subunit is further facilitated by 
A/U rich sequences and SD-sequence upstream of the start codon. A/U rich 
sequences are recognized by the ribosomal protein S1, which interacts with the mRNA 
upstream of the SD sequence and thereby facilitates docking and unfolding of the 
mRNA (Demo et al., 2017a; Komarova et al., 2002; Marzi et al., 2007; Sengupta et al., 
2001). The SD sequence can be found around seven to ten bases upstream of the 
start codon and has the consensus sequence AGGAGG. It assists placing the start 
codon of the mRNA into the P-site of the ribosome by forming interactions with the 
anti-SD sequence, located at the interface of the ribosomal head and back of the 
platform, where it base pairs with the 3’-end of the 16S rRNA (Figure 3C,D) (Jacob et 
al., 1987; Kaminishi et al., 2007; Ma et al., 2002; Skorski et al., 2006; Yusupova et al., 
2006). 
It is noteworthy that not all mRNAs contain all the above-mentioned features. In 
this context, there are three different kind of mRNAs, namely one that have a SD-
sequence upstream of the start codon (SD-led mRNAs), one that do not have a SD-
sequence upstream of the start codon and ,dependent on the bacterial species, also 
leaderless mRNAs that directly start with AUG. The abundance of these types can 
change significantly (Chang et al., 2006; Ma et al., 2002; Scharff et al., 2011a). SD-led 
mRNAs are the most favorable mRNAs for translation, as they inherit every feature 
needed for fast initiation. On the other hand non SD-led mRNAs do not contain a SD-
sequence in proximity to the start codon. It remains elusive how ribosomes, 
programmed with these mRNAs, are able to faithfully position the start codon at the P-
site, despite forming a stable complex with the 30S subunit (Milon et al., 2008; Scharff 
et al., 2011a). Last but not least, leaderless mRNAs lack the 5’-end upstream of start 
codon. It was shown that they mainly associate with 70S rather than 30S (Grill et al., 
2000). Moreover they do not require the interaction of S1 and other proteins that form 
the initial docking site of the mRNA (Kaberdina et al., 2009; Moll et al., 2002). 
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Figure 3. Main events during formation of the 70S initiation complex. (A)  Cryo-EM 
reconstruction of the 30PIC containing IF1 (purple), IF2 (blue), IF3 (NTD, orange; CTD, 
brick red), mRNA (pink), init iator-tRNA (green) (adapted from (Hussain et al., 2016)). (B) 
Cryo-EM reconstruction of a 30S subunit in complex with mRNA in the absence of tRNA 
and IFs (red mesh) or presence of tRNA and IFs (30SIC, semitransparent yellow). 
Indicated is the clockwise rotation of the 30S head towards the platform. The inset shows 
the positions of protein S13 indicating a shift of 10 Å during rotation (adapted from (Julián 
et al., 2011)). (C) View on the SD helix (SD-sequence, yellow; aSD-sequence, blue) on 
the 30S with the surrounding proteins (purple) and helices (blue) indicated (adapted from 
(Kaminishi et al., 2007)). (D) Model for the accommodation of the start codon AUG in the 
ribosomal P-site in cooperation with IFs (IF1, green; IF2, blue; IF3, yellow) and SD helix 
(SD-sequence, orange; aSD-sequence, blue) (adapted from (Kaminishi et al., 2007)).(E) 
Comparison of several tRNA posit ions from a 70S post- initiation complex and the P/I 
(red) state that forms during the formation of the 30SIC adapted from (Julián et al., 
2011)). (F) Posit ions of IF2 during several states of translation init iation (IF2 .GTP 30SIC, 
green; IF2 .GDPNP 70SIC, yellow; IF2 .GDP 70SIC; red) (adapted from (Simonetti et al., 
2008)). 
 
Formation of the 30SIC. The main event during transition to the 30SIC is the formation 
of an interaction between the anticodon of the initiator-tRNA and the start codon of the 
mRNA. It requires the correct positioning of a start codon into the ribosomal P-site. 
This process is facilitated by the formation of a SD-aSD pairing, but does not 
necessarily rely on this interaction, as non-SD led mRNA and leaderless mRNA are 
still able to initiate translation (Calogero et al., 1988; Van Etten and Janssen, 1998; 
Milon et al., 2008; Scharff et al., 2011b). Presumably, the SD helix helps to increase 
the concentration of start codon triplets near the P-site, whereas its recognition is 
achieved kinetically by IFs (Figure 3D) (Calogero et al., 1988; Canonaco et al., 1989; 
Kaminishi et al., 2007). In bacteria, all start codon triplets share a U at the second 
position. AUG, GUG and UUG are the most common one with AUG being the most 
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favored (Sussman et al., 1996). Recruitment of the correct tRNA to the ribosomal P-
site is mediated by the CTD of IF2, that specifically recognizes the blocked αNH2-group 
as well as by IF1 and IF3, which dissociate incorrect tRNAs from the ribosome (Antoun 
et al., 2006; Caban et al., 2017; Hartz et al., 1989; Hussain et al., 2016; Wintermeyer 
and Gualerzi, 1983). Recognition of the correct start codon and tRNA allows placement 
of the initiator-tRNA in its P/I state (peptidyl/initiation state) by forming contacts 
between the ASL and stop codon (Figure 3E) (Allen et al., 2005; Julián et al., 2011; 
Simonetti et al., 2008; Sprink et al., 2016). Thereby, the 30S·IF1·IF2·initiator-tRNA 
complex gets further stabilized, whereas IF3 gets destabilized (Milón and Rodnina, 
2012; Milon et al., 2008). IF3 interferes with the binding of the 50S subunit as it 
occupies a space important for the formation of an intersubunit bridge. Thereby, 
destabilization of IF3 might work as the trigger for 50S association (Antoun et al., 2006; 
Dallas and Noller, 2001; Julián et al., 2011; Milon et al., 2008). 
Formation of the 70SIC. The large subunits binds the 30S in its rotated state with all 
IFs and the initiator-tRNA attached to it (Allen et al., 2005; Milon et al., 2008). First of 
all, IF3 dissociates from the complex before GTP hydrolysis (Goyal et al., 2015). Next, 
IF2 interacts with the Sarcin-Ricin loop (SRL) inducing the hydrolysis of GTP bound to 
IF2, causing several structural rearrangements (Figure 3F) (Qin et al., 2009; La Teana 
et al., 2001). As a first step, IF2 undergoes a conformational change that loosens its 
contacts with both subunit as well as with the initiator-tRNA (Goyal et al., 2015; 
Myasnikov et al., 2005). Secondly, IF1 leaves the complex (Milon et al., 2008). 
Subsequently, the transition of the 30S from a rotated-state to an unrotated-state 
occurs and thereby the initiator-tRNA get rearranged in its P/P position (Julián et al., 
2011; Marshall et al., 2009; Myasnikov et al., 2005; Sprink et al., 2016). Lastly, IF2 
leaves the ribosome committing the 70SIC for elongation (Marshall et al., 2009; 
Myasnikov et al., 2005). 
 
1.3.2 Elongation 
 
During elongation, the ribosome has to translate the genetic code into amino acid 
sequences. It starts with the dissociation of IF2 from the 70SIC, leaving an empty A-
site behind. The vacant A-site is recognized by a so called ternary complex, which 
consists of elongation factor thermo unstable (EF-Tu), an aminoacyl-tRNA (aa-tRNA) 
and guanosine-5’-triphosphate (GTP).  
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Based on the complementarity between the anticodon of the tRNA and the 
codon of the mRNA, the ternary complex gets either rejected or is allowed to 
accommodate in the ribosomal A-site (decoding). Once the correct tRNA is selected, 
the ribosome transfers the growing peptide chain to the aa-tRNA in the A-site and 
thereby elongates the nascent chain by one additional amino acid (peptide bond 
formation). Subsequently, EF-G binds to the ribosome and translocates the mRNA in 
3’direction by one codon, causing the now deacylated tRNA to move to the E site and 
the A-site tRNA to the P-site, respectively (translocation). Hence, the A-site is vacant, 
allowing the next ternary complex to enter. The three main steps of elongation continue 
until the ribosome encounters a stop codon at the A-site, marking the end of elongation 
and initiating termination. In the next following sections these three steps of elongation 
will be described in more detail. 
Decoding. Throughout elongation the ribosome discriminates between correct and 
incorrect ternary complexes, dictated by the mRNA codon in the ribosomal A-site. 
These ternary complexes contain EF-Tu, GTP and one of 50 different aa-tRNAs 
matching one or more of the 61 canonical codons on the mRNA (Rodnina and 
Wintermeyer, 2001). The basis for the discrimination is the base-complementarity of 
the anticodon stem loop (ASL) of the tRNA and the codon on the mRNA. Taking the 
“wobble hypothesis” into consideration which states that the first two positions of the 
codon create the coding specificity (explanation follows later), three possibilities arise 
to describe the complementarity between the mRNA and the tRNA (Crick, 1966). A 
tRNA can be either cognate (no mismatch between the first and second position), near-
cognate (one mismatch between the first and second position) or non-cognate (no 
match between the first and second position) (Ogle et al., 2001; Plant et al., 2007). 
However, studies showed that base pairing alone is not sufficient to account for the 
average misincorporation rate of 3x10-3 (Eisinger et al., 1971; Loftfield, 1963; 
McLaughlin et al., 1966; Sugimoto et al., 1986). Moreover, antibiotics as well as 
mutations affecting the ribosome can induce miscoding, demonstrating that the 
ribosome augments to the obtained fidelity rates (Brink et al., 1994; Moazed and Noller, 
1987; O’Connor et al., 1997; Rodnina et al., 2000).  
The kinetic proofreading model describes a two-step mechanism during 
accommodation of the A-site tRNA, in which the ribosome discriminates between 
cognate and near-cognate tRNAs (Rodnina et al., 1994, 1995). Under physiological 
conditions it was shown that non-cognate tRNAs are not accepted by the ribosome 
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and therefore are excluded from the discussions in the following section (Pape et al., 
1999). 
Initial selection begins with binding of the ternary complex to the A-site in a 
codon-independent manner, followed by codon recognition. Dependent on the 
complementarity of the anticodon/codon helix, the ternary complex gets either rejected 
or undergoes a conformational change triggering EF-Tu bound GTP hydrolysis 
(Voorhees et al., 2010). EF-Tu rearranges in the GDP-bound conformation and 
dissociates from the tRNA (Liu et al., 2015; Pape et al., 1998, 1999; Rodnina et al., 
1996). Release of EF-Tu from the ternary complex marks the second proofreading 
step. Dependent on the nature of the anticodon-codon helix the tRNA is rejected or 
accommodates within the ribosomal A-site followed by instantaneous peptide bond 
formation (Pape et al., 1999).  
First molecular details on how decoding works are based on X-ray structures of 
isolated 30S subunit crystals programmed with either cognate or near-cognate ASLs 
(Ogle et al., 2001, 2002). Binding of the ASL to the mRNA results in a double helical 
structure (anticodon-codon helix). This induces universally conserved nucleotides 
A1492 and A1493 to flip out of the internal loop of helix 44 and interact with the minor 
groove of the anticodon-codon helix reminiscent of A-minor motifs (Ogle et al., 2001, 
2002). These motifs consist of consecutive adenines that insert into the minor groove 
of RNA helices and thus contribute to their stability (Lescoute and Westhof, 2006).  
Additionally, G530 switches from the syn conformation to the anti conformation. 
The structural rearrangements allow A1493 to interact with the first base pair, whereas 
1492 acts together with G530 to monitor the second position. Interactions with the third 
position is less stringent as it involves fewer hydrogen bonds providing a structural 
explanation for the wobble hypothesis (Figure 4A-C, upper panel) (Crick, 1966; Ogle 
et al., 2001, 2002). The energy derived from a cognate interaction prevents the tRNA 
to dissociate from the ribosome and induces domain closure, a movement of the head 
towards the shoulder of the 30S, triggering hydrolysis of EF-Tu bound GTP (Ogle et 
al., 2001, 2002). However, a near-cognate interaction leads to a disturbed geometry 
within the anticodon/codon helix, disrupting important hydrogen bonds between 
A1492, A1493, G530 and the ASL/codon interaction and displacing them from each 
other (Ogle et al., 2001). The resulting energy penalty leads to the dissociation of the 
near-cognate tRNA and prevents domain closure (Ogle et al., 2001, 2002).  
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X-ray analysis of 70S ribosomes programmed with cognate or near-cognate tRNAs 
and longer mRNAs further refined the understanding of the decoding process 
(Demeshkina et al., 2012; Rozov et al., 2015). In complex with 70S ribosomes near-
cognate anticodon/codon helices adopt base pairs reminiscent of canonical Watson-
Crick pairs (Figure 4A-C). Moreover, nucleotides G530, A1492 and A1493 seem to 
adopt the same conformation relative to the anticodon/codon helix as in the case of a 
cognate interaction (Figure 4D) (Demeshkina et al., 2012).  
A possible explanation for the differences in those structures can be attributed 
to the set up used for the 30S subunit crystal. The 30S crystals were soaked with a 
hexanucleotide RNA (U6) mimicking mRNA. Moreover, the P-site codon was occupied 
by the 3’ end of the 16S rRNA, forcing the U6 mRNA to the A-site, resulting in a 
discontinuous mRNA. This creates an artificial situation as the P/A kink cannot form, 
which is an interaction between the P-tRNA, the 16S rRNA, a metal ion and the mRNA 
kink. As a result the mRNA is less stabilized. Furthermore, density for the near-cognate 
ASL was only observed in the presence of paromomycin, an antibiotic that induces the 
“out” position of A1492 and A1493 (Ogle et al., 2001, 2002; Rozov et al., 2016a). Thus, 
there is a general flexibility within the A-site of the 30S structures that allows wobble 
base pairing (Rozov et al., 2016a). 
 
Figure 4. Codon-anticodon interactions inside the decoding centre. (A-C) Codon-
anticodon (mRNA, yellow; tRNA, red) interactions at the f irst (A), second (B) and third 
(C) posit ion for cognate as well as near-cognate tRNAs. (D) Superimposition of residues 
G530, A1492 and A1493 relative to the codon/anticodon helix comparing the cognate 
(cyan) with the near cognate structure (blue). (E) Superimposition of the 16S rRNA 
comparing the cognate (blue) with the near-cognate structure (purple) shows identical 
domain closure in both cases (adapted from (Demeshkina et al., 2012)). 
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Based on these observations, decoding errors derive from mismatched 
anticodon-codon helices that mimic a Watson-Crick shape. The energy costs of 
mimicking a Watson-Crick like geometry requires a keto-enol tautomerization, pushing 
the equilibrium towards dissociation of the near–cognate ternary complex 
(Demeshkina et al., 2012; Rozov et al., 2015, 2016a, 2016b). This is also a bona fide 
explanation why non-cognate tRNAs never surpass the initial selection checkpoint as 
the energy penalty would be even higher (Rozov et al., 2015, 2016b).  
Recognition of the codon is followed by domain closure, which is identical for 
cognate and near-cognate interactions mimicking Watson-Crick geometry (Figure 4E) 
(Demeshkina et al., 2012; Loveland et al., 2017). Recent cryo-EM structures explain 
the necessity of the Watson-Crick geometry for domain closure. Near-cognate 
interaction with a G U base pair fail to stabilize G530 to an extend that is favorable for 
domain closure and thereby keeps the ribosome in an open conformation (Loveland et 
al., 2017).  
During domain closure, the ternary complexes gets pushed towards the sarcin 
ricin loop (SRL) of the 50S. This allows the catalytic important His84 of EF-Tu to 
interact with A2662 of the SRL, hydrolyzing GTP by coordinating a water molecule for 
nucleophilic attack on the γ-phosphate of GTP (Loveland et al., 2017; Voorhees et al., 
2010). Hydrolysis and release of the inorganic phosphate induces conformational 
changes within EF-Tu and its release from the ribosome. Following the release of EF-
Tu, the aa-tRNA shifts from its EF-Tu bound state (A/T state) to the A/A state, a 
movement that includes the accommodation of the aminoacyl end of the tRNA into the 
PTC (Blanchard et al., 2004; Nissen et al., 2000; Schmeing et al., 2009; Voorhees et 
al., 2010). It was recently shown that the conversion from the A/T state to the A/A state 
can be inhibited by the orthosomycins evernimicin and avilamycin (Arenz et al., 2016). 
Both antibiotics interact with H89 and H91 of the 23S rRNA as well with L16. This 
binding site overlaps with the elbow region of fully accommodated A-site tRNA but not 
A/T tRNA  
tRNA accommodation is fast for cognate tRNAs, but slow for near-cognate 
tRNAs therefore providing an evidence for the second proofreading step during tRNA 
selection (Pape et al., 1998, 1999). Structural insights that explain the different 
accommodation rates are lacking, however misalignment of the anticodon-codon helix 
as well as sterical restrains imposed by the ribosome are likely (Fischer et al., 2016; 
Rodnina and Wintermeyer, 2001).  
Introduction 
23 
 
Peptide bond formation. Formation of a peptide bond between the aa-tRNA and 
peptidyl-tRNA is the main chemical reaction during protein synthesis. It involves the 
aminolysis of the ester bond that links the nascent chain to the ribose of the P-site 
tRNA and transfer of the chain on to the A-site tRNA adding an additional residue 
(Satterthwait and Jencks, 1974). This happens in a stepwise manner. After the 
accommodation of the aa-tRNA, a nucleophilic attack of the α-amine of the aa-tRNA 
on to the carbonyl carbon of the peptidyl-tRNA occurs. This leads to the formation of a 
transition state, the rate-limiting step of peptide bond formation (Hiller et al., 2011; 
Satterthwait and Jencks, 1974). In comparison, the transition state decomposes fast 
on the ribosome while it accumulates in solution. Hence, the ribosome catalyses this 
reaction by 105-107 fold faster compared to reactions in solution, highlighting the 
significance of the translation apparatus (Sievers et al., 2004).Fast breakdown of the 
transition state results in a deacylated tRNA in the P-site and a peptidyl-tRNA in the A-
site (Hiller et al., 2011). 
Structural as well as biochemical studies point out that the reaction on the 
ribosome is RNA-driven (Ban et al., 2000; Maden and Monro, 1968; Nissen et al., 2000; 
Schmeing et al., 2005a; Wohlgemuth et al., 2006). Hence it is not surprising that the 
peptidyl transferase center (PTC), the catalytical center of peptide bond formation, is 
comprised of a cluster of universally conserved rRNA nucleotides located within the 
central loop of domain V of the 23S rRNA (Ban et al., 2000; Nissen et al., 2000). These 
residues form a tight cavity that serves as a platform for the accommodation of the 
CCA-ends of the A and P-site tRNAs bringing them in close contact and shielding them 
from the close surrounding. This is in line with experiments showing that the 50S 
subunit alone is capable of peptide bond formation (Maden and Monro, 1968; Okuda 
et al., 2005; Schmeing et al., 2002; Seila et al., 2005; Wohlgemuth et al., 2006). 
Crystal structures of Haloarcula marismortui 50S subunits provided a first 
detailed picture. In the absence of A-site tRNA the PTC adopts the uninduced state. 
C74 and C75 of the P-site tRNA form Watson Crick base pairing with G2251 and 
G2252 holding the acceptor end in place. A76 is stacking on to A2451 and is in 
hydrogen bond distant to A2450 (Kim and Green, 1999; Nissen et al., 2000; Polikanov 
et al., 2014; Voorhees et al., 2009a). Nucleotides C2063, A2451 and U2585 form a 
pocket around the ester group of the peptidyl-tRNA to sterically exclude water that 
would otherwise hydrolyze the ester bond (Schmeing et al., 2005a, 2005b). G2583 
forms a G U wobble pair together with U2506 blocking the A-site pocket. Binding of the 
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A-site tRNA causes an induced fit that is a conformational change in the PTC (referred 
as the induced state). A-tRNA nucleotides C74 stacks with U2555, C75 base pairs with 
G2253 and A76 forms an A-minor motif with G2583 (Figure 5A) (Kim and Green, 1999; 
Nissen et al., 2001; Schmeing et al., 2005a, 2005b). The latter interaction leads to 
disruption of the G2583-U2506 wobble base pair, shifting U2506 away from the A-site 
pocket. Hence, the CCA end gets stabilized leading to positioning of the amino acid 
moiety that allows formation of hydrogen bonds with the N3 and 2’-OH of A2451 as 
well as the 2’OH of A76. Accompanied by the A-tRNA accommodation is a shift of 
A2602 and U2585 exposing the peptidyl-tRNA ester for a nucleophilic attack 
(Schmeing et al., 2005a, 2005b). Thus, the PTC mainly functions as an entropic trap 
leading to a significant reduction of the reaction entropy (Schmeing et al., 2005a, 
2005b; Sievers et al., 2004). 
Most enzymes contribute to chemical reactions in two ways. The first 
contribution is to arrange the substrates in close proximity, allowing them to react. The 
second step involves the functional groups of the enzyme that influence the chemistry 
of the reaction. The contribution of both steps can differ significantly from one enzyme 
to the other. An important question is whether the peptidyl-transfer reaction is solely 
dependent on substrate alignment or if functional groups within the PTC exist that 
influence the chemical reactivity (Polacek and Mankin, 2005). Biochemical 
experiments as well as the crystal structures of H. marismortui 50S suggested a 
general acid/base mechanism involving the N3 of A2451. However, mutations of this 
adenine as well as neighboring nucleotides did not lead to a significant reduction in 
peptide bond formation (Hansen et al., 2002b; Muth et al., 2000; Nissen et al., 2001; 
Polacek et al., 2001; Thompson et al., 2001). Furthermore, using full length tRNA 
substrates for kinetic experiments, showed no pH-dependency for peptide bond 
formation (Beringer et al., 2005; Youngman et al., 2004). 
Therefore, a substrate assisted mechanism was proposed with the 2’OH group 
of A76 of the P-site tRNA being the main candidate (Dorner et al., 2003; Erlacher et 
al., 2006; Weinger et al., 2004). The α -amino group of the aa-tRNA forms an extensive 
network of hydrogen bonds with the N3 of A2451 and the 2’OH group of A76 
(Schmeing et al., 2005a, 2005b). As it was demonstrated that the former is neglectable, 
a substrate assisted mechanism was suggested, in which a proton is transferred from 
the nucleophile to the 2’OH group to the 3’OH group of A76 (Dorner et al., 2003; 
Schmeing et al., 2005a, 2005b). Indeed, deletion of the 2’OH of the A76 showed at 
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least a decrease of activity by 100-fold (Aqvist et al., 2012; Huang and Sprinzl, 2011; 
Weinger et al., 2004; Zaher et al., 2011). Hence, a proton shuttling mechanism was 
proposed, either as a six or eight membered mechanism, in which two or three protons 
together with a water molecule coordinate the attack of the nucleophile in a fully 
concerted manner. (Hiller et al., 2011; Kuhlenkoetter et al., 2011; Schmeing et al., 
2005b; Wallin and Aqvist, 2010). 
Recent high resolution structures of pre-attack and post-catalysis states 70S 
ribosomes of Thermus thermophilus provided further molecular details (Polikanov et 
al., 2014; Voorhees et al., 2009a). Owing to the higher resolution the position of three 
water molecules (W1-3) inside the PTC could be identified. These water molecules are 
coordinated by A2451, U2584, C2063 and A2602, the N-terminal part of L27 as well 
as with the A76 of both tRNAs. Based on this findings a proton wire mechanism is 
suggested in which residues of the PTC and both tRNAs obtain a catalytical role by 
activating the water molecules (Figure 5A+B) (Polikanov et al., 2014). 
A tight network of hydrogen bonds between the N6 of A2602, the phosphate oxygen 
of A76 of the A-site tRNA, the 2’OH of A2451 and the N-terminus of L27 coordinates 
W1 to the attacking amine and shields W1 from exchange with the bulk solvent (pre-
attack). This guarantees a geometry that allows the concerted attack by the α-amine 
of the aa-tRNA onto the carbonyl-carbon of the peptidyl-tRNA via transfer of the proton 
from the nucleophile via A76 2’OH of the P-site tRNA to the A2451 2’OH to W1 (Hiller 
et al., 2011; Kingery et al., 2008; Polikanov et al., 2014). This results in the tetrahedral 
intermediate state, which is stabilized by the donation of a proton to the negatively 
charged ester carbonyl carbon by W2. The ribosome facilitates the fast break down of 
this state to prevent premature termination by hydrolysis (Hiller et al., 2011; Polikanov 
et al., 2014; Satterthwait and Jencks, 1974). On the basis of the 70S structure a 
transfer of a proton from the positively charged W1 to W3 to form a H30+ ion is 
suggested, that catalyzes the hydrolysis of the intermediate state into their respective 
products (Polikanov et al., 2014). Thus the ribosome provides a prearranged proton-
transfer network that contributes to the reaction besides being an entropic trap (Figure 
5D) (Polikanov et al., 2014; Sievers et al., 2004). 
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Figure 5. Conformation of residues involved in the proton wire of the PTC. (A) 
Interactions between the CCA end of A-site tRNA (green) with residues of the A-loop of 
the 23S rRNA (blue) (from (Voorhees et al., 2009b)). (B+C)  Coordination of water 
molecules in the PTC involving the A-site tRNA acceptor stem (pink), residues of the 23S 
rRNA (yellow), L27 (cyan) and P-site tRNA (green). Possible hydrogen bonds are 
indicated as dashed lines. (D) Model for proton wire mechanism in presence of three 
trapped water molecules (yellow) inside the PTC. Adapted from (Polikanov et al., 2014) 
 
Another question raised from that study is the contribution of L27 in peptide 
bond formation. L27 represents the closest ribosomal protein to the PTC. From crystal 
and cryo-EM structures it was shown that, upon accommodation of the A-site, the last 
three N-terminal residues protrude into the PTC, which is not the case for complexes 
that are not committed for peptide bond formation (Huter et al., 2017a; Polikanov et al., 
2014; Voorhees et al., 2009a). Thus, L27 stabilizes residues of the 23S rRNA and both 
tRNAs upon accommodation of the A-site tRNA (Polikanov et al., 2014; Voorhees et 
al., 2009a; Wang and Xiao, 2012; Wang et al., 2014). Additionally it is suggested to 
coordinate the W1 molecule and together with the A-tRNA A76 and the 5 ’phosphate 
oxygen of A2451, is the source responsible for the deprotonation of the α-amine 
(Polikanov et al., 2014). In contrast to structural studies, biochemical studies show a 
contradicting picture. Whereas some groups reported that ribosome lacking L27 
showed no defect in peptide bond formation, another group demonstrated that deletion 
of the three N-terminal residues leads to a decreased rate of translation (Maguire et 
al., 2005; Maracci et al., 2015). Further biochemical and kinetic experiments are 
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needed to further address the contribution of L27. However, it is not entirely incorrect 
to assume that L27 facilitates the peptidyl-transfer activity. 
Translocation. Following peptide bond formation the ribosome is occupied with a 
deacylated tRNA in the P-site and a peptidyl-tRNA in the A-site (PRE-state). In order 
to allow translation to continue, the ribosome has to translocate the bound tRNAs 
together with their associated mRNA codons from the P- to the E-site and A- to the P-
site, respectively. As a result, the ribosome provides a vacant A-site programmed with 
the next codon of the mRNA (POST-state).  
Translocation happens in a stepwise manner, with the acceptor ends of tRNAs 
moving first with respect to the 50S subunit (A/P, P/E) followed by a movement of the 
tRNA with respect to the 30S subunit (P/P, E/E) (Blanchard et al., 2004). The driving 
force behind translocation are large conformational changes of the SSU that 
coordinate the movement of mRNA and tRNAs to their respective place (Frank and 
Agrawal, 2000). The ribosome possesses the capability to perform this movements on 
its own. However, in the absence of factors, this process is bidirectional, meaning the 
ribosome translocates backward and forward (Konevega et al., 2007; Shoji et al., 
2006). It requires the assistance of EF-G and GTP that drives translocation into a 
unidirectional process by acting like a pawl and therefore preventing backtranslocation 
(Konevega et al., 2007; Liu et al., 2014; Shoji et al., 2006). 
Researchers in recent years revealed the underlying mechanisms and could dissect 
the events of translocation in a sequential order. Following peptide bond formation the 
CCA ends of the tRNAs spontaneously move from the P- to the E site and A- to the P-
site on the 50S (A/P and P/E hybrid states) (Figure 6D) (Fu et al., 2011; Munro et al., 
2007). The driving force for these movements is the deacylated state of the P-site 
tRNA, as the E-site tRNA sterically occludes the accommodation of a peptidyl-tRNA 
(Rheinberger and Nierhaus, 1983; Schmeing et al., 2003). This, on the other hand, 
results in a vacant 50S P-site, which has a strong affinity for peptidyl-tRNAs 
(Semenkov et al., 1992; Sharma et al., 2004).  
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Figure 6. Structural rearrangements of the ribosome and EF-G during translocation. 
(A) Structural comparison between a non-rotated classical state (PDB 4V9D) and a 
rotated, hybrid state (PDB 4V7C) r ibosome reveals a CCW rotation of the SSU (green) 
relative to the LSU (grey). (B)  Conformation of the L1 stalk shown in the open (magenta), 
semi-closed (blue) and closed (blue) posit ion. (C) Comparison of a non-rotated with a 
partially rotated ribosome depicting the CCW swiveling of the head. (D-F) Progressive 
movement of domain IV of EF-G (blue) from a rotated-hybrid state (PDB 4V7D) to a 
partially rotated state (PDB 4W29) to a non-rotated posttranslocation state (PDB 4V5F) 
and their corresponding states of the deacylated (orange) and peptidyl (yellow) tRNA are 
depicted. Adapted from (Ling and Ermolenko, 2016). 
 
Coupled to the movement of the acceptor stem of the deacylated tRNA on the 
50S is a counterclockwise (CCW) rotation of the platform and body domains of the 
SSU relative to the LSU (~3-10°), often referred to as ‘ratcheting’ (Figure 6A) 
(Agirrezabala et al., 2008; Dunkle et al., 2011; Ermolenko et al., 2007a; Julián et al., 
2008). In the absence of EF-G, kinetic studies observed a back and forth fluctuation 
between the classic non-rotated state and the rotated-hybrid state. Interestingly, EF-G 
can bind both states (Blanchard et al., 2004; Cornish et al., 2008; Munro et al., 2007). 
The binding of EF-G, however, accelerates the formation of the rotated-hybrid state, 
driving the reaction towards the formation of the POST-complex (P/P, E/E) (Belardinelli 
et al., 2016; Chen et al., 2011).  
Rotation of the small subunit moves domain 1 of EF-G in close proximity to the 
SRL. Domain 1 is structurally similar to other translational GTPases (traGTPase), 
comprising the important G subdomain required for the hydrolysis of GTP (Maracci and 
Rodnina, 2016). Hence, the close proximity to the SRL triggers GTP hydrolysis and 
thereby the release of inorganic phosphate (Belitsina et al., 1975; Koch et al., 2015; 
Moazed et al., 1988; Rodnina et al., 1997). Akin for EF-Tu during decoding, the energy 
released by hydrolysis does not have an influence on translocation per se, but is stored 
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to dissociate EF-G after translocation. This is exemplified by the fact, that in presence 
of non-hydrolysable GTP analogues a single round of translocation can occur (Pan et 
al., 2007; Rodnina et al., 1997). 
Binding of EF-G triggers an additional independent movement of the 30S 
termed the head swivel (Guo and Noller, 2012). During head swiveling, the head of the 
30S subunits rotates CCW towards the platform (Figure 6C). Thereby it frees the path 
for the movement of tRNAs on the 30S subunit, which is usually blocked by the head 
domain (Dunkle et al., 2011). Translocation of the mRNA is passive and dependent on 
the movement of A- and P-tRNAs (Joseph and Noller, 1998). This is exemplified by 
the fact that tRNA can translocate in the absence of mRNA (Belitsina et al., 1981). 
However, translocation of mRNA cannot be observed in the presence of only a 
deacylated tRNA in the P-site (Joseph and Noller, 1998). 
Simultaneously with the CCW movement of the head, the body and platform 
start to inverse their movement in a CW direction (Guo and Noller, 2012; Ratje et al., 
2010). The exact time point of this reverse rotation is not known. Cryo-EM and 
crystallographic studies were able to capture an intermediate state, with body-platform 
being backrotated to 3.5°, while the head swivel reaches is maximum rotation. The 
tRNA in the complex are configured in an ap/P and pe/E state (Figure 6F). These 
states are characterized by accommodated acceptor stems in the 50S as well ASL in 
on the 30S in their respective tRNA binding sites. However, on the 30S some tRNA 
elements still interact with residues of the A- and P-sites on the 30S head domain 
(Ratje et al., 2010; Zhou et al., 2013, 2014). This might represent a late stage 
intermediate showing that reverse rotation of the 30S body and platform is initiated 
before head swiveling reaches its maximum. Followed by positioning of the ASL and 
mRNA in the 30S is a back swivel of the head and further reverse rotation of the 30S 
body and platform transforming the ribosome in its classic non-rotated state with a 
vacant A-site (POST-state; P/P, E/E) (Guo and Noller, 2012). 
Coupled to the movements of the small subunit and tRNAs is the conformation 
of the L1 stalk of the LSU, that compromises parts of helices 76, 77 and 78 of 23S 
rRNA, as well as the L1 protein. Dependent on the rotation of body and platform, the 
L1 stalk was visualized in three different conformations. In the non-rotated classic 
state, the L1 configuration can be described as outwards or open, directed away from 
the ribosomal core (Cornish et al., 2008; Dunkle et al., 2011; Fei et al., 2009). In the 
rotated hybrid state, the L1 stalks undergoes a 45-60 Å movement interacting with the 
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elbow of P/E tRNA (Cornish et al., 2008; Dunkle et al., 2011; Fei et al., 2009). Upon 
completion of translocation the L1 is still contacting the now fully accommodated E-
tRNA, but only differs by 20 Å difference compared to the open conformation (Figure 
6B) (Cornish et al., 2008). Dissociation of the deacylated tRNA moves the L1 stalk 
back to its open position. Based on these observed conformations it is likely that the 
L1 stalk facilitates the movement of the E-site tRNA at different stages as suggested 
by Bock et al (Bock et al., 2013). 
Not only the ribosome but also EF-G undergoes conformational changes 
throughout translocation. Structural studies with EF-G in solution and bound to different 
states of translocation reveal a transition from a free conformation in solution into an 
extended conformation on the ribosome (Brilot et al., 2013; Czworkowski et al., 1994; 
Gao et al., 2009; Lin et al., 2015; Ramrath et al., 2013; Zhou et al., 2014). Notably, one 
X-ray structure observed the compacted form of EF-G on the ribosome. However, the 
observed compact form might have been the result of fusing EF-G to L9 of the 
neighboring ribosome and/or the usage of the antibiotic dityromycin trapping EF-G and 
therefore does not represent a physiological state (Lin et al., 2015).  
The extension of EF-G is driven by the progressive movement of domain IV, resulting 
in docking of this domain in the A-site of the 30S as observed in non-rotated post-
translocation complexes (Brilot et al., 2013; Gao et al., 2009; Zhou et al., 2014). 
Structures of intermediate states showed that domain IV contacts the ASL of the 
peptidyl-tRNA still bound to the 30S A-site as well as important residues of the 
decoding center (Figure 6D+E) (Brilot et al., 2013; Gao et al., 2009; Ramrath et al., 
2013; Zhou et al., 2014). These contacts might form barriers which need to be 
destabilized by EF-G for fast translocation. The fully accommodated domain IV in the 
POST-state might on the other hand, work as a barrier or pawl that prevents 
backtranslocation of the peptidyl-tRNA from the P-site to the A-site (Figure 6F) (Ling 
and Ermolenko, 2016). 
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1.3.3 Termination 
 
The presence of one of three stop codons within the A-site terminates protein synthesis 
by releasing the nascent chain from the ribosome. These three stop codons are 
encoded as UAG, UAA and UGA. In contrary to canonical codons, stop codons are 
recognized by Class I release factors that mediate the hydrolysis of the ester bond of 
the peptidyl-tRNA. Release factor 1 (RF1) thereby recognizes UAG and UAA codons, 
whereas release factor 2 (RF2) is specific for UGA and UAA. After release of the 
peptide, the class II release factor RF3 binds the ribosome and dissociates RF1/2 from 
the ribosome. 
RF1/2 share highly conserved regions and consist of four domains with domains 
2,3 and 4 of the factors overlapping with the binding site of A-site tRNA.(Zhou et al., 
2012a). For a long time, it remained elusive how these decoding factors are capable 
of discriminating between the different stop codons or if they indirectly recognize stop 
codons through interactions with the ribosome. Swapping of conserved domains 
between RF1 and RF2 revealed the presence of a crucial tripeptide motif, namely 
P(A/V)T in RF1 and SPF in RF2, located in a loop of domain 2 (Ito et al., 2000). 
Exchanging these motifs between both RFs changes the specificity towards the stop 
codon suggesting that the tripeptide motif efficiently deciphers stop codons, in an 
anticodon-like manner (Ito et al., 2000; Nakamura et al., 2000).  
Four high-resolution crystal structures of RF1/2 bound to both their respective 
stop codons explain the molecular mechanism behind deciphering stop codons (Ito et 
al., 2000; Korostelev et al., 2008, 2010; Laurberg et al., 2008). P(A/V)T/SPF motives 
are located in loops that are directed towards the decoding site, interacting with the 
stop codon. The stop codon itself adopts an unusual conformation with the first two 
bases stacking and the third base being sandwiched between G530 and residues of 
the release factors. Surprisingly, only a single amino acid in both motifs is in direct 
contact with the second position of the respective stop codon, namely the T186 for 
RF1 and the S206 for RF2 (Korostelev et al., 2008, 2010; Laurberg et al., 2008; 
Weixlbaumer et al., 2008). This is in agreement with studies from Ito et al., showing a 
prerequisite of those two aa in overexpressed RF1/2 mutants in ∆RF1 or ∆RF2 strains 
(Ito et al., 2000). The acceptance of an A and a G for RF2 might be due to the potential 
of serine to interact with A and G at this position. 
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U1 position of the stop codon is recognized by backbone elements of the 
decoding factors that interact with N3 of uridine and explains the restriction to U at this 
position (Korostelev et al., 2008, 2010; Laurberg et al., 2008; Weixlbaumer et al., 
2008). Due to the backbone interaction, mutations failed to confirm this interaction. 
However, by introducing non-canonical RNA residues at the first position, Erlacher and 
coworkers were able to show that this interactions relies on the exocyclic group of 
uridine, explaining its exclusiveness at this position (Hoernes et al., 2018). RF1 
monitors the third position via interactions of Thr194 and Q181, whereas RF2 
interactions depends on T194 (Korostelev et al., 2008, 2010; Laurberg et al., 2008; 
Weixlbaumer et al., 2008). Mutational studies show that exchange of aa adjacent to 
the tripeptides motif can change the specificity of RF1/2 (Ito et al., 1998; Korkmaz and 
Sanyal, 2017; Young et al., 2010). These findings, however, should not question the 
importance of the tripeptide motives, but rather highlight an elaborate network of 
interactions in which the P(A/V)T/SPF motif is a prerequisite (Figure 7A+B). 
Using metal ion fluorescence resonance energy transfer, Trappl et al could 
show that upon recognition of the stop codon, RF1 opens from a closed to an open 
extended conformation on the ribosome. In contrary, this induced fit does not happen 
in the presence of a sense codon (Trappl and Joseph, 2016). Structures of the isolated 
decoding factors reveal a tight packing of domain 2 and 3 against each other, whereas 
bound to the ribosome, domain 3 escapes this packing and is orientated towards the 
PTC (Korostelev et al., 2008, 2010; Laurberg et al., 2008; Shin et al., 2004; 
Vestergaard et al., 2001; Weixlbaumer et al., 2008). Opening of domain 3 requires a 
rearranged state of a switch loop within RF1/2, connecting domain 3 and 4. This 
rearranged state of the switch loop is stabilized by residues of the decoding site that 
adopt an alternative conformation upon stop codon recognition by release factors 
(Figure 7C) (Korostelev et al., 2010; Laurberg et al., 2008). Thus, recognition of the 
stop codon is coupled to the opening of release factors on the ribosome (Figure 7D). 
Sequence alignments between all kingdoms showed the abundance of a GGQ 
motif in all release factors (Frolova et al., 1999). In bacteria this motif is found within 
the tip of domain 3, placing it next to A76 of the peptidyl-tRNA upon release factor 
opening. Mutations affecting the first and second glycine abolished hydrolysis, 
whereas mutations of glutamine were tolerated, indicating a direct involvement of the 
motif for hydrolysis (Frolova et al., 1999; Shaw and Green, 2007). This came as a 
surprise as the glutamine is post-translationally methylated in vivo leading to enhanced 
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activity for peptide release (Dincbas-Renqvist et al., 2000; Heurgué-Hamard et al., 
2002). From structural analysis it came apparent that the side chain of Gln of the GGQ 
motif in RF1 is orientated away from A76 and the catalytic center. The backbone NH, 
however, is in hydrogen bonding distance to the 3’OH of A76. Mutation of Gln to Pro 
in RF1 eliminates the NH backbone interaction and thereby abolishes the activity of 
RF1 (Figure 7E) (Santos et al., 2013; Shaw and Green, 2007). Recent structures, that 
used release factors carrying the methylated glutamine, showed a tighter packing of 
the glutamine against its neighboring residues and thereby additionally stabilizing the 
backbone of the glutamine (Pierson et al., 2016; Zeng and Jin, 2016). The two glycines, 
on the other hand, are not directly involved in catalysis but are important for the 
conformation and integrity of the loop (Laurberg et al., 2008; Shaw and Green, 2007). 
 
 
Figure 7. Termination of translation in the presence of a stop codon. (A) Decoding 
of the stop codon (green) by the P(A/V)T motif of RF1 (yellow). (B) Same as (A) but in 
the presence of RF2 and the corresponding SPF motif . (C) Comparison of the switch loop 
region of RF2 (red) in its open, r ibosome bound conformation (yellow) and closed 
conformation (pink) as observed in solution. Remodeling of the switch loop on the 
ribosome involves stacking interaction between A1492 (16S, blue) and the switch loop. 
(D) After remodeling of the switch loop of RF2 (yellow) the t ip of domain III gets 
posit ioned into the PTC. This involves a movement of 60 Å compared to the closed RF2 
conformation (pink). (E) Backbone interaction between the catalytic important Q230 of 
RF2 (yellow) and A76 of P-tRNA (orange) is shown. (F) Crystal structure of RF3 (orange) 
bound to a rotated r ibosome. Pictures adapted from (Laurberg et al., 2008; Zhou et al., 
2012b) 
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Likewise, during peptide bond formation, the presence of an A-site substrate 
induces a similar conformational change within the PTC (Shaw and Green, 2007). In 
the presence of RF1/2 this includes residues U2506, which overlaps with the binding 
site of RFs and U2585 which moves away from the ester bond allowing its hydrolysis 
by a water molecule (Shaw and Green, 2007; Schmeing et al., 2005b). This leads to 
the following situation: Accommodation of domain 3 and conformational changes within 
the PTC allow the activation of an attacking water molecule. The backbone of Gln 
interacts via its NH-group with the 3’OH of A76, whereas its side chain is shielding the 
PTC from other nucleophiles larger than water (Figure 7E) (Jin et al., 2010; Korostelev 
et al., 2008, 2010; Laurberg et al., 2008; Shaw and Green, 2007; Shaw et al., 2012; 
Weixlbaumer et al., 2008). Similar to peptide bond formation, this reactions proceeds 
through a tetrahedral intermediate (Korostelev et al., 2008, 2010; Laurberg et al., 2008; 
Trobro and Åqvist, 2009; Weixlbaumer et al., 2008). Break down of this state results in 
deacylated tRNA and free peptide. In contrast to peptide bond formation, hydrolysis of 
the peptide is less understood. One model suggests that 2’OH of A76 acts as a protein 
shuttle by accepting a proton from the nucleophilic water and subsequently transferring 
it to the leaving group on the 3’OH, that is stabilized by the main chain amide of the 
glutamine (Schmeing et al., 2005a; Shaw et al., 2012; Sievers et al., 2004; Trobro and 
Åqvist, 2009; Weinger et al., 2004). Other models suggest a step-wise proton transfer 
with only one proton moving at the same time (Kuhlenkoetter et al., 2011).  
 After hydrolysis the class II release factor RF3 binds the ribosome and 
stimulates the release of RF1/2 (Freistroffer et al., 1997; Goldstein and Caskey, 1970). 
Like EF-Tu and EF-G, RF3 is a translational GTPase (traGTPase) and binds the 
ribosome preferentially in complex with GTP (Figure 7F) (Adio et al., 2018; Koutmou 
et al., 2014a; Peske et al., 2014). Additionally, the binding site of RF3 overlaps with 
their position on the ribosome (Gao et al., 2007; Jin et al., 2011; Pallesen et al., 2013; 
Zhou et al., 2012a, 2012c). Hence, a direct interaction between RF3 and RF1/2 is 
unlikely as there is no overlap in the binding site, suggesting that RF3 promotes 
dissociation of RF1/2 indirectly (Gao et al., 2007; Jin et al., 2011; Pallesen et al., 2013; 
Zhou et al., 2012a, 2012c). From crystal structures it is evident that in the absence of 
RF3, but presence of RF1/2, the ribosome adopts a non-rotated state (Jin et al., 2010; 
Korostelev et al., 2008; Laurberg et al., 2008; Weixlbaumer et al., 2008). By contrast, 
it could be shown that in the presence of RF3, but absence of RF1/2, the ribosome is 
in a rotated state (Gao et al., 2007; Jin et al., 2011; Zhou et al., 2012c). Hence, it is 
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likely that RF3 dissociates RF1/2 by inducing subunit rotation. Recent biophysical 
studies further refined the understanding for this process. Like EF-Tu, RF3 binds the 
ribosome preferentially in complex with GTP (Adio et al., 2018; Koutmou et al., 2014b; 
Peske et al., 2014). Binding of RF3 facilitates the transition from non-rotated RF1/2-
bound state to a rotated state and thereby removing the decoding factors (Adio et al., 
2018; Ermolenko et al., 2007b; Sternberg et al., 2009). The conversion from a non-
rotated to a rotated state seems to be dependent on the presence of GTP bound to 
RF3, as non-hydrolysable analogues showed a reduced rate in conversion (Adio et al., 
2018; Shi and Joseph, 2016). Interestingly, RF3 mutants that are able to bind GTP but 
are deficient in hydrolysis are also able to induce this transformation, suggesting that 
the presence of the hydrolysable analogue is needed but not its hydrolysis (Adio et al., 
2018; Shi and Joseph, 2016). It rather seems that hydrolysis is needed to reset 
ribosomes back to a non-rotated state by dissociating RF3 from the ribosome (Adio et 
al., 2018; Peske et al., 2014; Shi and Joseph, 2016).  
Last but not least it should be noted that cells lacking RF3, show no growth 
defect (Grentzmann et al., 1994; O’Connor, 2015). Even more, RF3 is only found in a 
subset of bacteria suggesting that RF3 is not part of a conserved mechanism but an 
auxiliary factor fine tuning the RNA machinery (Margus et al., 2007).  
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1.3.4 Recycling 
 
Dissociation of RF1/2 results in a post termination complex (PoTC) programmed with 
a deacylated tRNA and mRNA. To return the ribosomal subunits to the pool of 
translating ribosome, the ribosome has to be disassembled into its individual 
components. Recycling is mediated by three factors, namely the ribosome recycling 
factor (RRF), EF-G and IF3. 
RRF binds the ribosome in its rotated state.(Fu et al., 2016; Prabhakar et al., 
2017; Sternberg et al., 2009). Binding of RRF to the ribosomal A-site prevents 
reassociation of RF1/2, as evident from single molecule Förster resonance energy 
transfer (smFRET) experiments. While binding of RF1/2 converts the ribosome to a 
non-rotated state, increasing concentrations of RRF stabilize the rotated state. This is 
also in agreement with structural studies showing that binding of RRF to a physiological 
PoTC was only observed in the rotated state (Dunkle et al., 2011; Fu et al., 2016; Gao 
et al., 2005). Notably, there was also a structure of RRF bound to a non-rotated 
ribosome. however, in this crystal structure the ASL of a P-tRNA was used, thereby 
allowing accommodation of RRF as it would otherwise clash with the body of the tRNA 
(Weixlbaumer et al., 2007). RRF consists of two domains connected by a linker and 
binds the A- and P-site cleft of the 50S. Domain II is contacting S12 and intersubunit 
bridge B2a on the SSU while domain I forms several contacts with 23S rRNA on the 
50S subunit with domain I, including the SRL and L7/L12 stalk (Agrawal et al., 2004; 
Barat et al., 2007; Fu et al., 2016; Gao et al., 2005).  
Binding of RRF alone is not sufficient to split subunits but requires EF-G to do 
so (Frank et al., 2007; Hirokawa et al., 2006; Peske et al., 2005; Zavialov et al., 2005). 
Reconstructions of time-resolved cryo-electron microscopy showed a conformational 
change of RRF upon binding of EF-G that directs domain II towards domain I bringing 
it in closer contact to the intersubunit bridge B2a (Fu et al., 2016; Zhang et al., 2015). 
This structural rearrangement together with domain IV of EF-G is thought to split B2a 
and thereby facilitates subunit dissociation (Dunkle et al., 2011; Fu et al., 2016; Pai et 
al., 2008; Yokoyama et al., 2012; Zhang et al., 2015). It is noteworthy to mention that 
a crystal structure of T. thermophilus RRF together with E. coli EF-G on the E. coli 
ribosome exists (Yokoyama et al., 2012). However, biochemically assays revealed that 
this complex is not functional and therefore is not physiological relevant. 
Experimentally it was shown that additionally to the presence of RRF and EF-G 
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recycling requires the hydrolysis of GTP bound to EF-G to split subunits (Borg et al., 
2016; Prabhakar et al., 2017). However, it remains elusive if hydrolysis or resulting Pi 
release trigger the above mentioned structural changes or if they are required to 
dissociate EF-G from the ribosome. 
 Upon subunit dissociation, RRF and EF-G leave the ribosome and IF3 binds the 
ribosome preventing rebinding of the 50S (Hirokawa et al., 2005; Karimi et al., 1999; 
Peske et al., 2005; Prabhakar et al., 2017). Furthermore, it was shown that binding of 
IF3 accelerates the departure of P-site tRNA and thereby indirectly causes the 
dissociation of the mRNA (Karimi et al., 1999; Prabhakar et al., 2017). Thus, IF3 
facilitates the departure of tRNA and mRNA, but also connects recycling with 
translation initiation by preventing reassociation of the 50S. 
 Noteworthy, the above described pathway of recycling might just be one 
possible way to split subunits. There are many possibilities described in the literature 
how this might be achieved. For example a recent paper suggests that in presence of 
RRF and EF-G, the mRNA is first to leave the 70S, followed by the tRNA and delayed 
subunit dissociation. However, in presence of an upstream SD-sequence, mRNA and 
tRNA dissociate after 70S splitting (Chen et al., 2017). Interestingly, mRNAs used for 
recycling experiments mostly contain a start codon followed by a stop codon with an 
upstream SD-sequence, pushing the experimental outcome towards prior splitting 
followed by tRNA/mRNA dissociation. On the other hand the absence of a SD-
sequence would provide a pool of vacant 70S that can be used to initiate translation 
(Chen et al., 2017; Grill et al., 2000; Qin et al., 2016; Yamamoto et al., 2016). Another 
model suggests that EF-G translocates RRF into the P-site and thereby dissociates 
tRNA and hence indirectly the mRNA (Hirokawa et al., 2005). This would again provide 
a vacant 70S pool. Another explanation for the discrepancy in experimental outcomes 
is the presence of different Mg2+ concentrations. The lower the Mg2+ concentration is, 
the more likely it is to observe a 70S splitting event. In summary, there might be several 
pathways to return ribosomes to the translation pool.  
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1.4 Rescue of translational stalled ribosomes 
 
Translation is a pivotal event in every single cell and thus cells invest considerable 
amounts of energy to produce, recycle and provide ribosomes and other translation 
factors. Interventions that disturb a smooth running translation cycle would lead to 
increased energy consumption and as a consequence, death of the cell (Buttgereit and 
Brand, 1995; Russell and Cook, 1995). There are two scenarios that interfere with 
active translation, namely the formation of a ‘non-stop’ or ‘no-go’ complex, both of them 
leading to stalled ribosomes (Giudice and Gillet, 2013). Non-stop complexes derive 
from the lack of a stop signal, leading to stalled ribosomes at the 3’ end of mRNA 
bearing a vacant A-site (Giudice and Gillet, 2013; Keiler, 2015). On the other hand, 
‘no-go’ complexes derive e.g. from rare codon stretches, amino acid starvation, stalling 
peptides/motifs and antibiotics (Giudice and Gillet, 2013; Himeno et al., 2015; Keiler, 
2015; Li et al., 2005; Roche and Sauer, 1999; Starosta et al., 2014a; Wilson, 2014; 
Wilson and Beckmann, 2011). 
Bacteria have evolved various mechanisms to cope with these stress situations 
and alleviate stalled ribosomes. Non-stop complexes are resolved by a rescue 
mechanism called trans-translation, the protein alternative rescue factor ArfA or ArfB 
(Giudice and Gillet, 2013; Himeno et al., 2015; Huter et al., 2017b; Keiler, 2015). By 
contrast, ‘no-go’ complexes are alleviated by a variety of factors that depend on the 
cause of stalling. One way is to convert the ‘no-go’ complex into a ‘non-stop’ complex 
by an A-site specific cleavage, making it a bona fide target for trans-translation (Buskirk 
and Green, 2017; Hayes and Sauer, 2003; Ivanova et al., 2004; Janssen et al., 2013). 
Other possibilities include rescue factors that help to continue translation instead of 
terminating it. The so called ribosome protection proteins (RPP) alleviate drug-induced 
stalling by binding to the ribosome and displacing the drug from the ribosome (Arenz 
et al., 2015; Farrell et al., 2011; Nguyen et al., 2014). Another scenario is caused by 
translation of consecutive proline motifs that arrest ribosomes. Binding of elongation 
factor P (EF-P) restores translation on those ‘no-go’ complexes (Doerfel et al., 2013; 
Huter et al., 2017a; Ude et al., 2013). The sum of reasons for ‘no-go’ complexes and 
their respective mechanisms make it impossible to describe them all within this thesis. 
Hence, only those that were directly related to my research during my PhD will be 
described  
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Last but not the least, it is worth mentioning that stalling is not always harmful 
to the cell but can also be used as a tool to regulate the expression of genes (Wilson 
and Beckmann, 2011). These ‘physiological’ stalling events, also known as translation 
attenuation, often occur on small open reading frames and thereby influence the 
expression of downstream genes  
 
1.4.1 Trans-translation, ArfA and ArfB 
 
Studies in E. coli reveal that 2-4% of translating ribosomes are stalled due to the 
formation of a ‘non-stop’ complex at any one time (Ito et al., 2011). Reasons for the 
appearance of non-stop complexes are manifold. They can derive from random events 
like mRNA damage, premature termination of transcription or exonucleolytic cleavage. 
This causes the lack of the 3’-located stop codon resulting in a non-stop complex with 
the very 3’-end of the mRNA in the P-site and a vacant A-site (Hong et al., 2007; 
Svetlanov et al., 2012). Miscoding inducing antibiotics, frameshift events and nonsense 
suppression (readthrough of a stop codon), although not physically removing the stop 
codon, lead to the formation of the same complex by suppressing the stop signal and 
thereby promoting translation to the 3’ end of the mRNA (Abo et al., 2002; Ueda et al., 
2002). 
However, reaching the 3’ end of an mRNA is not the only way to create a non-
stop complex. It was shown that trans-translation is also active on ribosomes that are 
stalled on intact mRNAs, e.g. after encountering rare codons or stalling sequences 
(Roche and Sauer, 1999; Wilson and Beckmann, 2011). In such cases the mRNA 
might be exposed to exonucleases like RNase II, which specifically cleaves the A-site 
to make the complex a target for trans-translation (Garza-Sánchez et al., 2008; 
Janssen et al., 2013). Similar to that is the toxin-antitoxin system RelBE. Upon amino 
acid starvation the antitoxin RelB becomes degraded, leading to the activation of RelE 
toxin that on the other hand cleaves mRNAs in the ribosomal A-site (Neubauer et al., 
2009; Starosta et al., 2014a). Hence, rescue of ‘non-stop’ complexes are even part of 
regulatory circuits. 
The first line of defense against non-stop complexes is trans-translation 
mediated by a molecule called tmRNA. Remarkably, tmRNA or its encoding gene ssrA 
has been found in all sequenced prokaryotes (Gueneau de Novoa and Williams, 2004). 
Deletion of ssrA is either lethal in many medically relevant species or results in severe 
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phenotypes including defects in virulence (Brunel and Charpentier, 2016; Huang et al., 
2000; Personne and Parish, 2014; Ramadoss et al., 2013a; Thibonnier et al., 2008). 
However, other species like E. coli, show rather mild phenotypes upon deletion of ssrA, 
due to the existence of back-up systems like ArfA or ArfB (Abo et al., 2002; Chadani 
et al., 2010). Indeed, deletion of tmRNA and ArfA is synthetically lethal in E. coli, 
despite the presence of ArfB. However, if ArfB is overexpressed, it can rescue the 
synthetic lethal effect of ∆ssrA∆arfA (Chadani et al., 2010, 2011a). On the other hand, 
deletion of tmRNA from Neisseria gonnorrhoeae is lethal despite the presence of ArfA 
(Schaub et al., 2012). Deletion of tmRNA in Bacillus subtilis is not lethal, despite the 
apparent absence of ArfA and ArfB, suggesting the presence of other yet unknown 
rescue mechanisms (Muto et al., 2000; Shin and Price, 2007; Wiegert and Schumann, 
2001). Hence, it is likely that at least one rescue mechanism is required for the viability 
of the cell, pointing out the importance of resolving stalling on non-stop complexes. 
Trans-translation, rescue by ArfA and ArfB will be discussed further in the following 
sections. 
 
Figure 8. Phylogenetic distribution of tmRNA, ArfA and ArfB based on the sequence 
of the 16S rRNA. For organisms in bold, trans-translation is essential and cannot be 
compensated by ArfA or ArfB. Fil led boxes for ArfA or ArfB means that the alternative 
rescue factor is capable of compensating the loss of trans-translation. Hashed boxes 
indicate that it hasn’t been shown so far to be essential or not. Adapted from (Keiler and 
Feaga, 2014). 
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Trans-translation. trans-translation is mediated by a ribonucleoprotein complex made 
out of tmRNA and SmpB. Both molecules are required to rescue non-stop complexes. 
While SmpB is a small RNA binding protein, tmRNA is a specialized RNA molecule. 
tmRNA is comprised of a tRNA-like domain (TLD) and a messenger-like domain 
(MLD), which are connected by a series of pseudoknots (Figure 9A) (Felden et al., 
1996; Karzai et al., 1999a; Keiler et al., 1996, 2000; Komine et al., 1994; Ushida et al., 
1994). In most bacterial lineages tmRNA comprises a single RNA molecule of about 
350 nt in length. The secondary structure is conserved throughout bacteria, however 
some lineages use two RNA transcripts to produce a functional two-piece tmRNA 
(Keiler et al., 2000). The TLD of the RNA molecule form structures reminiscent of 
tRNAAla, allowing it to be charged by alanyl-tRNA synthetase and interact with EF-Tu, 
but is lacking the ASL (Moore and Sauer, 2007). The lack of the ASL is compensated 
by SmpB. SmpB is a small 160 amino acids containing protein with a globular core and 
a C-terminal tail that remains unstructured in solution (Dong et al., 2002; Karzai et al., 
1999b). Together with the TLD, SmpB functionally and structurally mimics a tRNA 
molecule. The MLD part of the tmRNA contains an open reading frame (ORF) that 
encodes 8-35 aa long degradation tag, which helps to restore translation by providing 
a template (Figure 9A) (Moore and Sauer, 2007).  
The vacant A-site is recognized by a quaternary complex, consisting of tmRNA, 
SmpB and EF-Tu.GTP with the SmpB-tmRNA module in the A/T site of the 70S (Kaur 
et al., 2006; Valle et al., 2003). An X-ray structure revealed that the C-terminus of 
SmpB binds in close proximity to the decoding bases A1492, A1493 and G530 and 
extends into the mRNA entry channel forming a α-helix that would overlap with the 
position of a full-length mRNA (Neubauer et al., 2012). This is in agreement with 
biochemical studies showing a decrease in peptidyl transfer to tmRNA with increasing 
length of the 3’-end of the mRNA from the P-site (Kurita et al., 2014a; Miller and 
Buskirk, 2014). Interestingly, it could be shown that GTP hydrolysis occurs 
independent of the length of the 3’-extension, suggesting that hydrolysis of GTP serves 
as a proofreading step that rejects the quaternary complex upon encountering an 
extended mRNA (Himeno et al., 2015). In case of an empty channel GTP hydrolysis 
allows the C-terminal part of SmpB to accommodate within the tunnel and thereby 
stabilizing the tmRNA/SmpB complex permitting the CCA end to interact with the PTC 
(Kurita et al., 2014a; Miller and Buskirk, 2014; Neubauer et al., 2012). Hence, peptide 
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bond formation between the nascent chain and alanine of tmRNA can occur. While the 
TLD and SmpB undergo conformational changes within these early steps, the 
pseudoknots and MLD remain static, forming an “arc” around the 30S subunit (Himeno 
et al., 2015).  
Subsequently, EF-G binds the ribosome and translocates SmpB and the TLD 
from the A-site to the P-site, placing the first codon of the MLD into the A-site (Ramrath 
et al., 2012). Comparing cryo-EM reconstructions of preaccommodated tmRNA/SmpB 
with fully translocated tmRNA/SmpB revealed that in both states the tmRNA maintains 
its “arc” structure, raising the question how the MLD can be placed into the decoding 
site (Kaur et al., 2006; Valle et al., 2003; Weis et al., 2010). 
A cryo-EM reconstruction together with fusidic acid was able to stall the 
ribosome in concert with tmRNA/SmpB and EF-G (Ramrath et al., 2012). The resulting 
structure was similar to a translocation intermediate, but revealed an additional 
movement of the head. While the translocation intermediate showed 30S rotation of 4° 
and a head swivel of 18°, this reconstruction showed an extra movement of the head, 
parallel to the path of the mRNA (Figure 9B) (Ramrath et al., 2012; Ratje et al., 2010). 
This tilt opens the intersubunit bridge B1A and allows translocation of the tmRNA. On 
the solvent side of the 30S, S2 and S3 are interacting with elements of the tmRNA 
suggesting that these interactions work as a pivot point for placing the MLD into the 
decoding center. Accompanying the large head movements is the opening of the 
decoding site around G530 allowing the placement of the new ORF into the mRNA 
entry channel (Figure 9C). Hence, the head movements open the intersubunit space 
around B1A, the decoding center and together with fixation of the tmRNA through S2 
and S3, allow the MLD to move freely and place the ORF into the mRNA channel 
(Figure 9D) (Ramrath et al., 2012). Another observation that could be made is that the 
conformation of EF-G is similar to that observed in canonical POST complexes. 
Domain IV interacts with SmpB close to the DC, detaching SmpB from the channel and 
thus allowing accommodation of the MLD (Ramrath et al., 2012; Ratje et al., 2010). 
These structural rearrangements allow translation to proceed on the ORF of the MLD 
until a stop codon is encountered, recruiting RF1/2 which leads to termination of 
translation and recycling of the ribosome (Keiler et al., 1996). The ORF, when 
translated, incorporates a degradation tag at the C-terminus of the polypeptide, which 
is recognized by Clp and other proteases (Withey and Friedman, 1999). Hence, the 
faulty protein is degraded upon release from the ribosome (Keiler et al., 1996). It is 
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worth to mention that recycling of the ribosome and not degradation of the protein is 
the essential part of trans-translation (Huang et al., 2000). This was shown by Huang 
et al., who altered the MLD sequence of tmRNA in a way that it cannot be recognized 
by the degradation machinery anymore. Cells expressing this altered tmRNA were still 
viable, whereas when they used a tmRNA defective of amino acid charging the effect 
was lethal. 
. 
 
Figure 9. Rescue of non-stop complexes by tmRNA. (A) Secondary structure of 
tmRNA, with the TLD (l ight purple), MLD (dark purple) and its connecting helices and 
pseudoknots (purple). (B) Rotational analysis of the 30S movement during translocation 
of tmRNA. An addit ional “t i lt”  of the head is observed, resulting in an addit ional opening 
of the intersubunit space. (C) Cryo-EM map of a translocation intermediate in concert 
with tmRNA revealing the mechanism of MLD placement into the SSU. (D) Schematic 
representation of the conformation of the elements of tmRNA and the interplay with 
elements on the 50S (l ight blue) and 30S (yellow). Adapted from (Ramrath et al., 2012). 
 
ArfB. The third discovered ribosome rescue factor working on non-stop ribosomal 
complexes is ArfB (former YaeJ) (Chadani et al., 2011b; Handa et al., 2011). The very 
first hints that ArfB alleviates stalling on non-stop complexes came from a screening in 
∆ssrA∆arfA mutants. In those studies it was shown that ArfB can rescue the phenotype, 
however, only when overexpressed (Chadani et al., 2011b). Further analysis revealed 
that its N-terminal domain contains a GGQ motif, reminiscent of other release factors, 
suggesting that the factor alone is sufficient in peptidyl-tRNA hydrolysis. Indeed, 
mutations within the GGQ motif abolished its capability to hydrolyze the peptidyl-tRNA, 
suggesting that ArfB on its own is capable of rescuing non-stop complexes (Chadani 
et al., 2011b; Handa et al., 2011). This observation is further supported by the crystal 
structure of ArfB bound to the ribosome. ArfB consists of two domains, separated by a 
~12 aa long linker. The globular N-terminal domain is structurally similar to domain III 
of RF1/2. The C-terminal domain is unstructured in solution but forms a α-helix that 
reaches into the mRNA channel similar to SmpB (Figure 10A) (Gagnon et al., 2012). 
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Comparable to SmpB and ArfA, accommodation of the C-terminus within the empty 
mRNA channel is essential for its function. Truncations of the C-terminal domain 
prohibit binding of ArfB to the ribosome, whereas mutations or truncations in the GGQ 
domain or linker domain do not decrease binding (Chadani et al., 2011b; Handa et al., 
2011; Kogure et al., 2014). Thus, the C-terminal helix monitors the empty mRNA 
channel and helps to direct the globular domain towards the PTC (Figure 10B,C) 
(Gagnon et al., 2012). Likewise for SmpB, ArfB is more tolerant towards extended 
mRNAs, as evident from experiments showing that ArfB can resolve stalling upon rare 
codon stretches (Handa et al., 2011). 
Positioning of the C-terminus of ArfB causes rearrangements within the decoding site 
through stacking interactions of residues of the linker of Arg118 on G530 and Pro110 
on A1493. These interactions might help to guide the globular domain towards the PTC 
by determining the path of the linker region (Figure 10B,C) (Gagnon et al., 2012). 
Indeed, progressive truncations of the linker region severely decrease peptidyl-tRNA 
hydrolysis (Handa et al., 2011; Kogure et al., 2014). Positioning of the GGQ motif into 
the PTC results in hydrolysis. Superimposing the ArfB model with the model of RF2 
bound to the ribosomes reveals an identical conformation of the GGQ motif and PTC 
residues, suggesting a similar mechanism of peptide release (see 1.3.3) (Gagnon et 
al., 2012; Zhou et al., 2012b). 
 
 
Figure 10. Interaction of ArfB with a non-stop ribosomal complex. (A) Overview of 
the ArfB binding site (red) on the 70S ribosome (50S, blue; 30S, yellow) in complex 
with P-tRNA (green) and truncated mRNA (purple). (B) Accommodation of the C-
terminus of ArfB within the mRNA entry channel. Stacking interactions between R118 
and G530 (orange) as well as between P110 and A1493 (orange) are indicated. (C) 
Accommodation of the C-terminus of ArfB induces conformational changes within 
A1492/A1493 (orange) that are different to the position during decoding of a sense 
codon (blue). These reorientations allow to place the N-terminus of ArfB into the PTC. 
Taken from (Gagnon et al., 2012). 
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 Homologs of ArfB exist in organelles of eukaryotes with the best-characterized 
one being the human mitochondrial immature colon carcinoma transcript 1 (ICT-1) 
(Akabane et al., 2014; Duarte et al., 2012; Feaga et al., 2016; Kogure et al., 2014). 
Like ArfB, ICT-1 has a GGQ domain and a similar C-terminal tail and can restore cell 
viability in ∆ssrA∆arfA strains, when overexpressed (Kogure et al., 2014). Vice versa, 
the knockdown of ICT-1 in eukaryotes can be rescued by the expression of bacterial 
ArfB (Feaga et al., 2016). This suggest that ArfB and ICT-1 are functional 
interchangeable (Akabane et al., 2014). 
 
ArfA. ArfA, a 72 aa long protein, was initially identified in genetic screens as a factor 
that is essential for cell viability in ∆ssrA background in E. coli (Chadani et al., 2010). 
In more detail, the amino acid substitution A18T, found within this study, caused a loss-
of-function mutation within ArfA and thereby displayed a severe growth defect. 
Although both variants, wt ArfA and A18T ArfA co-localize with the ribosome, only wt 
ArfA was able to rescue non-stop complexes in an S30 lysate (Chadani et al., 2010). 
Indirect proof for ArfA working on non-stop complexes came from studies revealing 
that the expression of ArfA is dependent on trans-translation (Chadani et al., 2011c; 
Garza-Sánchez et al., 2011). The mRNA of arfA contains secondary structures that 
can either cause premature transcription termination or are cleaved by RNase III at 
defined positions within the ORF (Chadani et al., 2011c; Garza-Sánchez et al., 2011; 
Schaub et al., 2012). Thus, translation of arfA results in a non-stop ribosomal complex 
which is rescued by trans-translation and targets ArfA for degradation (Chadani et al., 
2011c; Garza-Sánchez et al., 2011). Even if the ribosome is able to synthesize full-
length ArfA, it is prone for aggregation due to the hydrophobicity of the C-terminus 
(Chadani et al., 2011a). However, if tmRNA is absent or overwhelmed a truncated 
version of ArfA lacking the terminal 17-18 aa is released. Remarkably, the truncated 
version retains its rescue activity, making the C-terminus dispensable for its function, 
which is in line with its poor conservation (Chadani et al., 2011c; Garza-Sánchez et al., 
2011; Schaub et al., 2012). Overexpression of ArfA in wt cells on the other hand has 
an inhibitory effect on cell growth (Chadani et al., 2010). Hence, ArfA serves as a back-
up system for trans-translation which is only active when trans-translation is hampered. 
The mode of action of ArfA however remained obscure. Although it was able to 
rescue non-stop complexes in a S30 lysate, it failed to do so on isolated ribosomal 
complexes, indicating that additional factors are involved (Chadani et al., 2010, 2011a). 
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Experiments in a reconstituted cell-free translation system identified RF2, but not RF1, 
as the factor cooperating with ArfA. Rescue activity was strictly dependent on the GGQ 
motif of RF2, but not on the SPF motif (1.3.3) (Chadani et al., 2010; Shimizu, 2012). 
Hydroxyl-radical probing on ribosomal non-stop complexes showed that binding of the 
C-terminus of ArfA exposes nucleotides that are close to the mRNA entry channel and 
the decoding site overlapping with the position of SmpB, whereas the N-terminus 
appeared to be flexible. Binding of RF2 to the 70S-ArfA complex changed the mode of 
interaction of ArfA with the ribosome. Location of the C-terminus did not change 
significantly, however the N-terminus caused a more defined cleavage pattern (Kurita 
et al., 2014b).  
 
 
Figure 11. Interactions of ArfA and RF2 on a non-stop ribosomal complex. (A) 
Transverse section of the cryo-EM reconstruction of ArfA-RF2-SRC, highlighting the 30S 
(yellow), 50S (grey), P-tRNA (green), RF2 (orange), ArfA (red) and truncated mRNA (dark 
blue). Zoom in showing the model for ArfA with secondary structures (a-helix, green; b-
strand, blue) and motifs highlighted (RKGK, yel low; KKGK orange). Addit ionally position 
of G530 of 16S rRNA (pale yellow) and C1914 (grey) of 23S rRNA are indicated. (B)  
Position of ArfA within the mRNA entry channel revealing a steric clash with a 
superimposed full- length mRNA (FL-mRNA, cyan) compared to truncated mRNA (Tr-
mRNA). (C) Overview of the interaction surface between ArfA and RF2ArfA. (D) 
Superimposit ion of RF2stop (blue, PDB 4V5E) with ArfA and RF2ArfA from the ArfA-RF2-
structure. (E) Interaction of ArfA with W319 of RF2Ar fA and conformation of decoding 
nucleotides A1492/A1493 in the presence of ArfA (pale blue) or presence of RFstop 
(yellow). (F) Remodeling of the switch loop (yellow) and α7 helix (purple) of domain 3 of 
RF2 (orange) by ArfA (red) compared to the conformation of RF2 when decoding a 
canonical stop codon (blue). 
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Recently, five different groups were able to resolve cryo-EM structures of truncated 
ArfA in interplay with RF2 on 70S non-stop complexes (see Discussion) (Figure 11A). 
The outcome of all reconstructions was nearly identical. Hence, the following sections 
will describe the common conclusions of these studies, whereas differences will be 
discussed in the discussion section (Demo et al., 2017b; Huter et al., 2017c; James et 
al., 2016; Ma et al., 2017; Zeng et al., 2017).  
In line with hydroxyl-radical probing, the C-terminus resides within the mRNA 
entry channel with clear density observed up to position 46-48 and lack of density for 
the remaining C-terminal residues, in agreement with their poor conservation (Figure 
11B) (Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; Kurita et al., 2014b; 
Ma et al., 2017; Zeng et al., 2017). In contrast to the C-termini of SmpB or ArfB that 
form helices and follow the predetermined path of the mRNA channel, the C-terminus 
of ArfA appears to rather block the tunnel. Comparing the path of full-length mRNA 
with the position of C-terminus of ArfA shows that only up to two to three nucleotides 
are allowed to accommodate within the mRNA channel in presence of ArfA (Figure 
11B) (Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; Ma et al., 2017; 
Zeng et al., 2017). This is in line with biochemical data, showing that mRNA extended 
by more than 3 nt. reduces the efficiency of rescue with nearly no rescue activity 
observed if the mRNA is extended by six or more nucleotides (Chadani et al., 2011c; 
Kurita et al., 2014b; Zeng and Jin, 2016).  
 Furthermore, the C-terminus of ArfA contains two highly conserved positively 
charged stretches (KKGK33-36; RKGK41-44) that anchor the C-terminus into the channel 
by forming contacts with the surrounding 16S rRNA. It is worth to mention that single 
mutations within these stretches do not have an effect on the rescue activity by ArfA, 
suggesting a redundancy in their interaction network (Kurita et al., 2014b; Ma et al., 
2017; Zeng et al., 2017). Proceeding from the mRNA entry channel towards the N-
terminus, the C-terminal loop makes a 90° turn around G530, placing the N-terminus 
in a pocket formed by decoding center, h18, h44 and S12. The only contact with the 
LSU is through Lys12 of ArfA contacting C1914 of H69 resulting in a ~180° bend that 
directs the very N-terminus towards S12. The described conformation of ArfA creates 
a platform for the interaction with RF2 (Demo et al., 2017b; Huter et al., 2017c; James 
et al., 2016; Ma et al., 2017; Zeng et al., 2017).  
Recruitment of RF2 to the non-stop complex results in an overall similar 
conformation as seen upon canonical termination (Figure 11C). However, a small shift 
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is observed within the decoding domain 2/4 affecting the SPF motif. Importantly, the 
SPF does not interact with ArfA, demonstrating that ArfA does not mimic a stop codon 
(Figure 11D). This is further highlighted by the fact that mutations within the SPF motif 
do not interfere with rescue of non-stop complexes (Chadani et al., 2012). The 
conformation of ArfA rather provides an interface for RF2, involving residues 15-31 of 
ArfA that interact with β4-β5 strands of domain 2 and the distal end of α-helix α7 of 
domain of RF2. ArfA thereby augments a β-strand to the β-sheet of RF2 domain 2/4 
(Figure 11C,E) (Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; Ma et al., 
2017; Zeng et al., 2017). 
During canonical termination, the transition of the closed to the open state of 
RF2 is mediated by rearrangements within the switch loop between domain III and IV 
of RF2 (1.3.3). Through stacking interactions between the switch loop and the 
decoding nucleotides A1492/A1493, the α-helix α7 becomes extended by two or three 
turns, when compared to the close conformation of RF2 (Figure 11E,F) (Jin et al., 
2010; Korostelev et al., 2008, 2010; Laurberg et al., 2008; Weixlbaumer et al., 2008; 
Zhou et al., 2012b). However, in the presence of ArfA, A1492/A1493 adopt distinct 
conformations restricting interactions with the switch loop (Figure 11E). Instead, ArfA 
itself stabilizes an alternative conformation of the switch loop. These interactions 
include a hydrophobic patch within the α-helical region of ArfA and Trp319 of RF2. 
Hence, the α7 of domain III of RF2 adopts a similar conformation as seen upon 
canonical termination (Figure 11E,F). These movements help to direct the GGQ motif 
towards the PTC (Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; Ma et 
al., 2017; Zeng et al., 2017). 
Additionally, two groups reported reconstructions of RF2 in an intermediate 
state but bound to the 70S-ArfA complex. While James et al. were able to obtain this 
intermediate state using independent reconstructions, one with ArfA A18T bound to 
the 70S-RF2 complex and the other one with T. thermophilus RF2 bound to 70S-ArfA 
complex, Demo et al. were able to obtain this state as a subpopulation of their 70S-
ArfA-RF2 reconstruction (Demo et al., 2017b; James et al., 2016). The overall 
conformation of RF2 in those reconstructions reflects the conformation of closed RF2 
in solution with the GGQ motif being 70 Å away from its respective target (Vestergaard 
et al., 2001; Zoldák et al., 2007). Interestingly, in all of those reconstructions the N-
terminus of ArfA as well as the switch loop of RF2 was disordered. Hence, it seems 
plausible that the opening of RF2 is dependent on the ordering of the switch loop by 
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the N-terminus of ArfA and that the observed states represent a preaccommodation 
state of RF2 (see Discussion) (Demo et al., 2017b; James et al., 2016).  
Hence, biochemical and structural studies lead to the following model (Chadani 
et al., 2012; Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; Kurita et al., 
2014b; Ma et al., 2017; Zeng et al., 2017). ArfA binds the ribosome and probes the 
empty mRNA entry channel with its C-terminus, similar to SmpB. Accommodation of 
ArfA recruits RF2 that transits from a closed to open conformation upon stabilization 
of the switch loop by the N-terminus of ArfA. Similar to canonical termination, opening 
of the release factor places the catalytic important GGQ motif into the PTC and allows 
release of the nascent chain. 
 
1.4.2 Polyproline mediated stalling and rescue by elongation factor P 
 
Translation elongation proceeds with an average speed of 12-20 aa/s-1 under optimal 
conditions (Bilgin et al., 1992; Proshkin et al., 2010). This rate, however, can strongly 
vary and is dependent on several factors like tRNA abundance, the availability of amino 
acids, structural features of the translated mRNA and many other parameters 
(Bullwinkle and Ibba, 2016; Moine et al., 1988; Yanofsky and Horn, 1994). 
Interestingly, it was shown that the nature of amino acids themselves can influence the 
rate of elongation, implicating that not every amino acid is a perfect substrate for 
peptide bond formation (Johansson et al., 2011; Pavlov et al., 2009). Of particular 
interest is the amino acid proline that is distinct from the other 19 proteinogenic amino 
acids as it is a secondary amine with a pyrrolidine ring as a side chain, curving back 
from the Cα to the nitrogen of the amine (Figure 12A). It was shown that proline is a 
poor A-site acceptor as well as a poor donor when present in the P-site, as judged by 
its strongly reduced reactivity with puromycin when compared to other amino acids 
(Doerfel et al., 2013; Muto and Ito, 2008; Wohlgemuth et al., 2008). Hence, proline 
significantly reduces the rate of peptide bond formation when compared to other amino 
acids. In vitro experiments showed that this effect is most severe when ribosomes 
encounter a stretch of consecutive prolines, as it leads to the arrest of translation 
(Doerfel et al., 2013; Ude et al., 2013). Surprisingly, such polyproline motifs are quite 
abundant in every living organism, despite their effect on translation. For example 
roughly 2% of all genes in E.coli contain polyproline coding motifs with increasing 
numbers as the genome gets larger (Starosta et al., 2014b). Presumably every 
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organism, including archaea and eukaryotes, has at least one polyproline-containing 
gene which is the valS gene coding for the Val-tRNA synthetase (Starosta et al., 
2014b). Mutation within the proline triplet leads to the formation of mischarged Thr-
tRNAVal in vitro and interferes with viability in E.coli.  
Given the importance and abundance of such triplets, this raises the question 
of the advantage of prolines over other amino acids. Indeed, due to the cyclic structure 
of the side chain, prolines show an exceptional conformational rigidity (Morris et al., 
1992). Hence, prolines restrain their own conformational freedom as well as the 
conformation of neighboring residues and act as a structural disruptor of secondary 
structure elements within α-helices and β-sheets and are often found at the start or 
end of such elements. On the other hand, proline can be found as cis and trans 
isomers, altering the torsion angle of peptide bonds by 180°, whereas all other amino 
acids prefer the trans conformation (Lu et al., 2007; Yaron et al., 1993).  
Thus, prolines display properties that are crucial for the architecture of proteins. 
However, the fact that sequential prolines can arrest translation in vitro but are crucial 
for the viability of an organism implies that cells utilize additional mechanisms to 
alleviate those stalling events.  
EF-P was initially described as a factor that associates with the ribosome and 
promotes peptide bond formation between fMet-tRNAfMet and puromycin (Glick and 
Ganoza, 1975; Glick et al., 1979). Phylogenetically, EF-P is ubiquitously distributed 
throughout bacteria and has orthologous in eukaryotes and archaea (eIF5a and aIF5a, 
respectively) (Kyrpides and Woese, 1998). Crystal structures of EF-P alone revealed 
a three-domain architecture and an overall conformation mimicking the L-shape of a 
tRNA (Figure 12B) (Choi and Choe, 2011; Hanawa-Suetsugu et al., 2004; Kristensen 
and Laurberg, 2002; Yanagisawa et al., 2010). Domain 2 and 3 exhibit oligonucleotide-
binding folds responsible for DNA/RNA binding. Domain 1, on the other hand, occupies 
the most conserved region within EF-P located at the tip of a loop. Further insights on 
the mode of action of EF-P came from a crystal structure of Thermus thermophilus EF-
P-70S structure programmed a short mRNA and tRNAfMet (Blaha et al., 2009). EF-P 
binds between the P and E-site of the ribosome and interacts with both subunits. 
Domain 3 is orientated towards the SSU but lacks density in this structure for its loop 
close to the mRNA. Domain 2 interacts with the L1 protein leading to a conformation 
of the L1 stalk/protein that is similar to the position during translocation. The highly 
conserved loop of domain 1 interacts with the CCA-end of the P-tRNA with the closest 
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residue being Arg32 (analogous to Lys34 in E.coli). From that structure it was 
concluded that EF-P helps to position the fMet-tRNA and hence assists in formation of 
the first peptide bond. 
 
 
Figure 12. EF-P alleviates proline-induced stalling by contacting the CCA-end of the 
peptidyl-tRNA. (A) The a-amino group of the proline attached to the A-site tRNA 
nucleophil ic attacks the carbonyl carbon of the proline attached to the P-site tRNA during 
peptide bond formation. (B) Cryo-EM density with molecular model for E.coli EF-P 
(salmon) with domains 1-3 (d1-d3) indicated. (C) Representation of a PPP-stalled 
ribosomal complex in presence of A-site tRNA (orange), P-site (green) tRNA and EF-P. 
Further indicated are the 30S (yellow), 50S (grey) and the ‘ in’ position of the L1 protein 
(dark grey). Inlet shows the interaction of the ε(R)-β -lysyl-hydroxylysine modif ication 
contacting the backbone of the CCA-end of P-site tRNA. 
 
Studies by Doerfel et al. as well as Ude et al. further refined the understanding 
for EF-P (Doerfel et al., 2013; Ude et al., 2013). In their studies both groups could show 
that consecutive prolines, but no other amino acid, arrest ribosomal translation in vitro 
and that rescue of those ribosomes is strictly dependent on EF-P. In support of that, 
ribosomal profiling data as well as proteomic analysis by mass spectrometry in 
absence of EF-P identified additional pausing motifs containing diprolyl motifs, thus 
expanding the range of sequences that require EF-P (Elgamal et al., 2014; Peil et al., 
2013; Woolstenhulme et al., 2015). Interestingly, not every diprolyl motif requires the 
help of EF-P. It was shown that the accumulation of ribosomes on diprolyl motifs was 
dependent on the amino acid preceding or following the PP sequence (Elgamal et al., 
2014; Peil et al., 2013; Woolstenhulme et al., 2015). Following in vitro studies also 
confirmed the influence of the upstream amino acid on proline triplets (Starosta et al., 
2014c).  
A commonality between those stalling motifs is that the ribosome arrests with 
the second proline in the P-site and that this state is recognized by EF-P (Doerfel et 
al., 2013). Indeed, biochemical studies could show that EF-P recognizes a specific 
architecture of the D-loop that is shared by all isomers of tRNAPro in E.coli (Katoh et 
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al., 2016). Interestingly, tRNAfMet has the same D-loop architecture explaining the 
beneficial effect of EF-P on the first peptide bond formation.  
Other studies revealed that endogenous EF-P bears a posttranslational 
modification at the tip of the highly conserved loop of domain 1 (Figure 12B) (Aoki et 
al., 2008). In E.coli this leads to an additional mass of +144 Da at position of Lys34 
resulting from the activity of three modification enzymes (Bailly and de Crécy-Lagard, 
2010; Navarre et al., 2010; Peil et al., 2012; Yanagisawa et al., 2010). In a first step 
the enzyme EpmB, a 2,3 - aminomutase converts (S)-α-lysine to (R)-β-lysine, which is 
ligated to the ε-amino group of Lys34 by EpmA (Bailly and de Crécy-Lagard, 2010; 
Navarre et al., 2010; Peil et al., 2012; Yanagisawa et al., 2010). In a last step EpmC 
completes the posttranslational modification by hydroxylation of C5 of Lys34 resulting 
in a ε(R)-β-lysyl-hydroxylysine modification (Peil et al., 2012). Interestingly, deletion of 
the modification enzymes EpmB and EpmA lead to similar phenotypes as observed 
upon deletion of EF-P, indicating that the cellular function of EF-P is dependent on 
those modification enzymes (Zou et al., 2012a, 2012b). Indeed, Doerfel et al and Ude 
et al could show that only modified EF-P is capable of alleviating polyproline stalled 
ribosomes (Doerfel et al., 2013; Ude et al., 2013). In more detail it was shown that the 
action of EpmB and EpmA is essential, whereas the final hydroxylation by EpmC is 
dispensable for the function of EF-P. It is noteworthy to mention that only a subset of 
bacteria have the above mentioned modification enzymes. Other bacteria use 
unrelated different posttranslational modification systems that lead to the addition of, 
for example, rhamnosylation of Arg32 in Pseudomonas aeruginosa or 5-
aminopentanol moiety at Lys32 in Bacillus subtilis (Lassak et al., 2015a; Rajkovic and 
Ibba, 2017). So far such pathways have only been discovered in 35% of available 
bacterial genomes. Hence it is not clear, if the posttranslational modification of EF-P is 
a general strategy or just utilized by a subset of bacteria (Lassak et al., 2015a; Rajkovic 
and Ibba, 2017).  
Despite these insights it remained unclear as to how consecutive prolines 
perturb translation and on how modified EF-P is contributing to the rescue of the 
arrested ribosomes. From the crystal structure of Tth. 70S-EF-P complex it was hard 
to deduce any information in this regard as the ribosomes were not programmed with 
prolines and EF-P was lacking the modification (Blaha et al., 2009). Biochemical 
experiments using proline analogues as a substrate revealed that the steric properties 
of proline rather than its electrophilic nature make it a poor substrate for peptide bond 
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formation as it interferes with the precise positioning of substrates within the PTC 
(Doerfel et al., 2015). Furthermore, it was concluded that the modification might 
stabilize the CCA end of the peptidyl-tRNA and thereby helps to position the P-site 
substrates in the PTC. First structural insights on the contribution of the modification 
came from a cryo-EM reconstruction containing eIF5A (Schmidt et al., 2016). eIF5A 
contains a hypusinylated lysine at position Lys51 that is analogous to Lys34 in E.coli 
(Zanelli et al., 2006). The modification in this structure reaches towards the PTC 
contacting the backbone of the CCA-end demonstrating that the modification does not 
directly contribute to catalysis (Schmidt et al., 2016). Nevertheless, no conclusion on 
relieving of polyproline-stalled ribosomes could be drawn as the ribosomes resulted 
from a native pull-out and hence do not represent a defined state.  
Recently, Huter and coworkers were able to elucidate the mode of action of EF-
P and its modification on polyproline stalled ribosomes using cryo-EM and MD 
simulations (Huter et al., 2017a). Based on their reconstructions it is suggested that 
the favorable all-trans conformation of consecutive prolines is not possible in context 
of the ribosomal tunnel. Hence, no density for the nascent chain could be observed in 
the absence of EF-P, indicating strong flexibility within the growing peptide. 
Furthermore, the A-site tRNA had severe problems to accommodate within the PTC. 
However, when EF-P was present the nascent chain and A-site tRNA were stabilized 
due to EF-P and the modification contacting the peptidyl-tRNA (Figure 12C). Based 
on the density and modelling of the peptidyl-moiety an alternative conformation of 
prolines is suggested that allows the nascent chain to overcome the sterical restrictions 
imposed by the ribosomal tunnel. Last but not least, stabilization of the CCA end by 
the modification leads to an optimal positioning of the substrates for peptide bond 
formation. Hence, the effect of EF-P is of entropic nature rather than directly 
contributing to the catalysis of peptide bond formation (Doerfel et al., 2015; Huter et 
al., 2017a)
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2 Objectives of these Studies 
 
Structure of orthosomycins avilamycin and evernimicin (Publication 1). 
Most of the medically used antibiotics target the ribosome and thereby inhibit bacterial 
growth. The rise of multidrug resistance in pathogenic bacteria, however, highlights the 
need for new therapeutic agents. The orthosomycin antibiotics, avilamycin and 
evernimicin were shown to be promising candidates as they do not display any cross-
resistance with other classes of antibiotics that target the ribosome (Buzzetti et al., 
1968; Wright, 1979). Biochemical experiments suggested binding of these agents 
around H89 and H91 of the 23S rRNA, indicating that they bind to a unique site of the 
ribosome (Belova et al., 2001; Kofoed and Vester, 2002). The aim of the study was to 
determine the binding site of avilamycin and evernimicin on the 70S ribosome using 
cryo-EM. The study was complemented with smFRET data to unravel the mode of 
action of those two orthosomycins. 
 
Structure of the spinach chloroplast ribosome (Publication 2). 
Recent advances in cryo-EM have led to procurement of high-resolution structures of 
bacterial as well eukaryotic ribosomes. However, high-resolution structures of the 
chloroplast ribosome had been lacking. Chlororibosomes are very specialized as they 
only translate a limited number of proteins encoded in the chloroplast genome. 
Sequence alignments imply high structural and mechanistic similarities between 
chlororibosomes and the translation machinery of other bacteria, for example 
Escherichia coli. On the other hand, proteomic studies identified six plastic-specific 
ribosomal proteins. The aim of the study was to obtain a high-resolution structure of 
the chlororibosomes to gain deeper insights into the architecture of the chlororibosome 
as well as the location of the plastic-specific ribosomal proteins. 
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Structural insights into ribosome rescue by trans-translation, ArfA and ArfB 
(Publication 3 and 4). 
Ribosomes stall on the 3’ end of messenger RNAs without a stop codon (Giudice and 
Gillet, 2013; Keiler and Feaga, 2014). These ‘non-stop’ complexes are rescued by 
tmRNA, the alternative factor A (ArfA) or B (ArfB). While all of these factors recognize 
such stalled ribosomes, they use different strategies to recycle them. tmRNA resumes 
translation on the tmRNA open reading frame, that encodes for a degradation tag and 
includes a stop codon, allowing canonical termination and recycling. ArfB, on the other 
hand, provides its own GGQ motif capable of peptidyl-tRNA hydrolysis. ArfA rescues 
stalled ribosomes together with release factor 2. Our aim was to understand how ArfA 
cooperates with RF2 to alleviate stalling on ‘non-stop’ complexes. Therefore, we 
sought to obtain a high-resolution reconstruction of 70S ribosomes stalled on truncated 
mRNAs in the presence of ArfA and RF2. Based on our results, we were able to 
structurally compare and summarize the available structures of all three rescue factors. 
 
Structural basis for polyproline-induced stalling and rescue by EF-P  
(Publication 5). 
It was shown that the amino acid proline is a poor substrate for peptide bond formation 
as it is a suboptimal A-site acceptor and P-site donor (Doerfel et al., 2013; Johansson 
et al., 2011; Muto and Ito, 2008; Pavlov et al., 2009; Wohlgemuth et al., 2008). Thus, 
prolines significantly reduce the speed of translation. This effect becomes even more 
pronounced, when ribosomes try to translate a consecutive stretch of prolines, 
leadings to arrest of translation in vitro (Doerfel et al., 2013; Ude et al., 2013). Recent 
studies showed that EF-P is required to alleviate stalling on such polyproline-arrested 
ribosomes. Furthermore, EF-P needs to be posttranslationally modified to restore 
translation.  
Structural insights into the mode of action of EF-P on polyproline stalled ribosomes 
have been lacking. Thus, the aim of this study was to obtain high resolution structures 
of ribosomes stalled on consecutive proline sequences in the absence and presence 
of EF-P, to understand why polyprolines are stalling ribosomes and to explain the mode 
of action of EF-P and its modification to rescue such stalling events. 
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3 Cumulative Thesis: Summary of Publications 
 
3.1 Structures of the orthosomycin antibiotics avilamycin and 
evernimicin in complex with the bacterial 70S ribosome 
(Publication 1). 
Stefan Arenz, Manuel F. Juette, Michael Graf, Fabian Nguyen, Paul Huter, Yury 
S. Polikanov, Scott C. Blanchard and Daniel N. Wilson 
Proceedings of the National Academy of Sciences. 113, 7527-7532 (2016) 
 
Increasing multidrug resistance in pathogenic bacteria highlights the need for new 
antibiotics. Two promising candidates are the orthosomycins avilamycin and 
evernimicin as they utilize a unique binding position on the ribosome. Thus, they do 
not show any cross-resistance with other classes of antibiotics and therefore might be 
clinical relevant. In this paper, we present two cryo-EM reconstructions of avilamycin 
and evernimicin bound to the E. coli 70S ribosome. The reconstructions show that both 
antibiotics bind the LSU close to the minor groove of H89 and H91 and interacts with 
arginine residues of L16. This binding site suggests that the presence of either 
avilamycin or evernimicin interferes with the transition of IF2-30S conformation to the 
IF2-70S conformation. Furthermore, complementing smFRET data demonstrated that 
avilamycin and evernimicin prevent accommodation of aa-tRNA at the A-site of the 
ribosome. 
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3.2 Cryo-EM structure of the spinach chloroplast ribosome reveals 
the location of plastid-specific ribosomal proteins and 
extensions (Publication 2). 
Michael Graf, Stefan Arenz, Paul Huter, Alexandra Dönhofer, Jiri Novacek and 
Daniel N. Wilson 
Nucleic Acids Research. 45, 2887-2896 (2017) 
 
Recent advances in cryo-EM allowed the visualization of a variety of ribosomes of 
different species. However, insights into the architecture of chloroplast ribosomes have 
so far been missing. Sequence comparison show a high degree of similarity between 
the translation machinery of chloroplasts and other bacteria, including cyanobacteria 
and γ-proteobacteria, however chloroplast additionally have six non-orthologous 
proteins termed ‘plastid-specific ribosomal proteins’ (PSRP). This works comprises a 
cryo-EM structure of the spinach chlororibosome at 3.6 Å resolution for the LSU and 
5.4 Å resolution for the SSU. With respect to the E. coli 70S ribosome, the structure 
shows that most differences are located in the periphery of the ribosome, whereas the 
functional core remains highly similar. Furthermore, we were able to allocate the 
binding site of PSRPs. Last but not least, we identified a group of protein extension at 
the back of the LSU that might assist in binding of the chlororibosome to the thylakoid 
membrane. 
 
3.3 Structural basis for ArfA-RF2 mediated translation termination 
on mRNAs lacking stop codons (Publication 3). 
Paul Huter, Claudia Müller, Bertrand Beckert, Stefan Arenz, Otto 
Berninghausen, Roland Beckmann and Daniel N. Wilson 
Nature. 541, 546-549 (2017) 
 
Ribosomes that stall at the 3’ end of mRNAs get rescued by either tmRNA, ArfA or 
ArfB. While structures of such stalled complexes together with tmRNA or ArfB have 
been obtained, information on the interplay of ArfA with the ribosome and RF2 have 
been lacking. By using the same A-site truncated SRC as for EF-P, we were able to 
bind ArfA together with RF2 to the stalled complex and subject the sample for cryo-EM 
analysis, resulting in a reconstruction at 3.1 Å. As evident from the structure, ArfA binds 
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close to the decoding site of the A-site. The C-terminus of ArfA resides within the 
mRNA entry channel, a position that would overlap with a 3’ extended mRNA. 
Proceeding from the mRNA entry channel towards the N-terminus, the C-terminal loop 
makes a 90° turn around G530, placing the N-terminus in a pocket formed by the 
decoding center, h18, h44 and S12. The only contact with the LSU is via Lys12 of ArfA 
contacting C1914 of H69 resulting in a ~180° bend that directs the very N-terminus 
towards S12. The described conformation of ArfA creates a large interaction interface 
with RF2, augmenting a β-strand to the β-sheet of domain 2/4 of RF2. The overall 
position of RF2 in complex with ArfA is similar to that observed during canonical 
termination. Surprisingly, the conserved SPF motif of RF2, does not contact ArfA and 
therefore ArfA does not mimic a stop codon. Instead, ArfA interacts with the switch 
loop of RF2. These interactions extend the α-helix α7 of domain 3 by several turns, 
thereby facilitating the opening of RF2 and placement of the catalytical important GGQ 
motif at the PTC. Hence, our structure demonstrates that ArfA not only recruits RF2 in 
a codon-independent manner, but also induces conformation changes that direct 
domain 3 towards the PTC. 
 
3.4 Structural basis for ribosome rescue in bacteria  (Publication 4). 
Paul Huter, Claudia Müller, Stefan Arenz, Bertrand Beckert and Daniel N. Wilson 
Trends in Biochemical Sciences. 42, 669-680 (2017) 
 
Ribosomes that get stuck at the 3’ end of mRNA require the interaction of tmRNA, ArfA 
or ArfB. Based on our previous structure on ArfA, we could compare the mode of action 
of other rescue factors that operate on non-stop complexes. tmRNA is dependent on 
a small protein called SmpB, which probes the empty mRNA entry channel and thereby 
recruits tmRNA. Thus, tmRNA is able to resume translation on its provided ORF that 
leads to canonical termination and degradation of the faulty protein. ArfB probes the 
empty mRNA entry channel via its C-terminus and provides its own GGQ motif allowing 
it to hydrolyse the peptidyl tRNA. ArfA, on the other hand, was shown to be a back-up 
system for tmRNA. Under circumstances, when tmRNA is overwhelmed, a truncated 
version of ArfA is translated, which is capable of recognizing stalled complexes via its 
C-terminus. Binding of ArfA provides a platform for RF2 recruitment that allows 
translation to terminate in a codon-independent manner. 
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3.5 Structural basis for polyproline-mediated ribosome stalling and 
rescue by the elongation factor P (Publication 5). 
Paul Huter, Stefan Arenz, Lars V. Bock, Michael Graf, Jan Ole Frister, Andre 
Heuer, Lauri Peil, Agata L. Starosta, Ingo Wohlgemuth, Frank Peske, Jiri 
Novacek, Otto Berninghausen, Helmut Grubmüller, Tanel Tenson, Roland 
Beckmann, Marina V. Rodnina, Andrea C. Vaiana and Daniel N. Wilson 
 
Prolines are suboptimal substrates for peptide bond formation, as evident by 
biochemical studies showing that they are poor A-site acceptors as well as P-site 
donors. This effect is even more pronounced, when ribosomes encounter stretches of 
consecutive prolines leading to the arrest of translation in vitro. Those polyproline-
arrested ribosomes are rescued by EF-P, which requires a posttranslational 
modification to be functional. By using a previously characterized reporter mRNA as a 
template for translation, we were able to stall ribosomes on a consecutive proline 
stretch in the absence of EF-P. The stalled ribosomes were isolated from the 
translation reaction and subjected for cryo-EM analysis in the absence of EF-P. This 
dataset revealed two major subclasses with resolution ranging from 3.6 to 3.9 Å. In 
both of the reconstructions, it was evident, that the quality of density for the tRNAs was 
progressively deteriorating from the SSU to the PTC. Furthermore, no density for the 
nascent chain could be observed, indicating that polyproline containing nascent chains 
cannot accommodate within the peptide tunnel in the absence of EF-P. As a result, 
consecutive prolines destabilize the peptidyl-tRNA and prevent accommodation of the 
A-site tRNA, which leads to ribosomal stalling. Our second dataset in the presence of 
exogenous modified EF-P showed that the tRNAs are more stably bound due contact 
between EF-P and the body of the P-site tRNA. Furthermore, we could show that the 
modification of EF-P contacts the CCA end of the P-site tRNA. We also observed 
density for the nascent chain, however, due to the presence of EF-P the density was 
fused to the A-site tRNA and therefore no conclusions on the conformation of 
polyprolines in the peptide tunnel could be made.  
Hence we created a third SRC that was based on the above described reporter mRNA 
but was truncated after the second proline. Thus, by eliminating the codon at the A-
site we could exclude any interference by the A-site tRNA. Subjecting this SRCs for 
cryo-EM analysis resulted in a reconstruction at 3.1 Å in the presence of P-tRNA and 
EF-P. Using this approach, we could show that the conformation of the diprolyl moiety 
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deviates from the favored all-trans conformation of prolines. EF-P stabilizes the P-site 
tRNA and most importantly the CCA end via its modification, thereby stabilizing the 
nascent chain by forcing it into an alternative conformation. MD simulations 
complemented this result showing that in presence of EF-P the alignment of substrates 
for peptide bond formation is restored. However, in the absence of EF-P or its 
modification the substrates have an unfavorable geometry and thus peptide bond 
formation is prevented. 
 The high-resolution structure also allowed us to describe critical interactions of 
EF-P with the P-site tRNA as well as the E-site codon and S7. Based on our 
reconstructions we could confirm the result of Katoh et al. showing that the extended 
D-loop architecture of tRNAPro is critical for the recognition of polyproline-stalled 
ribosomes by EF-P. Furthermore, we could show that Tyr183 and Arg186 interact with 
residues of the 16S rRNA as well as the ASL of the P-site tRNA. Using our well-
established firefly luciferase translation assay, we could show that mutation of these 
two residues abolished the activity of EF-P on stalling.  
  Additionally, we observed interactions of domain 3 of EF-P with the E-site codon 
and ribosomal protein S7. Based on our structural insights, we suggested that this loop 
region of domain 3 might recognize the nature of the E-site codon. Surprisingly, 
mutations of residues of domain 3 that interact with the E-site codon and S7 did not 
significantly reduce the rescue activity of EF-P, raising the question about the 
importance of these interactions. Further biochemical experiments will be needed to 
elucidate the role of those interactions.  
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4 Discussion 
 
4.1 Rescue of ‘non-stop’ complexes with focus on ArfA 
 
The five recently published structures on ‘non-stop’ ribosomal complexes in the 
presence of ArfA and RF2 allow us to not only complete the picture of the ArfA-RF2 
rescue mechanism, but also provides the opportunity to compare the different rescue 
pathways with each other (Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; 
Ma et al., 2017; Zeng et al., 2017). The structures are in excellent agreement with each 
other, despite the different strategies used for the formation of the SRCs. These 
different approaches will be discussed in the following section. 
Four out of five ‘non-stop’ complexes were formed by incubating 70S ribosomes 
with a small mRNA containing SD-sequence, linker sequence and an AUG start codon 
(Demo et al., 2017b; James et al., 2016; Ma et al., 2017; Zeng et al., 2017). This led 
to programmed ribosomes with the AUG codon in the ribosomal P-site and a vacant 
A-site. Furthermore, these complexes were incubated with either deacylated tRNAfMet 
or non-hydrolysable fMet-NH-tRNAfMet together with C-terminal truncated ArfA and 
RF2. These reconstructions resulted in one major population of 70S ribosomes within 
the cryo-EM datasets that were programmed with P-site tRNA, RF2 and ArfA. One 
exception is the dataset of Demo et al. that revealed, besides the presence of E-site 
tRNA, a second major class with RF2 in its closed form (42% after subtraction of junk 
particles compared to 34% with RF2 in its open conformation on the ribosome). 
Huter et al. created a truncated mRNA based on the nlpD ORF, leading to 
stalled ribosomes that are programmed with a peptidyl-tRNAPro in the P-site and a 
vacant A-site when translated (see EF-P) (Huter et al., 2017a, 2017c). These stalled 
ribosomes were also incubated with C-terminally truncated ArfA but contrary to other 
studies RF2-GAQ was used. Hence, this experimental set up represents the only ‘non-
stop’ ribosomal complex, as the other SRCs are rather initiation complexes. 
Nevertheless, sorting of this cryo-EM dataset resulted in two major subclasses after in 
silico sorting. One class was programmed with peptidyl-tRNAPro in the P-site, C-
terminal truncated ArfA and RF2 (49% of particles of the dataset after subtraction of 
junk particles), the other class had additional density for E-site tRNA (40% of particles 
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of the dataset after subtraction of junk particles). However, besides the presence of 
the E-site tRNA, the two classes do not differ in context to ArfA-mediated rescue.  
 The different approaches for creating the SRCs in the presence of ArfA and RF2 
resulted in two observed states dependent on the nature of tRNA and RF2 used (Demo 
et al., 2017b; Huter et al., 2017c; James et al., 2016; Ma et al., 2017; Zeng et al., 2017). 
While the usage of deacylated tRNA mimics a post-hydrolysis state, using RF2-GAQ 
or non-hydrolyzable P-tRNA mimics a pre-hydrolysis state. Nevertheless, these two 
different states did not lead to changes within domain 3 of RF2 at the PTC and 
therefore the same conclusions could be made from all the studies. Remarkably, none 
of the applied strategies resulted in a ribosomal complex with only ArfA bound, 
indicative for a high affinity of RF2 for the ribosome once ArfA is recruited. 
 
 
Figure 13. Transition of RF2 from a closed to open state on the ribosome in 
presence of ArfA. (A) Conformation of the N-terminus of ArfA in presence of closed (red, 
I) and open RF2 (blue, II). (B)  Interaction of ArfA (red) with elements of the decoding 
center in presence of closed RF2 (blue, I) with the switch loop highlighted in pale yellow. 
(C) Interaction of ArfA (red) with elements of the decoding center in presence of open 
RF2 (blue, II)  with the switch loop highlighted in pale yellow. (D) Superposit ion of RF2 in 
its closed (blue) and open conformation (cyan) in context of ArfA mediated rescue. Taken 
from (Demo et al., 2017b) 
 
 Lastly, James et al. created two additional SRCs, one with ArfA-A18T and RF2 
and another one with ArfA but T. thermophilus rather than E. coli RF2 resulting in the 
closed conformation of RF2 bound to the ribosome that is similar to the compact 
conformation of RF2 in solution (James et al., 2016; Vestergaard et al., 2001). The 
observed closed conformation of RF2 in those two independent datasets as well as in 
the dataset of Demo et al. is nearly identical, revealing several interesting points  
(Demo et al., 2017b; James et al., 2016). In all of those structures, the N-terminus of 
ArfA as well as the switch loop of RF2 remained disordered, whereas the contacts 
between the β-strand of ArfA and β-strand β 4 of domain 2 of RF2 are already 
established (Figure 13A+B). Hence, the observed closed conformations might be a 
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pre-accommodated conformation of RF2 as proposed for canonical termination. 
Furthermore, decoding nucleotides A1492 and A1493 of h44 adopt a different 
conformation when compared to the open conformation of RF2 in complex with ArfA 
(Figure 13B+C). The nucleotides reside inside helix 44 and are sandwiched between 
A1913 of H69 and Pro23 of ArfA. In presence of the open conformation of RF2, 
however, A1493 flips out and allows A1913 of H69 to stack on A1492. This newly 
established interaction brings H69 closer to the SSU and thereby allows C1914 to 
stabilize the N-terminal domain of ArfA and coordinate its 180° turn to establish 
interactions with S12 (Figure 13C) (Demo et al., 2017b; Huter et al., 2017c; James et 
al., 2016; Ma et al., 2017; Zeng et al., 2017). The ArfA inactivating mutant A18T fails 
to stabilize the N-terminus but does not interfere with RF2 binding (James et al., 2016). 
Ala18 resides within the α-helix of ArfA but does neither interact with the ribosome nor 
RF2. Instead, the residue is in close proximity to Ile11 of ArfA that is located in the N-
terminal part of ArfA that runs antiparallel to the α-helix, when stabilized. Hence, a 
polar Thr cannot pack against Ile11 and would interfere with the placement of the N-
terminus of ArfA. 
Positioning of the N-terminal domain of ArfA allows it to interact with elements of the 
switch loop (Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; Ma et al., 
2017; Zeng et al., 2017). Especially a hydrophobic patch formed by residues Leu19, 
Leu 24 and Phe25 of the α-helical part of ArfA interact with Trp319 of the switch loop, 
inducing an alternative conformation of the latter element (Figure 13C). This is in line 
with the observed closed conformation in presence of T.thermophilus RF2, as it has a 
distinct switch loop composition failing to interact with the hydrophobic patch (James 
et al., 2016). Thus, the α7 of domain 3 of RF2 gets extended similar to the conformation 
during canonical termination. This leads to the positioning of domain 3 into the PTC 
(Figure 13D).  
The five cryo-EM reconstructions also provide a structural basis on how ArfA is 
able to discriminate between RF1 and RF2 (Demo et al., 2017b; Huter et al., 2017c; 
James et al., 2016; Ma et al., 2017; Zeng et al., 2017). Comparing the sequence of 
RF1 and RF2 as well as aligning RF1 on to RF2 in complex with ArfA identifies several 
residues within the switch loop and domain 2 of RF1 that might interfere with the 
recruitment by ArfA. Especially the hydrophobic interface between by Ile16, Leu20 and 
Phe25 of Arfa and Val198, Phe217 and Phe 221 of β5 element of RF2 would be 
disrupted as the latter amino acids would be substituted to Gly, Ala and Ala. As 
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previously mentioned this hydrophobic interface is important for the initial recruitment 
of RF2. This is in line with biochemical studies showing that RF1 cannot even bind to 
the ribosome in presence of ArfA. 
An interesting question that is raised by the amount of cryo-EM reconstructions 
is the fact that Demo et al. could obtain the closed conformation of RF2 using wt RF2 
and ArfA (Demo et al., 2017b). On the one hand, this indicates that the closed 
conformation might represent a bona fide intermediate state as it represents a major 
subpopulation within their reconstruction. On the other hand, four out of five groups 
were not able to detect this conformation, probably due to differences within the 
experimental set-up. Indeed, Demo et al. were the only group that used the FREALIGN 
software for processing the dataset, whereas the other groups used RELION or a 
FREALIGN/RELION combination (Demo et al., 2017b; Huter et al., 2017c; James et 
al., 2016; Ma et al., 2017; Zeng et al., 2017). However, differences between those two 
softwares cannot account for the fact that there was no trace of the closed 
conformation within four out of five reconstructions. Even more, classification of the 
dataset of Huter et al was performed with FREALIGN. Additionally, the percentage of 
particles analyzed after the initial 3D classification is comparable for Demo et al. and 
Huter et al, with approximately 60% of particles being further classified (Demo et al., 
2017b; Huter et al., 2017c). The remaining 40% of particles were discarded as they 
either showed no relevant programming of ribosomes with respect to ArfA and RF2 or 
due to poor particle alignment. Furthermore, James et al used 82% of particles after 
initial 3D classification for further analysis (James et al., 2016). Thus, it seems unlikely 
that particles programmed with the closed conformation of RF2 were discarded during 
processing of the datasets. In this respect, the data of Ma et al. and Zeng et al could 
not be further analyzed as the sorting schemes lack the necessary details (Ma et al., 
2017; Zeng et al., 2017). 
Hence, additional factors might have contributed. One possibility is the different 
buffer conditions used for preparing the cryo-EM grids, as different concentrations of 
Mg2+ or other ions might have an effect. In this regard, it is interesting that Demo et al. 
used by far the highest MgCl2 concentration (20 mM of MgCl2). High Mg2+ 
concentrations result in more rigid ribosomes (Yamamoto et al., 2010). Thus, the rigid 
conformation of the ribosome might have led to a prolonged transition time from the 
closed to open conformation for RF2. Another interesting possibility is that only Huter 
et al. and Demo et al. used an N-terminal His6-tag, whereas the other groups removed 
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the N-terminal tags during purification of the protein. The His-tag itself might have led 
to stabilization of the closed conformation in the case of Demo et al. but did not in the 
case of Huter et al, as they had an additional 3C-protease cleavage tag between the 
His-tag and the first amino acid of ArfA. A counter argument is the fact that there is no 
density for the N-terminal His-tag of ArfA in presence of closed RF2. It is important to 
mention, that both groups showed biochemically, that the purified proteins are active 
in rescuing ‘non-stop’ complexes. To summarize, there might be many reasons why 
the closed conformation was only observed by Demo et al. However, the high number 
of particles occupied with RF2 might not reflect a physiological situation and is most 
likely caused by the experimental set up changing the equilibrium between closed and 
open conformation. It would be interesting to further elucidate the reason behind that 
as it would provide a possible tool to visualize intermediate states that otherwise would 
be too transient for cryo-EM. 
Another difference within the five different reconstructions was the length of the 
ArfA protein (Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; Ma et al., 
2017; Zeng et al., 2017). As described in the introduction, full length ArfA is 72 aa but 
aggregates in vivo due to its hydrophobic C-terminus. Moreover, it is mainly C-terminal 
truncated ArfA that is active on non-stop ribosomes in vivo. Hence, C-terminal 
truncated versions of ArfA were used, that either lacked 12 (60 aa length in total) or 17 
aa (55 aa length in total). These truncated versions were also shown to be functional 
in previous biochemical investigations (Chadani et al., 2012; Kurita et al., 2014b). 
Interestingly, in every reconstruction only up to 48 aa could be modelled, indicating 
that the very C-terminal residues do not contribute to the functionality of ArfA (Figure 
13A) (Demo et al., 2017b; Huter et al., 2017c; James et al., 2016; Ma et al., 2017; 
Zeng et al., 2017). In line with that is the poor sequence conservation of the very C-
terminus (Kurita et al., 2014b).  
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Figure 14. Monitoring of the vacant mRNA entry channel by the C-termini of 
ribosome rescue factors. (A) Probing of the mRNA entry channel by ArfA. (B) Probing 
of the mRNA entry channel by SmpB. (C) Probing of the mRNA entry channel by ArfB. 
(D) Superimposit ion of full- length mRNA on to the 70S-ArfA-RF2 ribosome. Posit ively 
charged residues are highlighted in red. Conservation of the respective C-terminus is 
represented as a Weblogo. Taken from (Huter et al., 2017b) 
 
The visualization of the C-terminal domain of ArfA allows us to compare it with 
the C-termini of SmpB and ArfB (Figure 14A-C). Both of them, SmpB and ArfB, probe 
the mRNA entry channel by forming an α-helix (Gagnon et al., 2012; Neubauer et al., 
2012). Like for ArfA, the respective C-terminal domains are enriched in conserved 
positively charged stretches that help to place the C-termini inside the mRNA channel 
(Huter et al., 2017b). The importance of these conserved stretches is underlined by 
mutational studies. In case of SmpB, triple alanine substitution within these positive 
stretches interfere with recycling activity, whereas it is tolerant towards single 
substitutions (Miller et al., 2011; Sundermeier et al., 2005). The C-terminal domain of 
ArfB is even more sensitive as the substitution of a single positively charged residue 
already abolishes its activity (Kogure et al., 2014). For the C-terminus of ArfA, the 
mutational studies are a bit unambiguous. While one group reports that single 
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mutations of positively charged residue to Cys (e.g R41C) does not interfere with its 
activity, other groups report a severe decrease in activity (Kurita et al., 2014b; Ma et 
al., 2017; Zeng et al., 2017). Furthermore, evidences for triple substitutions, like in the 
case of SmpB, are missing. However, it seems likely that such a mutation would 
interfere with the anchoring of the C-terminal tail of ArfA, as judged by the cryo-EM 
reconstructions.  
In contrast to the C-termini of SmpB or ArfB that form helices and follow the 
predetermined path of the mRNA channel, the C-terminus of ArfA appears to rather 
block the tunnel and therefore is less tolerant towards 3’ extended mRNAs (Figure 
14B-D) (Huter et al., 2017b). In more detail, the C-terminal domain would overlap with 
the second or third nucleotide of the A-site codon (Demo et al., 2017b; Huter et al., 
2017c; James et al., 2016; Ma et al., 2017; Zeng et al., 2017). Indeed, these structural 
observations are in agreement with biochemical data. The efficiency in ribosomal 
recycling by ArfA-RF2 decreases with extended mRNA by up to four residues into the 
A-site, with nearly no activity after six nucleotides (Shimizu, 2012; Zeng and Jin, 2016). 
By contrast, SmpB and ArfB are more tolerant towards extended 3’ mRNAs (Asano et 
al., 2005; Ivanova et al., 2004; Kurita et al., 2014a; Shimizu, 2012). In vitro data showed 
that trans-translation and ArfB are active up to 9-15 nt. downstream from the P-site 
codon. The length dependency is less restricted in vivo, as pausing in the middle of 
mRNAs possibly induces nucleolytic cleavage that generates non-stop complexes 
(Janssen et al., 2013). Thus, combining the structural and biochemical data it seems 
likely that the C-termini of those rescue factors compete with the presence of mRNA 
in the mRNA entry channel. Accommodation of the C-terminus in the mRNA channel 
is essential for stable binding of the rescue complex. Notably, biochemical assays 
could show that ArfA and RF2 can bind to the ribosome regardless of the length of the 
3’extension of the mRNA but remains inactive concerning recycling activity (Kurita et 
al., 2014b). It seems that the C-terminus in such a case fails to stably bind the mRNA 
channel and induce a favorable conformation. 
Upon stabilization of the C-termini within the mRNA entry channel all of the three 
factors form contacts with the universally conserved nucleotides G530, A1492 and/or 
A1493 (Huter et al., 2017b). All three factors interact with G530 via interactions of 
Glu30 of ArfA, Arg118 of ArfB or His136 of SmpB. In contrast, the conformation of 
A1492 and A1493 differs depending on the rescue factor. In the presence of ArfA or 
SmpB, A1493 is flipped out of helix 44 and a stacking interaction between A1492 and 
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A1913 of the 23S rRNA can be established. Binding of ArfB on the other hand induces 
a conformation in which A1493 remains inside the helix and is sandwiched between 
Pro110 of ArfB and A1913. Mutations effecting decoding nucleotides (G530A, A1492G 
and A1493G) are lethal in the context of aa-tRNA accommodation but seem to be 
tolerated in the case of tmRNA recycling (Miller et al., 2011; Schrode et al., 2017). 
Such data is lacking for ArfA and ArfB. However, amino acid substitutions of residues 
that interact with decoding nucleotides (Pro23Cys, Glu30Cys for ArfA, Pro110Ala and 
Arg118Lys for ArfB) do not significantly impair their function (Kogure et al., 2014; Kurita 
et al., 2014b; Ma et al., 2017; Zeng et al., 2017). It is important to mention that mutation 
of His136Ala of SmpB reduces the rate of GTP hydrolysis by EF-Tu, but is not essential 
for peptidyl transfer (Kurita et al., 2014a; Miller and Buskirk, 2014). Therefore, it seems 
plausible that the decoding residues do not actively contribute to the positioning of the 
factors, but rather adopt conformations that do not interfere with the positioning of the 
rescue factors.  
Taken together, the recently published cryo-EM structures on ArfA, as well as 
structural studies on ArfB and tmRNA/SmpB revealed molecular details on how those 
factors recognize a ‘non-stop’ ribosomal complex and mediate ribosome recycling 
(Huter et al., 2017b). All of those factors monitor the empty mRNA channel via their 
respective C-termini, thereby showing different degree of tolerance towards 
3’extended mRNA. Accommodation of the C-termini induces conformational changes. 
In the case of SmpB this leads to the stabilization of the tmRNA/SmpB complex 
resulting in the positioning of the CCA end of tmRNA into the PTC. Hence, peptide 
bond formation between the peptidyl-tRNA and the Ala charged tmRNA in the A-site 
can occur. Translocation replaces the ORF of tmRNA with the aberrant mRNA and 
translation can continue until the ribosome encounters the stop codon on the MLD of 
mRNA, inducing canonical termination via class 1 release factors and subsequent 
recycling of subunits. The ORF provided by the MLD encodes for a degradation tag, 
which is recognized by specific proteases resulting in degradation of the faulty protein 
ArfB, on the other hand, provides its own GGQ motif making it independent of 
class 1 release factors. Upon stabilization of the C-terminus, the N-terminus gets 
placed towards the PTC allowing the GGQ motif to mediate peptidyl-hydrolysis.  
ArfA again utilizes a different approach to mediate rescue of non-stop 
complexes. Interaction of the C-terminus with the empty mRNA channel induces 
conformational changes within ArfA. Thereby, ArfA provides a platform for RF2 
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recruitment that permits RF2 to transit from a closed to an open conformation placing 
the catalytic important domain 3 towards the PTC. 
Although the molecular mechanisms behind ‘non-stop’ mediated rescue is well 
understood, their distribution and interplay among species remains puzzling (Keiler 
and Feaga, 2014). While it is clear that trans-translation plays an essential role in 
nearly all bacteria, the interplay with ArfA and ArfB remains elusive. This is best 
exemplified in Neisseria gonorrhoeae (Huang et al., 2000). In this organisms trans-
translation is essential despite the presence of ArfA. On the other hand, N.gonorrhoeae 
ArfA is able to compensate the ∆ssrA∆arfA double deletion in E.coli (Schaub et al., 
2012). In contrast to that, ArfB is present in E.coli but can compensate the lethality of 
∆ssrA∆ArfA only if overexpressed (Chadani et al., 2011a). In Caulobacter crescentus, 
however, chromosomally encoded ArfB is able to compensate the lack of tmRNA 
despite the absence of ArfA (Keiler and Feaga, 2014). It is hard to draw general 
conclusions as all findings are based on a limited set of examined species. Hence, it 
is impossible to explain, why sometimes ArfA can compensate for the loss of trans-
translation in vivo, but not ArfB and vice versa. Last but not least, the deletion of ssrA 
in Bacillus subtilis is not lethal (Wiegert and Schumann, 2001). Although it is likely that 
yet unknown rescue factors compensate for the loss of tmRNA, there is no certainty. 
On the other hand it raises the question of yet undiscovered alternative rescue factors 
(Keiler and Feaga, 2014). Last but not least, these studies were all carried out under 
controlled laboratory conditions, which might favor the importance of one factor over 
the other. One needs a systematic approach, in different bacterial systems as well as 
under varying environmental conditions, to fully understand the interplay of these 
factors. 
Finally, due to the importance of recycling of non-stop ribosomal complexes in bacteria, 
these factors would be preferable targets for antimicrobial agents. Moreover, 
eukaryotic cells utilize different pathways to deal with ‘non-stop’ complexes (Buskirk 
and Green, 2017). Indeed, agents that target trans-translation have already been 
discovered (Alumasa and Keiler, 2015; Macé et al., 2017; Ramadoss et al., 2013b).It 
is noteworthy to mention that the initially described inhibitor KKL-35 turned out to not 
specifically target trans-translation (Macé et al., 2017). On the other hand, it was 
demonstrated that antisense RNAs targeting the MLD of tmRNA or small proteins 
mimicking SmpB are an effective agent to silence trans-translation. 
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Nevertheless, as already mentioned above, the loss of one system can often be 
compensated by another one. Thus, such agents might be used as an adjuvant in 
combination with other antibiotics but not as a main therapy. 
 
4.2 Structural insights into polyproline-mediated ribosome stalling 
and rescue by EF-P 
 
Prolines harbor physical and chemical properties that interfere with peptide bond 
formation. This effect is most dramatic, when ribosomes encounter stretches of 
consecutive prolines, as it leads to arrest of translation in vitro (Doerfel et al., 2013; 
Ude et al., 2013). It was shown that EF-P is responsible for alleviating stalling on 
polyproline stretches, however, the mode of action of EF-P on unlocking these arrested 
ribosomes remained elusive. Biochemical studies could show that the activity of EF-P 
is dependent on the posttranslational modification of a conserved residue (Lys34 in E. 
coli) within the tip of the loop of domain 1 (Doerfel et al., 2013; Ude et al., 2013). In 
E.coli, this posttranslational modification system comprises the sequential action of 
three enzymes, namely EpmB, EpmA and EpmC, resulting in a ε(R)-β-lysyl-
hydroxylysine modification at position Lys34 (Bailly and de Crécy-Lagard, 2010; 
Navarre et al., 2010; Peil et al., 2012; Yanagisawa et al., 2010).  
On the basis of the structure of Blaha et al. using unmodified EF-P bound to the 
70S ribosome it was suggested that the modification extends towards the PTC and is 
either directly involved in the catalysis or indirectly by stabilization of the peptidyl-tRNA 
(Blaha et al., 2009; Doerfel et al., 2015; Lassak et al., 2016). In the light of new 
biochemical insights and the absence of modified EF-P, interpretation of the structure 
is limited as it was based on the assumption that EF-P is an initiation factor. Thus, we 
sought to obtain high-resolution structures of polyproline-stalled ribosomes in absence 
and presence of modified EF-P using single particle cryo-EM. The study was 
complemented with molecular dynamics simulations to gain further insights into the 
mechanism of EF-P (Huter et al., 2017a). The applied strategies and the resulting 
observations and conclusions as well as an outlook will be given in the following 
sections 
To elucidate the mechanism of polyproline induced stalling and the mode of 
action of EF-P to alleviate this arrest, we created RNCs based on a reporter mRNA 
coding for NlpD-PPP in the absence of EF-P. To enhance the efficiency of stalling we 
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introduced an Arg upstream of the PPP motif as was demonstrated by Starosta et al. 
(Starosta et al., 2014c). The resulting SRCs were subjected to cryo-EM in the absence 
(Dataset 1) or presence of EF-P (Dataset 2). In silico sorting of dataset 1 revealed two 
major subpopulations comprising 70S ribosomes that were either programmed with a 
peptidyl-tRNAPro in the P-site or a peptidyl-tRNAPro in the P-site and a Pro-tRNAPro in 
the A-site. Sorting of dataset 2 revealed 70S ribosomes that were either programmed 
with a peptidyl-tRNAPro or peptidyl-tRNAPro in the P-site, a Pro-tRNAPro in the A-site as 
well as EF-P being located in between the P and E-site of the ribosome, spanning both 
subunits. 
By comparing both datasets, the following conclusions could be made. In the 
absence of EF-P, the density for the P-site tRNA was less uniform and strong as 
compared to the volume of dataset 2 containing A-tRNA, P-tRNA and EF-P. In more 
detail, while the density around the ASL of the P-tRNA was comparable to the density 
of the 30S, it progressively deteriorated towards the 50S. Furthermore, the CCA end 
was less resolved. This effect was even more pronounced in the case of the A-site 
tRNA in dataset 1, with no density for the CCA end even at low threshold. In line with 
the continuous decline of map quality for the tRNAs was the lack of a defined density 
for the nascent chain in absence of EF-P, which came as a surprise. So far, all cryo-
EM structures of stalled ribosome nascent chain complexes (RNCs) showed clear 
density for the nascent chain (Ito and Chiba, 2013; Su et al., 2017; Wilson et al., 2016). 
Secondly, prolines are restrained in their conformational freedom and restrict the 
possible conformation of its neighboring residues, thus one should expect a defined 
density for the nascent chain (Morris et al., 1992). However, the lack of density in two 
independently processed volumes indicates that the nascent chain is flexible and 
therefore could not be resolved.  
From the class containing EF-P, the following observations could be made. EF-
P occupied the same position as was observed in the Tth 70S ribosome (Blaha et al., 
2009). In this position, EF-P does stabilize the CCA end via its modification as well as 
the body of the peptidyl-tRNA as apparent by the uniform quality of density and local 
resolution calculations for the P-site tRNA. Furthermore, the quality for the density of 
A-site tRNA improved significantly. Consistent with this notion, the very N-terminus of 
L27 could be resolved, whereas density for the N-terminus of L27 was lacking in 
presence of A-site tRNA in dataset 1. This is indicative of a productive conformation of 
the PTC in the presence of EF-P (Polikanov et al., 2014; Voorhees et al., 2009b). 
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Additionally, although density for the nascent chain could be observed, it was rather 
fused to the A-site tRNA than the P-site tRNA. Hence, we concluded that the volume 
represents a post peptide bond formation state with a deacylated tRNA in the P-site 
and a peptidyl-tRNA in the A-site. Thus, no conclusions on the conformation of prolines 
in context of stalling could be made as the nascent chain was transferred.  
However, comparing the two different SRCs revealed several interesting facts. 
First of all, in the absence of EF-P the nascent chain appears to be flexible and parts 
of the A-site tRNA that are close to the PTC remained disordered. Thus, one can 
conclude that polyproline stretches destabilize the peptidyl-tRNA and thereby indirectly 
prevent A-tRNA accommodation. Or in other words, the flexibility of the nascent chain 
interferes with proper alignment of substrates within the PTC. EF-P, on the other hand, 
stabilizes the peptidyl-tRNA and especially the CCA end via its modification resulting 
in a conformation of the PTC favorable for peptide bond formation.  
Another interesting observation is the high proportion of empty ribosomes in 
both datasets (30% of particles in dataset 1, 19% of particles in dataset 2). This might 
have been a result of the purification procedure of the SRCs after elution from the 
Talon beads, however, no vacant 70S class could be detected in dataset 3 (will be 
described later), although the same procedure was applied to purify those SRCs. An 
alternative and highly speculative explanation is peptidyl-tRNA drop-off as a result of 
translational stalling. Peptidyl-tRNAs that carry short nascent peptides can dissociate 
from the ribosome (Cruz-Vera et al., 2004; Gonzalez de Valdivia and Isaksson, 2005), 
whereas peptidyl-tRNAs that carry more than five amino acids are stably associated 
with the ribosome (Ivanova et al., 2005). Although we use a template for our SRCs that 
causes stalling at position corresponding to the 72 aa of the ORF, the flexibility of the 
nascent chain as well as the resulting destabilization of the P-site tRNA and prolonged 
arrest might allow peptidyl-tRNA drop-off. This is in agreement with dataset 3, as the 
interaction of the stably bound peptidyl-tRNA and nascent chain hold the complex 
tightly together and thereby prevent drop-off (Ivanova et al., 2005). Thus, due to the 
absence of any cellular factors like tmRNA and the resulting prolonged arrest, peptidyl-
tRNA drop-off might occur. 
Nevertheless, as explained no conclusions on the conformation on prolines 
could be made due to flexibility of the nascent chain in absence and post-peptide bond 
state in the presence of EF-P. Furthermore, the resolution of the class containing EF-
P in dataset 2 was not good enough to unambiguously model EF-P and its modification. 
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To further gain insights we created a third SRC based on a variant of the 
previously used NlpD template. In more detail, we truncated the ORF after the second 
proline of the triple proline motif. This resulted in ribosomes being programmed with 
the peptidyl-tRNA at the second proline, but additionally bearing a vacant A-site. 
Moreover, we bound the antibiotic evernimycin to the SRC which is known to bind to a 
site of the ribosomal A-site that would overlap with the elbow region of an A-site tRNA 
and hence would be an additional sterical hinderance for the presence of A-site tRNA 
(Arenz et al., 2016). By doing this we were able to eliminate the influence of the A-site 
tRNA allowing us to catch translation in a pre-peptide bond formation situation. 
Furthermore, the homogeneity of the sample was increased, enhancing the average 
resolution of reconstructions. It is important to mention, that this SRCs were created 
using the PURExpress In Vitro Protein Synthesis Kit (NEB) and not in the E.coli lysate 
based translation system as mentioned before. The lysate based translation system 
comprises rescue factors like tmRNA, ArfA and ArfB that would immediately recycle 
the ‘non-stop’ complex (Huter et al., 2017b).  
In silico sorting revealed two major subpopulations being programmed with 
either P-site tRNA and EF-P or P-site tRNA and E-site tRNA. The obtained resolution 
allowed us to generate a molecular model of EF-P as well as of its modification. Based 
on this several critical residues could be identified.  
For example, we observed a possible backbone interaction of Asp69 with 
residue U17a of the D-loop of tRNAPro. The presence of this additional residue within 
the D-loop is unique to the isomers of tRNAPro as well as tRNAfMet but is lacking in all 
other tRNAs (Katoh et al., 2016). Additionally, it was shown to be an essential 
recognition element for EF-P. Notably, we do observe the same interaction in the Tth. 
EF-P ribosome structure of Blaha et al (Blaha et al., 2009). On the other hand, such 
an interaction cannot be established in the presence of other tRNAs as they lack this 
additional nucleotide. Remarkably, the extended D-loop structure of tRNAPro is a 
conserved feature among prokaryotic species indicating that recognition of the 
additional D-loop nucleotide by EF-P is a general mechanism (Katoh et al., 2016). 
Moreover, this interaction is similar to the interaction of EttA, an ABC-F protein that 
binds to 70SIC and thereby regulates the entry into translation elongation cycle in 
energy-depleted cells (Boël et al., 2014). Böel et al could show biochemically that Etta 
has specificity for tRNAfMet. Additionally, low resolution cryo-EM reconstructions 
provide a structural evidence for the interaction of Etta with the extended conformation 
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of tRNAfMet (Chen et al., 2014). Hence, D-loop recognition is a property shared by those 
two factors that bind in the ribosome E-site. It remains to be determined if other E-site 
associated ribosomal factors utilize similar recognition elements. 
eIF5A on the other hand might not rely on such a recognition motif, as first of 
all, the tRNAPro isomers in eukaryotes do not have an extended D-loop and secondly, 
recent ribosome profiling data revealed a diverse range of stalling motifs, not restricted 
to polyprolines, that are alleviated by eIF5A (Pelechano and Alepuz, 2017; Schuller et 
al., 2017). Thus, it is seems likely that eIF5A uses a more general mechanism to 
recognize stalled ribosomes. Indications for such a mechanism come from the study 
of Schmidt et al. using the elongation inhibitor cycloheximide to arrest cells (Schmidt 
et al., 2016). In the presence of this drug, the E-site tRNA cannot bind and allows eIF5A 
to bind (Buskirk and Green, 2017; Schmidt et al., 2016; Schneider-Poetsch et al., 
2010). Indeed, as eIF5A and EF-P need to enter the ribosome through the E-site, 
dissociation of the E-site tRNA upon prolonged stalling might allow eIF5A to recognize 
arrested ribosomes. The same mechanism can be applied for EF-P. Nevertheless, EF-
P might require additional recognition motifs as the speed of translation elongation is 
faster in bacteria than in eukaryotes and requires a more coordinated response. 
Other important contacts can be found within domain 3 of EF-P that interacts 
with the SSU as well as the P-site tRNA. In particular, two conserved residues Tyr183 
and Arg186 are interacting with A42 of the P-site tRNA as well as G1338 of the 16S 
rRNA. Interestingly, G1338 and A1339 are part of an interaction network that interacts 
with the ASL, including residue A42 of the P-site tRNA and thereby stabilizing the tRNA 
and prevent movement into the E-site (Abdi and Fredrick, 2005; Blaha et al., 2009; 
Selmer et al., 2006). On the other hand, it was suggested that interactions between 
the ASL and this part of the 16S rRNA need to be disrupted during translocation, 
probably by movements of the head (Dunkle et al., 2011; Selmer et al., 2006). Hence, 
we generated two variants of modified EF-P bearing the substitution of Tyr183Ala or 
Arg186Ala. Indeed, translation of a firefly luciferase (Fluc) reporter mRNA bearing a 
triple proline motif in presence of those mutants showed no activity. This suggests that 
those two residues are critical for the activity of EF-P. However, based on the limitation 
of this assay, we cannot address if the inactivity is due to the loss of stabilization of the 
P-site tRNA or might results from other events for example like translocation. 
Furthermore, we observed contacts of loop 1 of domain 3 of EF-P with the E-
site codon of the mRNA as well as ribosomal protein S7, which is in clear contrast to 
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the previously determined Tth. EF-P-ribosome structure, where the loop was 
disordered (Blaha et al., 2009). Especially highly conserved residues Gly144, Asp145 
and Thr146 (GDT motif) form backbone interactions with the E-site codon and Arg78 
of S7. In this conformation of the loop, S7 shifts about 7 Å towards the E-site codon, 
when compared to the volume of dataset 2 without EF-P but is essentially the same in 
the presence of E-site tRNA (from dataset 3). Based on our structural insights we 
designed various mutants addressing the role of loop 1 of domain 3 and concluded 
that the loop might be able to recognize proline codons (CCX). We rationalized this 
assumption as the Tth EF-P ribosome complex was programmed with a short mRNA 
displaying an AAA codon in the E-site and thus failed to interact with loop 1 as the AAA 
codon would sterically overlap with the path of our modeled loop 1. The same scenario 
would be true for a GGG codon when occupying the E-site. On the other hand, CUG 
(leucine codon) and CCG (proline codon) would not interfere with the position of loop 
1 and the difference between these two codons would be the presence of an additional 
interaction of the side chain of Asp145 with the second nucleotide of the E-site codon 
(Figure 15A+B). In contrast to that, eIF5A lacks domain 3 and its function is not limited 
to proline stalled ribosomes as revealed by ribosomal profiling (Pelechano and Alepuz, 
2017; Schuller et al., 2017). We concluded that loop 1 might recognize the nature of 
the codon and together with the D-loop interaction cause specificity for proline stalled 
ribosomes. 
Retrospectively seen, there might be an alternative explanation for the absence 
of loop 1 within the Tth EF-P ribosome structure. Jenner et al. compared the 
conformation of the E-site of the 30S in 70SIC as well as for elongating ribosomes 
(Jenner et al., 2007, 2010). Based on their observation, 70SIC programmed with 
mRNAs containing a SD-sequence are in a rather ‘tense’ conformation, which makes 
the E-site codon less favorable for codon-anticodon interactions. This is most likely 
due to the close proximity of the SD-anti-SD helix to the E-site codon. Additionally it 
makes sense from a biological point of view as an initiation complex does not have an 
E-site tRNA. However, the mRNA in an elongating complex is in a relaxed 
conformation due to the increased distance of the E-site codon and SD-sequence. 
Therefore, the disordered loop 1 as observed in the crystal structure of Tth EF-P 
ribosome complex might be a result of the tense conformation of the mRNA rather than 
the presence of the AAA codon. 
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In our experiments it was shown that despite the high degree of conservation of 
the GDT motif substitution to 144AAA146 failed to dramatically reduce the activity of EF-
P, probably due to the nature of mainly backbone interactions. Hence, it seems unlikely 
that the nature of the codon in the E-site is critical for the rescue activity on polyproline 
stalled ribosomes. It might be that GDT is an optimal amino acid sequence because it 
facilitates an active backbone architecture of loop 1. Thus, the importance of loop 1 
might not directly correlate with specific recognition of the E-site codon.  
Binding of loop 1 induces structural rearrangements within the 30S E-site that 
are comparable to the structural rearrangements in presence of E-site tRNA, for 
example the placement of the tip of S7 towards the E-site codon (Figure 15C) (Jenner 
et al., 2007; Yusupova et al., 2006). Indeed, mimicking the role of the E-site tRNA on 
the 30S might have an important physiological role. For example it was shown that 
truncations within the region of S7 (∆Arg77-Tyr84) that are normally contacting the E-
site codon as well as the E-site tRNA stimulate -1 and +1 frameshifting (Devaraj et al., 
2009; Márquez et al., 2004). It was suggested that these mutations increase the 
dissociation of E-site tRNA and thereby increase the possibility of having an 
unoccupied A and E-site at the same time, resulting in a single codon/anticodon 
interaction to hold the register of the mRNA. Alternatively, these mutations destabilize 
the E-site codon and thereby prevent interaction of the ASL of E-site tRNA with the 
codon. 
 
 
Figure 15. Interaction of loop 1 of domain 3 of EF-P with the E-site codon. (A)  
Interaction between loop 1 of domain 3 of EF-P (salmon) with a proline codon in the E-
site ( l ight blue) and S7 (cyan). (B) Interaction between loop 1 of domain 3 of EF-P with 
a leucine codon (beige) in the E-site and S7. Interaction of the GDT motif with CUG lacks 
the side chain interaction of D145 with the -2 nucleotide of the E-site codon. (C) 
Comparison of the 30S E-site in presence of EF-P (salmon) and E-site tRNA based on 
the model of dataset 3. Binding of any l igand to the 30S E-site involves a movement of 
the tip of S7 (cyan, EF-P; blue, E-site tRNA (PDB:4V8U), grey, no EF-P) towards the E-
site codon.  
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From the point of our structure, these deletions, especially of residue Arg78 
would abolish the interaction network between S7, the E-site codon and the loop 1 of 
EF-P (Figure 15). Thus, one can envision that the lack of loop 1 of EF-P has the same 
effect. In line with that is the recent finding that the presence of EF-P suppresses 
frameshifting in a situation where a proline codon (CCC-C) is located at the P-site, 
adjacent to the start codon in the E-site (Gamper et al., 2015). Dependent on the 
incoming aa in the A-site, this might lead to a prolonged stalling time relative to peptide 
bond formation, allowing the mRNA to shift out of register upon elimination of EF-P. 
Based on our structure one can assume that EF-P inherits the same function on 
ribosomes that are arrested in the middle of an ORF. Thus, prolonged stalling and the 
resulting dissociation of the E-site tRNA destabilizes the arrested ribosome. EF-P 
recognizes those stalled complexes and through interactions of its loop 1 with the E-
site codon contributes additional energy to prevent frameshifting. eIF5A, on the other 
hand, does lack domain 3. It remains to be determined if eukaryotes have a 
compensatory mechanism. 
The obtained high-resolution structure allowed us to model the ε(R)-β-lysyl-
hydroxylysine modification at position Lys34 of domain 1. The (R)-lysyl moiety forms 
several contacts with the backbone of the CCA-end especially with the backbone of 
A76 and 2’OH of the ribose of C75 but is also in hydrogen bond distance to the 
conserved nucleotide A2439 of the 23S rRNA. Last but not least, the hydroxyl group 
at position Lys34 that is added by the enzyme EpmC interacts with the 2’OH group of 
C74. Nevertheless, this interaction does not seem to be critical for the alleviation of 
polyproline-stalled ribosomes. However, such a modification might be able to enhance 
the stability or solubility of a protein. These interactions are in contrast to the previously 
observed interaction of Tth EF-P, which lacks the modification and hence is unable to 
contact the CCA-end (Blaha et al., 2009). On the other hand, the hypusine modification 
of yeast eIF5A seems to utilize similar interactions to contact the CCA-end of the 
peptidyl-tRNA as well as residue A2808, the eukaryotic counterpart of A2439 (Melnikov 
et al., 2016a; Schmidt et al., 2016).  
As mentioned in the introduction, the modification ε(R)-β-lysyl-hydroxylysine is 
found within a small subset of bacteria as judged by the presence of the corresponding 
modification enzymes (Lassak et al., 2016; Rajkovic and Ibba, 2017). We know of other 
modifications like rhamnosylation of an Arg32 that is the equivalent position to Lys34 
in bacteria like Pseudomonas aeruginosa and Neisseria meningitides (Lassak et al., 
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2015b). In contrast to that, B. subtilis has a 5-aminopentanol moiety attached to Lys32 
of EF-P (Rajkovic et al., 2016). Like for ε(R)-β-lysyl-hydroxylysine, these modifications 
were shown to be essential for alleviating polyproline-arrested ribosomes.  
By contacting the CCA end of the peptidyl-tRNA, the modification seems to 
indirectly stabilize the nascent chain as judged by the presence of density for the 
nascent chain within the ribosomal exit tunnel. However, density for the nascent chain 
still appeared flexible as evident from local resolution calculations. Nevertheless, it 
allowed us to place a model the four C-terminal residues. Surprisingly, we observed a 
conformation of the diprolyl moiety that is distinct to the favored all-trans conformation 
deviating in its Phi angle by roughly 30°. It is noteworthy to mention that the estimates 
dihedral angles within this structure are rough estimations as the resolution is too 
limiting within this region. This diprolyl-positioning was unexpected as proline-proline 
bonds lack the rotatory freedom around the Psi and Phi angle (Morris et al., 1992). 
However, this deviation in the conformation seems to be necessary, as evident by 
comparing our conformation of the diprolyl moiety with the one observed in the crystal 
structure of Melnikov et al (Melnikov et al., 2016b). On the basis of their modelled all-
trans diprolyl conformation, the N-terminus would be orientated towards the tunnel 
wall, thus directing the upstream amino acid into it, whereas in our structure the N-
terminus is directed towards the lumen of the tunnel, following the path of other stalled 
nascent chains. Indeed, an in silico modelled triprolyl peptide in the all-trans 
conformation (also known as a trans-polyproline helix or PII-helix) attached to the P-
site tRNA would not be possible in the context of the ribosomal tunnel as it would direct 
the most N-terminal Pro into the tunnel wall. Similar to that, an all-cis conformation 
(also known as a cis-polyproline helix or PI-helix) would interfere with ribosomal 
translation as it would interfere with the position of the A-site tRNA. The observed 
flexibility of the nascent chain in the absence of EF-P might be due to the prolyl moiety 
trying to adopt its favored configuration, which is prevented by the peptide passage, 
leading to destabilization of the peptidyl-tRNA. On the other hand, stabilization by EF-
P and its modification forces the prolyl moiety to adopt an alternative conformation that 
is compatible with the path of the tunnel.  
These observations raise several interesting questions. First of all, the favored 
all-trans conformation is not possible in the heart of the PTC. However, PII-helix are 
one of the most abundant secondary structure elements beside α-helices and β-sheets 
(Chebrek et al., 2014; Saha and Shamala, 2012). Moreover, prolines can also adopt a 
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cis-conformation as evident by the presence of peptidylprolyl isomerase enzymes 
present in prokaryotes and eukaryotes (Fischer et al., 1984; Lu et al., 2007; Yaron et 
al., 1993). Our results counter argue against a mechanism suggesting that these 
parameters are already adopted during peptide bond formation. Furthermore, there 
are genes like AmiB that have eight consecutive prolines which are efficiently 
synthesized in presence of EF-P (Doerfel et al., 2013; Ude et al., 2013). Even though 
it was shown that α-helices can form inside the ribosomal tunnel, it is unlikely that a 
conformational rigid polyproline helix can be passed through the ribosomal tunnel 
without interfering with peptide bond formation. 
Secondly, as stated in the introduction, prolines also restrain the conformation 
of their neighboring residues. Although we lack the resolution for placing side chains 
for the amino acids following the PP sequence, it seems likely that the presence of 
unfavorable residues immediately upstream of the proline moiety further restrict the 
rotatory and conformational freedom. Based on the chemical and physical properties 
of amino acids, there appears to be no shared attributes between the groups of amino 
acids that cause strong stalling. Unfortunately, our reconstructions also do not allow 
us to make conclusions as to why some amino acids in the A-site enhance stalling 
whereas others do not. 
There are known arrest peptides that have a proline codon either at the P-site 
codon (TnaC) or A-site codon (SecM) (Gong and Yanofsky, 2002; Ito et al., 2010; 
Nakatogawa and Ito, 2002). It was shown that stalling within these peptides critically 
rely on the presence of prolines, but as well as on the residue located further upstream 
of proline. Nevertheless, those stalling events cannot be alleviated by EF-P as the 
upstream residues interact with the ribosomal tunnel and provide enough energy to 
block peptidyl-transfer or peptide release and thereby overcome the effect of EF-P 
(Buskirk and Green, 2017). Furthermore, they are also resistant to tagging by trans-
translation as well as rescue by ArfA and ArfB (Cruz-Vera et al., 2005; Garza-Sánchez 
et al., 2006). A possible explanation for the resistance of those leader peptides is that 
they all stall with a ligand in a non-reactive state in the A-site. In the case of SecM this 
would be Pro-tRNAPro, whereas TnaC would have RF2 bound (Bhushan et al., 2011; 
Bischoff et al., 2014).  
 Finally, it needs to be determined at which time point EF-P leaves the ribosome. 
As described, the modification contacts the backbone of the CCA end of the deacylated 
P-tRNA after peptide bond formation. This position would interfere with early 
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movements during translocation when the acceptor arm has to move from the P- to the 
E-site in respect to the 50S (Blanchard et al., 2004). It seems likely that EF-P leaves 
the ribosome during the onset of the rotation of platform in parallel with opening of the 
L1 stalk. 
In many cases, the activity of EF-P is dependent on its posttranslational 
modification. However, given the fact that so far in only 35% of bacterial genomes the 
posttranslational modification systems have been identified, it is conceivable that some 
bacteria might lack such systems. Especially genomes that comprise a small number 
of polyproline coding genes might not depend on these modifications (Starosta et al., 
2014b). One example is Lactobacillus jensenii that has only one polyproline coding 
gene (Rajkovic and Ibba, 2017). Deletion of EF-P in such small genomes cause a more 
pronounced phenotype as deletion of modification systems for EF-P in other bacteria. 
This indicates that unmodified EF-P has some residual capacity of alleviating 
polyproline stalled ribosomes in vivo, as was also shown by Doerfel et al in vitro 
(Doerfel et al., 2013; Lassak et al., 2015b). In the light of our results, it might be that 
the stabilization effect of EF-P on the peptidyl-tRNA body might be enough to 
overcome the arrest. Another strategy for such organisms might be to prevent 
unfavorable residues that are upstream or downstream of the proline induced stalling 
site. Indeed, such a selection against strong staller might explain that the loss of EF-P 
is not lethal in many bacteria such as E. coli, B. subtilis or Shewanella oneidensis 
(Baba et al., 2006; Lassak et al., 2015b; Ohashi et al., 2003). On the other hand, the 
loss of EF-P is lethal in organisms like Mycobacterium tuberculosis (Sassetti et al., 
2003). Comparison between the genome of E. coli and M. tuberculosis reveals that 
although both genomes have comparable numbers of coding sequences, M. 
tuberculosis has approximately 420 proteins with a proline stalling sequence whereas 
E. coli only has 100 proteins (Lassak et al., 2016; Sassetti et al., 2003; Starosta et al., 
2014b). In line with that is the lethal effect of the deletion of eIF5A in eukaryotes, as 
those genomes contain more than 10% of polyproline containing genes (Ude et al., 
2013; Wöhl et al., 1993). On the other hand, the dependency on EF-P and especially 
modified EF-P might also be influenced by the importance of certain polyproline 
containing genes under stress conditions.  
Examples of such genes that depend on functional EF-P are the transcriptional 
activator CadC, the short ORF mgtP that is part of the mgtCBR leader RNA or the vals 
gene as described in the introduction (Nam et al., 2016; Starosta et al., 2014b; Ude et 
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al., 2013). Both of these genes contain stretches of consecutive prolines and regulate 
the expression of downstream genes in response to stress conditions. For example, 
activation of CadC requires two stimuli, exogenous lysine and mild acidic conditions to 
induce the downstream operon cadBA, that codes for proteins helping to maintain the 
intracellular pH (Ude et al., 2013). Removal of the polyproline cluster in CadC makes 
translation independent of EF-P, thereby increasing the copy number of CadC protein 
and thus leading to a dysregulation of the cadBA operon. 
Consecutive proline codons at mgtP are critical for the downstream ORF of 
mgtC (Nam et al., 2016). In the absence of EF-P, ribosomes stall at the polyproline 
motif, thereby uncoupling transcription from translation. Hence, an alternative stem-
loop is formed that allows induction of the mgtC coding region. Substitution of the 
consecutive prolines to glycine inhibits expression of mgtC.  
Given the abundance of ORFs encoding polyproline sequences it is likely that 
regulation of the expression of EF-P is a bona fide regulatory mechanism within cells. 
However, direct evidence for the regulation of expression of EF-P is lacking. An 
alternative mechanism to regulate the expression of ORFs encoding consecutive 
prolines might be through regulation of the modification enzymes or by limiting or 
increasing the amounts of substrates that are needed for the respective modification. 
For example, the modification enzyme EpmA is also able to α-lysinylate EF-P, which 
causes an inactive form of EF-P (Gilreath et al., 2011; Roy et al., 2011). Thus, 
downregulation of EpmB would decrease the pool of available β-lysine and increase 
the probability of α-lysinylated EF-P. Moreover, modification enzymes might compete 
with other cellular processes for substrates. Rhamnosylation requires dTDP-L-
rhamnose, which is a substrate for different cellular processes like production of 
rhamnolipids or glycosylated flagellin (Lassak et al., 2015b; Rajkovic and Ibba, 2017). 
Hence, competition with other enzymes might be a part of regulating the modification 
pathway. Another possibility arises from recent studies in B. subtilis. Briefly, in B. 
subtilis the modification enzyme ymfl reduces 5-aminopentanone to 5-aminopentanol 
in the final step of EF-P modification (Hummels et al., 2017; Witzky et al., 2018). It was 
shown that deletion of ymfl results in the same phenotype as the deletion of efp, 
whereas modified EF-P and EF-P with the amino acids substitution (Lys32Arg) and 
hence unmodified EF-P, suppressed the phenotype. It is possible that such 
intermediate modification alter the activity of EF-P. However, it is not clear in how far 
such intermediate states are stable and relevant under physiological conditions. 
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A recent report by Alejo et al expands the range of applications for EF-P (Alejo 
and Blanchard, 2017). Based on pre-steady-state smFRET imaging, it was shown that 
EF-P was able to rescue translocation defects that derived from mismatched peptidyl-
tRNA anticodon/mRNA codon interactions. In more detail, during translocation of 
mismatched peptidyl-tRNAs from the A- to the P-site, the translocation process arrests 
at a stage before translocation is complete but after the dissociation of the deacylated 
tRNA from the E-site. This would represent a state where the head domain of the SSU 
displays a swivel-like motion of 18-20°, whereas the body of the SSU shows a partial 
rotation of 2-4° (Borg et al., 2015; Ramrath et al., 2013; Zhou et al., 2013). The P-site 
tRNA resides in an ap/P state. As discussed above, prolonged pausing and a free E-
site allows EF-P to bind. Given the fact that the translocation defect arises from a 
mismatched anticodon/codon base pairing and the beneficial effect of EF-P to alleviate 
this arrest, an interaction between domain 3 and the ASL of the P-site tRNA is likely. 
Especially residues Tyr183 and Arg186 of EF-P might play a critical role, as they 
contact the ASL and the 16S rRNA in our structure. Thus, it is likely that EF-P 
establishes similar contacts with the P-site tRNA as judged by alignments of our 70S-
EF-P structure compared to the 70S-fusidic acid-EF-G structure of Ramrath et al. 
(Ramrath et al., 2013).
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The ribosome is one of the major targets for therapeutic antibiotics;
however, the rise in multidrug resistance is a growing threat to the
utility of our current arsenal. The orthosomycin antibiotics evernimicin
(EVN) and avilamycin (AVI) target the ribosome and do not display
cross-resistance with any other classes of antibiotics, suggesting that
they bind to a unique site on the ribosome and may therefore
represent an avenue for development of new antimicrobial agents.
Here we present cryo-EM structures of EVN and AVI in complex with
the Escherichia coli ribosome at 3.6- to 3.9-Å resolution. The structures
reveal that EVN and AVI bind to a single site on the large subunit that
is distinct from other known antibiotic binding sites on the ribosome.
Both antibiotics adopt an extended conformation spanning the minor
grooves of helices 89 and 91 of the 23S rRNA and interacting with
arginine residues of ribosomal protein L16. This binding site overlaps
with the elbow region of A-site bound tRNA. Consistent with this
finding, single-molecule FRET (smFRET) experiments show that both
antibiotics interfere with late steps in the accommodation process,
wherein aminoacyl-tRNA enters the peptidyltransferase center of
the large ribosomal subunit. These data provide a structural and
mechanistic rationale for how these antibiotics inhibit the elongation
phase of protein synthesis.
antimicrobial | cryo-EM | everninomicin | rRNA | Ziracin
Many clinically used antibiotics target the ribosome to inhibitbacterial growth (1). X-ray crystallography structures have
revealed that the majority of antibiotics that target the large ribo-
somal subunit bind at or near the peptidyl-transferase center (PTC),
the active site for peptide bond formation (1, 2). The emergence of
multidrug resistance in pathogenic bacteria, which has the potential
to render our current arsenal of antibiotics obsolete, highlights the
need for the development of new antibiotics that target distinct sites
on the ribosome. Although structurally uncharacterized, biochemical
and resistance studies indicate that one such class of antibiotics is the
orthosomycins (3), which includes evernimicin (originally termed
everninomicin, and hereafter referred to as EVN) and avilamy-
cin (AVI) (2).
AVI is produced by Streptomyces virdochromogenes strain Tü57
(4), whereas EVN was identified and isolated from the producer
Micromonospora carbonacea (5, 6). EVN and AVI display excellent
antimicrobial activity against Gram-positive bacteria (3), including
methicillin-resistant Staphylococcus aureus (7), as well as some
Gram-negative bacteria, such as Borrelia burgdorferi (8). Importantly,
strains resistant to EVN and AVI do not display cross-resistance to
any other known antimicrobial agents, including ribosome-targeting
antibiotics, such as chloramphenicol, tetracycline, or erythromycin
(9, 10).
EVN/AVI resistance in Streptococcus pneumoniae and in the
archaeon Halobacterium halobium arises via mutations within helix
89 (H89) and H91 of the 23S rRNA (10–12). Resistance to EVN
and AVI also occurs via the action of methyltransferases that
modify H89 and H91 (13, 14). Consistently, both EVN/AVI protect
nucleotides within H89 and H91 from chemical modification (11,
12), suggesting that these two rRNA helices comprise at least part
of the orthosomycin binding site. Additionally, EVN/AVI resistance
has been associated with mutations in Arg-51, Ile-52, and Arg-56
of the ribosomal protein L16 in Enterococcus faecalis, E. faecium,
S. pneumoniae, and S. aureus (15–18). However, it remains unclear
whether these effects are direct consequences of EVN/AVI inter-
acting with L16 or are mediated indirectly via changes in the 23S
rRNA, as observed for other ribosomal protein-derived resistance
mechanisms (2).
As expected based on the locations of the reported resistance
mutations, both AVI and EVN bind to the ribosomal 50S subunit
(19) and inhibit protein synthesis in vivo and in vitro (19, 20). Sub-
sequent in vitro studies revealed that EVN inhibits IF2-dependent
70S initiation complex formation (11, 21); however, the inhibitory
effect of EVN is not restricted to translation initiation because toe-
printing assays indicate that EVN also inhibits translation elongation
(22). EVN and AVI do not inhibit puromycin reaction (11, 12) and
do not compete for binding with antibiotics that target PTC of the
ribosome, such as chloramphenicol, linezolid, lincomycin, or
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clindamycin (19). Moreover, EVN has no inhibitory effect on the
ribosome-dependent GTPase activity of EF-G (21). EVN and AVI
are hypothesized to inhibit elongation by preventing tRNA binding
to the A site (12, 20); however, this model remains to be
conclusively demonstrated.
AVI has long been used in animal feed as a growth promoter
(Surmax/Maxus; Elanco Animal Health), thereby limiting its clinical
usefulness. However, EVN (SCH27899; Ziracin) underwent phase
II/III clinical trials before being dropped in 2000 by Schering-Plough
because of side effects and poor solubility. Nevertheless, the lack of
cross-resistance between AVI/EVN and other clinically used ribo-
some-targeting antibiotics makes the orthosomycins attractive for
further investigation (9, 10). The total chemical synthesis of EVN (23)
and the biosynthesis of novel AVI derivatives with improved solubility
(24) provide a good basis for further drug development; however, a
structural understanding of how these antibiotics interact with the
ribosome is necessary to facilitate rational design of improved
orthosomycin derivatives.
Here we present two cryo-EM structures of EVN or AVI in
complex with the Escherichia coli 70S ribosome at 3.6- to 3.9-Å
resolution. These structures reveal that the conserved hepta-
saccharide core of both orthosomycins spans across the minor
grooves of H89 and H91 of the 23S rRNA, whereas the terminal
dichloro-ring interacts with the arginine residues of ribosomal
protein L16. The binding positions of EVN and AVI overlap
with the elbow region of a tRNA bound in the A site. Consis-
tently, single-molecule FRET (smFRET) imaging of the tRNA
selection process demonstrates that EVN and AVI allow initial
binding of aminoacyl-tRNA (aa-tRNA) at the A site, but prevent
complete accommodation of the incoming aa-tRNA, thus pro-
viding a structural explanation of how orthosomycin antibiotics
inhibit translation elongation.
Results and Discussion
Cryo-EM Structures of EVN and AVI in Complex with the E. coli 70S
Ribosome. To determine the structures of EVN and AVI on the
ribosome, we prepared Erm-stalled ribosome complexes (SRCs) as
reported (25, 26). The SRCs were incubated with either 100 μM
EVN or AVI, and the complexes were then subjected to single-
particle cryo-EM analysis (Materials and Methods). The resulting
cryo-EM reconstructions of the EVN- and AVI-SRC had an average
resolution of 3.9 and 3.6 Å, respectively, with local resolution
extending to 3.5 Å within the core of the ribosome (Fig. S1). Careful
analysis of the cryo-EM maps revealed only a single binding site of
EVN on the 50S subunit of the 70S ribosome, consistent with
previous biochemical studies showing a 1:1 stoichiometry of EVN
with the 50S subunit (19). In contrast to early reports that AVI
binds to the 30S subunit (20), we observed only a single AVI
binding site on the 50S subunit at the same location as EVN, a
result that is consistent with the competition between these two
antibiotics for ribosome binding (19).
AVI has a terminal dichloroisoeverninic acid moiety (ring A)
linked to a linear heptasaccharide chain consisting of D-olivose
(rings B and C), 2-deoxy-D-evalose (ring D), 4-O-methyl-D-fucose
(ring E), 2,6-di-O-methyl-D-mannose (ring F), the unusual pentose
L-lyxose (ring G), and the bicyclic eurekanate (ring H) (ref. 27;
Fig. 1A). Similar to AVI, EVN contains a nearly identical core
heptasaccharide chain, but, unlike AVI, EVN is branched by a
2-deoxy-β-glycoside nitrosugar (ring A′) attached to ring B, and
also contains an additional terminal benzyl moiety (ring I) attached
to eurekanate ring H (28) (Fig. 1B). The presence of distinct elec-
tron density corresponding to the additional rings A′ and I of EVN
in the cryo-EM map of the EVN-SRC, and absence of the same
features in the AVI-SRC map, enabled us to unambiguously orient
both AVI and EVN on the ribosome (Fig. 1 C and D). Despite the
good fit of the refined molecular models to the cryo-EM electron
density maps, higher resolution will be required to provide an un-
ambiguous description of the hydrogen-bond interactions of the
Fig. 1. Cryo-EM reconstructions of EVN- and AVI-SRC. (A and B) Chemical
structures of the orthosomycins AVI (A) and EVN (B), with compositional
differences highlighted. (C and D) Cryo-EM electron densities (gray mesh)
with fitted models for AVI (red; C ) and EVN (yellow; D). (E ) Overview of
EVN/AVI binding site on the 70S ribosome (50S, gray, and 30S subunit
omitted for clarity). Binding position of EVN/AVI (yellow) is shown relative
to the P-site tRNA (blue), ribosomal protein L16 (cyan), H89 (green), and
H91 (red).
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Fig. 2. Interactions of EVN and AVI with the ribosomal protein L16.
(A) Overview of L16 (blue) interactions with EVN (gold) and AVI (red). (B and C)
Close-up views of showing interactions between Arg-51, -55, and -59 of L16
(blue) and ring A of AVI (B) and rings A and A′ of EVN (C). (D) Sequence
alignment of the L16 from E. coli (E.c), B. subtilis (B.s), E. faecalis (E.fl),
E. faecium (E.fc), S. aureus (S.a), and S. pneumoniae (S.p), with residues
conferring resistance to EVN and AVI highlighted in red.
7528 | www.pnas.org/cgi/doi/10.1073/pnas.1604790113 Arenz et al.
drugs with the ribosome. Nevertheless, these structures reveal that
both drugs adopt elongated conformations on the ribosome, with
the heptasaccharide rings B-H of both orthosomycins inserting into
the minor grooves of H89 and H91 of the 23S rRNA (Fig. 1E and
Movie S1) and the terminal ring A interacting with ribosomal
protein L16 (Fig. 2A).
Interactions of EVN/AVI with Arginine Residues of L16. The terminal
dichloroisoeverninic acid moiety (ring A) of AVI establishes stacking
interactions with the side chain of Arg-51 of L16 (Fig. 2 A and B and
Movie S1). In addition, the side chains of Arg-55 and -59 also ap-
proach ring A of AVI (Fig. 2B); however, the density for these side
chains is less well defined. In contrast to AVI, the electron density for
the terminal region of EVN is bifurcated (Fig. 1D), consistent with
the presence of the additional 2-deoxy-β-glycoside nitrosugar (ring A′)
(Fig. 1B). Unfortunately, the resolution does not allow unambiguous
assignment of ring A and A′ to the bifurcated density. Therefore, our
current model is based on the rationale that ring A of EVN occupies
the same position as ring A of AVI, and the remaining density is
then assigned to the ring A′ (Fig. 2C). Sequence alignments (Fig.
2D), as well as comparison with the structures of the B. subtilis 70S
ribosome (29) and S. aureus 50S subunit (30) (Fig. S2), reveals that
E. coli Arg-51 and -55 are equivalent to Ile-52 and Arg-56 in most
Gram-positive bacteria. Consistently, mutations of Arg-56–His
or Ile-52–Ser/Thr/Asn in L16 render E. faecalis, E. faecium, and
S. pneumoniae isolates resistant to EVN and AVI (15–17). Chemical
mutagenesis experiments in S. aureus led to the identification of
strains with Arg-51–Cys or Arg-51–His mutations in L16 that con-
ferred increased resistance to both compounds (18). In our structure,
residue Arg-50 (E. coli), equivalent to residue Arg-51 in S. aureus,
does not contact the drug (Fig. 2 B and C and Fig. S2). This finding
suggests that the Arg-51–Cys/His mutations may indirectly confer
EVN/AVI resistance in S. aureus, possibly by affecting the neigh-
boring Ile-52 residue. Alternatively, EVN/AVI may interact with
S. aureus ribosomes using a slightly different binding mode that
enables direct interaction between Arg-51 and the drugs. Never-
theless, the finding that both EVN and AVI directly interact with
L16 in the region where EVN/AVI resistance mutations occur il-
lustrates the importance of this interaction for drug binding. More-
over, it also reveals that resistance occurs because the mutations
directly perturb drug binding, rather than indirectly preventing drug
binding by distorting the local rRNA conformation of H89/H91.
Interaction of EVN and AVI with H89 and H91 of the 23S rRNA.Within
the limits of the present resolution, we observed no significant
difference between the interaction of the conserved heptasaccharide
cores of EVN and AVI with H89 and H91 of the 23S rRNA (Fig. 3
A–D). The largest interaction surface between the drugs and the
ribosome encompasses rings B–F of EVN/AVI and the minor groove
of H89, specifically, nucleotides A2468-G2472 and A2478-A2482
(Fig. 3 A–D), which base pair to form the stem of H89 (Fig. 3E).
Additional interactions were observed between rings G and H of
EVN/AVI with the minor groove of H91 (Fig. 3 A–D) formed by
nucleotides G2527–U2528 and A2534–G2536 (Fig. 3F). This
interaction pattern is consistent with footprinting data on E. coli,
E. feacium, and H. halobium ribosomes showing that EVN pro-
tects multiple nucleotides within H89, including A2468, A2469,
A2471, A2476, A2478, and A2482, as well as nucleotide A2534 in
H91, from chemical modification by dimethyl sulfate (DMS) (11,
13) (Fig. 3 A, E, and F). Similarly, AVI protects A2482 in H89 and
A2534 in H91 from chemical modification by DMS on E. coli 70S
ribosomes (12) (Fig. 3 B, E, and F). The terminal benzyl moiety
(ring I) of EVN establishes additional interactions with nucleo-
tides within the loop of H91 (Fig. 3 A and C), which may con-
tribute to the higher potency of EVN compared with AVI.
Resistance to EVN/AVI via 23S rRNA Mutations. A striking correlation
exists between the nucleotides that comprise the EVN/AVI binding
site observed here and the reported mutations in 23S rRNA that
confer resistance to these two drugs (Fig. 3 C–F). In S. pneumoniae,
selection for EVN resistance led to the identification of 23S rRNA
mutations A2469C, C2480U (in H89), G2535A, or G2536C (in
H91) (ref. 10; Fig. 3 C, E, and F). The G2535A mutation was also
subsequently reported to confer EVN resistance in E. faecalis (16).
The archaeon H. halobium has also been used to select for EVN
A B
C D
AVI
A2482
A2534
H89
H91
EVN
A2482
H89
A2534
A2468
A2469
A2471
A2478
H91
AVI
H89
H91
G2470
A2471
G2472
U2479
C2480
A2469
G2470
A2471
G2472
A2478
U2479
C2480
G2535
G2536 U2528
G2527
EVN
H91
H89
F
E
AVI/EVN resistance
Methylation
Evn resistance
EVN-protected
AVI-protected
U
G
G Cψ
G
A U A C C G C C C A A G GUU
A
U
ACGACGGCGGUG
UU
UGGC
A
C
2460 2470
24802490
2540
H89
A
C
A U C C U G G G G C U G A
A
G
UAGGUCCC
AA
GGGU
A
U
H912520 2530
A
A2476
Fig. 3. Interactions of EVN and AVI with H89 and H91 of the 23S rRNA.
(A and B) Binding site of EVN (gold) (A) and AVI (red) (B), with nucleotides
in H89 and H91 protected from DMS modification highlighted in red and
orange, respectively. (C and D) Binding site of EVN (gold) (C ) and AVI (red)
(D), with resistance mutations in H89 and H91 highlighted in blue and
green, respectively. (E and F ) Secondary structure of 23S rRNA with zoom
on H89 (E ) and H91 (F), with nucleotides protected by EVN (red) and AVI
(orange), EVN (blue) and AVI (green) resistance mutations and methyla-
tions (blue star) as indicated (10–18).
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resistance, producing A2471G/C, A2478C, U2479C, and C2480A/U
mutations in H89 and G2527A, U2528A, and G2535A mutations in
H91 (11) (Fig. 3 C, E, and F). In contrast, selection for AVI using
H. halobium only led to the identification of mutations within H89,
namely, G2470U, A2471G, G2473U, U2479C, and C2480U (12)
(Fig. 3 D and E). The increased frequency of resistance mutations
located in H89, as well as the higher resistance conferred by these
mutations compared with H91 mutations (11, 12), emphasizes the
importance of the extensive interaction surface between rings B-F
of EVN/AVI and nucleotides comprising the minor groove of H89.
Because all of the reported mutations are expected to alter base-
pairing potential, resistance is likely to arise from distortions of the
helical geometry of H89 and H91, which thereby reduce the affinity
of the drugs for their binding site.
Resistance to EVN/AVI via Methylation of the 23S rRNA. Analysis of
the binding site of EVN and AVI reveals a structural basis for the
resistance obtained via posttranslational modifications of nucleotides
within H89 and H91 (13, 14) (Fig. 4). S. virdochromogenes Tü57, the
producer of AVI, expresses two methyltransferases, AviRa and
AviRb, which confer resistance to EVN/AVI. Whereas AviRb
methylates the ribose 2′OH of U2479 within H89 to confer high-level
AVI resistance, AviRa methylates the N7 position of G2535 within
H91 to confer low-level resistance (14, 31). Inspection of the EVN/
AVI binding site reveals that a 2′O-methylation of U2479 would lead
to a direct clash with ring F of the drug (Fig. 4A). In contrast, N7-
methylation of G2535 appears to neither interfere with the drug
binding (Fig. 4B) nor disrupt base pairing with U2528, suggesting that
methylation at this position indirectly confers resistance by inducing
local conformational changes, possibly during ribosome assembly. We
note that both AviRa and AviRb are required to obtain full protection
against the AVI (31), suggesting that they function in a synergistic
manner, similar to the methyltransferases that cause resistance
to tylosin (32). The EVN methyltransferase EmtA, which was
identified on a plasmid-borne insertion element in EVN-resistant
E. faecium strains (isolated from animals given AVI as a growth
promotant), was shown to methylate G2470 of H89 (13). Although
the exact site of the modification has not been identified, we note
that methylation of the N2 position of G2470 or the ribose 2′OH
would lead to a direct clash with rings D and C, respectively, of
EVN/AVI (Fig. 4C), whereas an N7-methylation would most
likely confer resistance indirectly via conformational changes.
Inhibition of IF2 and A-tRNA Accommodation by EVN and AVI. EVN
has been reported to inhibit formation of the IF2-dependent 70S
initiation complex (70S-IC) (11, 21). Therefore, we compared the
binding sites of EVN/AVI relative to structures of IF2 on the 70S
ribosome (33) and 30S subunit (34, 35). No overlap was observed
between EVN/AVI and IF2 on the 70S, with the shortest dis-
tance between ring E of EVN/AVI being 2–3 Å away from the linker
between domains III and IV of IF2 (Fig. S3). In contrast, alignment
of IF2-30S complex to the AVI/EVN-SRC reveals a slight overlap
between EVN/AVI and domain IV of IF2 (Fig. S3), suggesting that
EVN/AVI may interfere with IF2-dependent 70S-IC formation by
blocking a transient intermediate state of IF2 that arises upon
subunit binding and transition from the 30S-IC to the 70S-IC.
EVN and AVI have also been suggested to inhibit translation
elongation by interfering with the tRNA binding to the A site of the
ribosome (12, 20, 22). Therefore, we compared the binding position
of EVN/AVI relative to the tRNA in the A/T state observed during
decoding when the aa-tRNA is bound to the ribosome but still
remains in complex with EF-Tu (36, 37), as well as with the tRNA
in the classical A/A state in which the acceptor arm of the aa-tRNA
is released from EF-Tu and has accommodated at the PTC on
the large ribosomal subunit (38). These comparisons show that the
EVN/AVI binding site does not overlap with aa-tRNA within the
A/T state, whereas there is direct clash between rings A-C of EVN/
AVI and nucleotides 51–53 within the stem region of the TΨC-loop
(elbow region) of fully accommodated aa-tRNA (Fig. 5A, Fig. S4,
and Movie S1).
To investigate the impact of EVN and AVI on the selection and
accommodation of aa-tRNA, we used pre-steady-state smFRET
measurements that enable real-time visualization of tRNA motion
during EF-Tu–catalyzed delivery of aa-tRNA to surface-immobilized
ribosomes (39–41) (Fig. 5B). Here, the time evolution of FRET
efficiency was monitored at 10 ms per frame time resolution within
individual 70S ribosomes bound with (Cy3-s4U8)-labeled fMet-
tRNAiMet in the P site upon stopped-flow injection of ternary
complex containing EF-Tu, GTP and (LD650-acp3U47)-labeled
Phe-tRNAPhe (Fig. 5B). As expected from previous studies (40, 41),
in the absence of the drug, productive FRET events leading to the
incorporation of aa-tRNA at the A site evolved from a low (∼0.2) to
high (∼0.63) FRET state via the reversible transit of at least one
intermediate (∼0.35) FRET configuration, which reflects the A/T
state of the A-site tRNA (Fig. 5 B and C) (39, 40). Consistent with
rapid aa-tRNA progression through the selection process, the time
delay between the initial observation of low FRET and formation of
the stable, high-FRET state, corresponding to the fully accommo-
dated, classically configured A/A-tRNA position, was ∼60 ms
(∼16 s−1) (Fig. 5 B and C and Fig. S5).
In the presence of saturating concentrations (20 μM) of EVN or
AVI, aa-tRNA progression into the ribosome was strongly and
specifically blocked during the transition between the A/T state
(∼0.35 FRET) and the fully accommodated A/A state (∼0.63
FRET) (Fig. 5 D and E and Fig. S5). To examine the dynamics
underlying this inhibition, we visualized the ensemble of observed
molecular transitions using transition density plots (42). In this
representation, observed transitions appear as peaks in a 2D his-
togram of initial and final FRET efficiencies (Fig. 5 F–H). The peak
corresponding to reverse transitions from high to intermediate
Fig. 4. Structural basis for EVN/AVI resistance via methylation of the 23S rRNA residues. (A) The 2′O-methylation of U2479 in H89 by AviRb (14) clashes with
the ring F of the drug. (B) N7 methylation of G2535 in H91 by AviRa (14) is located distal from the AVI binding site. (C) Methylation of the 2′OH of the ribose or
N2 position in the nucleobase of G2470 by EmtA (13) clashes with EVN (gold), whereas the N7 position is distal to the drug-binding site.
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FRET is significantly enhanced in the presence of both EVN or
AVI (arrows in Fig. 5 F–H), confirming that inhibition was char-
acterized by an exacerbation of the reversible excursions between
A/T and accommodated positions that normally accompany proof-
reading (40) (Fig. S4). These findings are in agreement with toe-
printing experiments demonstrating that 70S ribosomes initiated on
the AUG start codon of mRNA do not proceed into the elongation
phase of translation when increasing concentrations of EVN or AVI
are present (Fig. S6). Our findings contrast with a previous report
(22) in which Evn did not appear to significantly affect the first
elongation cycle, but, rather, allowed successive rounds of elonga-
tion before inhibition was observed. One possibility for this dis-
crepancy is that the strength of the inhibition of the orthosomycins
depends on the nature of the aa-tRNA that is being accommodated.
Conclusion
The cryo-EM structures of EVN- and AVI-SRC reported here re-
veal that both orthosomycins bind to a single site on the large subunit
that is distinct from other known antibiotic binding sites on the ri-
bosome (Fig. S7), explaining the lack of cross-resistance with other
ribosome-targeting antibiotics (9, 10). The orthosomycin binding site
comprises the minor grooves of H89 and H91 of the 23S rRNA, as
well as arginine residues of L16 (Fig. 1E), consistent with available
chemical protection and resistance data (Figs. 2–4) (10–18). The
binding position for EVN and AVI provides a structural explanation
for how the orthosomycins inhibit IF2-dependent 70S-IC formation
(11, 21)—namely, by interfering with the transition from the IF2-30S
conformation to the IF2-70S that occurs upon subunit joining (Fig.
S3). Additionally, our smFRET data demonstrate that both EVN
and AVI interfere with the accommodation of aa-tRNA at the A site
of the ribosome (Fig. 5 C–H), consistent with the overlap between
EVN/AVI and the elbow region of a fully accommodated A-tRNA
(Fig. 5A). Overall, our study also demonstrates that cryo-EM can be
used to determine de novo the binding site of antibiotics on the
bacterial ribosome, as was also recently demonstrated for the
antiprotozoan drug emetine in complex with the Plasmodium fal-
ciparum 80S ribosome (43).
Materials and Methods
The SRCs were prepared essentially as described (25, 44). Cryo-EM data
collection was performed on the Titan Krios (FEI) 300-kV TEM equipped
with a Falcon II direct electron detector. Images of individual ribosome
particles were aligned by using Motion Correction software (45), and then
particles were selected automatically by using SIGNATURE (46). All images
were processed by using a frequency-limited refinement protocol that
prevents overfitting (47) using the SPIDER software package (48), as de-
scribed (25, 44). The final maps were subjected to the program EM-
BFACTOR (49) to apply an automatically determined negative B factor for
sharpening of the map, and local resolution was calculated by using
ResMap (50). Molecular models were fitted and adjusted by using COOT
(51) and refined in Phenix (52). Model validation was carried out by using
the MolProbity server (53), and the final model statistics are presented in
Table S1. All figures showing atomic models as well as Movie S1 were
generated by using PyMOL (Schrödinger). Fig. S1 was generated by using
Chimera (54). The smFRET experiments were performed as described (39–
41, 55). Further details can be found in SI Materials and Methods. The cryo-
EM maps and models for the EVN- and AVI-SRC have been deposited in the
EMDatabank (accession nos. EMD-8238 and EMD-8237) and the Protein
Data Bank (PDB ID codes 5KCS and 5KCR).
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Fig. 5. EVN/AVI inhibit accommodation of tRNA
into the A site. (A) Comparison of the relative
binding positions on the ribosome of AVI (red), EF-
Tu (blue), A/T-tRNA (green) (36, 56), and A/A-tRNA
(teal) (38). (B) Schematic diagram of smFRET mea-
surements of tRNA selection. After delivery of EF-
Tu·GTP·tRNA ternary complex containing cognate
Phe-tRNAPhe(LD650) to the A site of E. coli 70S ri-
bosomes containing tRNAi
Met(Cy3) in the P site,
tRNA motion can be tracked through the progres-
sion of FRET efficiencies from low (0.2) to intermediate
(0.35) FRET during initial steps of selection to high
(0.63) FRET upon A-site tRNA accommodation, which is
inhibited by AVI/EVN. (C–E) Ensemble smFRET histo-
grams showing the time course of aa-tRNA selection,
imaged in the absence of drugs (C) or in the presence
of 20 μM AVI (D) or 20 μM EVN (E). The histograms
were postsynchronized by aligning each observed
event to the first appearance of nonzero FRET states.
(F–H) Transition density plots for the data shown in C–E,
respectively. These 2D histograms juxtapose the FRET
efficiencies immediately before and after FRET tran-
sitions. As indicated by arrows, EVN and AVI promote
reversible transitions between high and intermedi-
ate FRET.
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SI Materials and Methods
Cryo-EM and Single Particle Reconstruction. The SRCs were prepared
essentially as described (25, 44). TheAVI- andEVN-SRCs (4A260/mL)
were applied to 2-nm precoated Quantifoil R3/3 holey carbon
supported grids and vitrified by using a Vitrobot Mark IV (FEI).
Data collection was performed at NeCEN on a Titan Krios (FEI)
transmission electron microscope equipped with a Falcon II direct
electron detector at 300 kV with a magnification of 125,085×, a
pixel size of 1.108 Å, and a defocus range of 0.8–2.4 μm. The
data were provided as a series of seven frames (dose per frame is 4
e−/Å2), from which we summed frames 1–4 (AVI-SRC) or 1–6
(EVN-SRC) (accumulated dose, including the pre-exposure frame,
of 20 and 28 e−/Å2, respectively, as described in Table S1) after
alignment by using Motion Correction software (45). Images were
processed by using a frequency-limited refinement protocol that
helps prevent overfitting (47), specifically by truncation of high
frequencies (in this case at 7–8 Å using Butterworth filter). Power
spectra and defocus values were determined by using CTFFIND4
(57). Data were processed further by using the SPIDER software
package (48), in combination with an automated workflow as de-
scribed (58). After initial, automated particle selection based on
the program SIGNATURE (46), initial alignments were per-
formed (102,837 particles for AVI-SRC and 127,205 particles for
EVN-SRC) by using E. coli 70S ribosome as a reference structure
(25). After 3D classification using an incremental K-means-like
method of unsupervised 3D sorting (59), the final AVI- and EVN-
SRC maps [61,651 (60%) and 78,186 (75%) particles, respectively]
could be refined to average resolutions of 3.6 Å (AVI-SRC) and
3.9 Å (EVN-SRC) (Fig. S1). The final refined maps were subjected
to the program EM-BFACTOR (49) to apply an automatically
determined negative B-factor for sharpening of the map. Local
resolution calculations were performed by using ResMap (50),
revealing that the majority of the cores of the 30S and 50S subunits
extended to 3.5 Å (Fig. S1).
Model Building and Structure Refinement Procedures. The initial
atomic model for the E. coli 70S ribosome was generated by using the
50S subunit from Protein Data Bank (PDB) ID code 4YBB (60) and
the 30S subunit from PDB ID code 4TP9 (61). The initial model for
the P-tRNA was based on PDB ID code 3TVF (62), and the model
for the P-site mRNA was built de novo. Atomic models for AVI and
EVN were generated from their known chemical structures by using
PRODRG online software (63), which was also used to generate
CIF restraints for the subsequent fitting and refinement. The
initial models of the entire 70S ribosome with bound mRNA,
P-site tRNA, and either AVI or EVN were fitted into the cryo-
EM electron-density maps by real-space rigid-body refinement in
PHENIX (52) with the ribosome split into multiple rigid-body
domains. Resulting molecular models were further adjusted by
using COOT (51) and refined in PHENIX (52). Model validation
was carried out by using the MolProbity server (53). The final
model statistics are presented in Table S1. All figures showing atomic
models, as well as Movie S1, were generated by using PyMOL
(Schrödinger). Fig. S1 was generated by using Chimera (54).
smFRET Imaging. Single-molecule experiments were performed in
Tris-polymix buffer containing 50 mM Tris-acetate (pH 7.5), 5 mM
MgCl2, 100 mM KCl, 5 mM NH4(CH3COO), 0.5 mM CaCl2,
0.1 mM EDTA, 5 mM putrescine, 1 mM spermidine, 1.5 mM
β-mercaptoethanol, and 1 mM GTP, in the presence of an oxygen-
scavenging system consisting of 2 mM protocatechuic acid, 50 nM
protocatechuate 3,4-dioxygenase, and photostabilizing compounds
(1 mM Trolox, 1 mM cyclooctatetraene, and 1 mM nitrobenzyl-
alcohol) (64). EF-Tu·GTP·Phe-tRNAPhe(LD650-acp3U47) ternary
complex was prepared as described (39, 65). LD650 (Lumidyne
Technologies) is an intramolecularly photostabilized derivative
of Cy5 (66–68). Surface immobilization of ribosome complexes
(0.5 nM) programmed with biotinylated mRNA was achieved by
brief incubation in PEG-passivated, streptavidin-coated quartz mi-
crofluidic devices (55). Complexes lacking ribosomal protein L1
were used to minimize the contribution of hybrid state tRNA
configurations after peptide bond formation (55).
smFRET data were acquired on a home-built prism-based total
internal reflection microscope as described (41). Briefly, a 532-nm
laser (Opus 532; LaserQuantum)was used to excite Cy3 fluorophores
attached to tRNAfMet. Emitted fluorescence from Cy3 donor and
LD650 acceptor fluorophores was collected by using a 1.27-NA 60×
water immersion objective (Nikon), spectrally separated by using a
MultiCam-LS device (Cairn) equipped with a dichroic mirror
(T635lpxr-UF2; Chroma), and imaged onto two scientific comple-
mentary metal-oxide semiconductor cameras (Orca-Flash 4.0 V2;
Hamamatsu Photonics) acquiring at 10-ms integration time. FRET
efficiency time courses for individual ribosomes were calculated, se-
lected, and analyzed by using the freely available MATLAB-based
software package SPARTAN as described (41).
Toe-Printing Assay. The position of the ribosome on the mRNA was
monitored by using a toe-printing assay based on the PURExpress
(New England Biolabs) in vitro coupled transcription-translation
system, as described (69, 70). Briefly, each translation reaction con-
sisted of 2 μL of solution A, 1.5 μL of solution B, and 1 μL (0.6 pmol)
of DNA template (hns40aa): (5′- ATTAATACGACTCACTATA-
GGGATATAAGGAGGAAAACATATGAGCGAAGCACTTAA-
AATTCTGAACAACATCCGTACTCTTCGTGCGCAGGCAAG-
AGAATGTACACTTGAAACGCTGGAAGAAATGCTGGAAA-
AATTAGAAGTTGTTGTTAACGAACGTTGGATTTTGTAAG-
TGATAGAATTCTATCGTTAATAAGCAAAATTCATTATA-
ACC-3′, with the ATG start and TAA stop codon highlighted in
bold and the primer-binding site underlined) and 0.5 μL of addi-
tional agents (nuclease-free water, Ths, Ede, AVI, or EVN). The
template was synthesized via PCR from gDNA (E. coli MG1655).
Translation was performed at 37 °C for 15 min in 1.5-mL reaction
tubes with constant shaking at 500 rpm. After translation, 2 pmol
of Alexa 647-labeled NV-1 toe-printing primer (5′-GGTTA-
TAATGAATTTTGCTTATTAAC-3′) was added to each re-
action and incubated at 37 °C for 5 min without shaking. Reverse
transcription (RT) was performed with 0.5 μL of AMV reverse
transcriptase (NEB), 0.1 μL of dNTP mix (10 mM), and 0.4 μL of
Pure System Buffer and incubated at 37 °C for 20 min. The RT
reaction was quenched and RNA degraded by addition of 1 μL
of 10 M NaOH and incubation for at least 15 min at 37 °C and
then was neutralized with 0.7 μL of 25% HCl. Then, 20 μL of
toe-printing resuspension buffer and 200 μL of PN1 buffer were
added to each reaction before treatment with a QIAquick Nu-
cleotide Removal Kit (Qiagen). The Alexa 647-labeled DNA was
then eluted from the QIAquick columns with 80 μL of nuclease-
free water. A vacuum concentrator was used to vaporize the
solvent, and the Alexa 647-labeled DNA was then dissolved into
3.5 μL of formamide dye. The samples were heated to 95 °C for
5 min before being applied onto a denaturing 6% (vol/vol)
polyacrylamide (19:1) sequencing gel containing 7 M urea. Gel
electrophoresis was performed at 40 W and 2,000 V for 2 h. The
GE Typhoon FLA9500 imaging system was subsequently used to
scan the polyacrylamide gel.
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Fig. S1. Average and local resolution determination of AVI- and EVN-SRCs. (A and B) Transverse section of the cryo-EM reconstructions of the AVI-SRC (A) and
the EVN-SRC (B) colored according to local resolution. (Cand D) Average resolution of the AVI-SRC (C) and EVN-SRC (D) was 3.6 and 3.9 Å using the Fourier shell
correlation (FSC) cutoff value of 0.143. Because of image processing with an absence of spatial frequencies >8 Å, the FSC value of 0.143 was used for average
resolution determination (47). (E and F) Local resolution of the density for AVI (E) and EVN (F).
Fig. S2. Comparison of AVI/EVN binding site with respect to E. coli, B. subtilis, and S. aureus L16. Interaction of AVI (red; A) and EVN (gold; B) with E. coli L16
(blue) compared with the relative position of B. subtilis L16 (green; Cand D) (29) and S. aureus L16 (cyan; E and F) (30). In E. coli, Arg-50 is 6.3–7.3 Å from ring A
of AVI/EVN, whereas the equivalent residue Arg-51 is 6.7–7.1 Å and 4.3–4.8 Å when superimposing AVI/EVN with B. subtilis L16 (green; C and D) (29) and
S. aureus L16 (cyan; E and F) (30).
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Fig. S3. Comparison of AVI/EVN binding site with respect IF2. Binding position of AVI (red; A–C) and EVN (D–F) on the E. coli 70S ribosome relative to IF2-IC
conformation I (green; A and D) and IF2-IC conformation II (teal; B and E) on the 70S ribosome (33) and IF2-GTP conformation (olive; C and F) on the 30S
subunit (34, 35).
Fig. S4. EVN and AVI specifically block accommodation of A-tRNA into the classical state. Representative smFRET traces exemplifying the processes shown in
Fig. 5 C–E are shown. (A) In the absence of drug, aa-tRNA rapidly achieves the fully accommodated A/A state (0.63 FRET) via reversible forward-sampling from
the 0.35 FRET A/T state. (B and C) AVI (B) and EVN (C) inhibit formation of the A/A state, leading to repeated, unsuccessful sampling events.
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Fig. S5. Relative position of EVN/AVI to A/T- and A/A-tRNA. (A and B) Comparison of the relative binding position on the ribosome of AVI (red; A) and EVN (B),
with EF-Tu (blue) and A/T-tRNA (green) (36, 56), as well as with accommodated A/A-tRNA (teal) (38). (C and D) Zoom showing the overlap between AVI (red;
C) and EVN (gold; D) with nucleotides 51–53 with the TΨC stem of the an accommodated A/A-tRNA (teal) (38).
Fig. S6. EVN and AVI block ribosomes at the start codon of the mRNA. Toe-printing assay monitoring translation in the presence of increasing concentrations
(1, 10, and 100 μM) of EVN or AVI is shown. Additionally, control reactions without antibiotic (−) or including thiostrepton (Ths, 100 μM) or edeine (Ede, 50 μM)
are shown. AUG designates location of the ribosomes stalled at the start codon. C, U, A, and G indicate the sequencing lanes.
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Fig. S7. Relative position of EVN/AVI to other ribosome-targeting antibiotics. (A) Overview of ribosomal 50S subunit (gray) with relative position of EVN/AVI
(yellow) compared with known antibiotics that target the PTC. (B) Relative position of EVN/AVI (green) compared with known antibiotics that target the small
and large ribosomal subunit, with A-, P-, and E-tRNAs shown for reference.
Table S1. Data collection and refinement statistics
Data collection and refinement EVN-SRC AVI-SRC
Particles 78,186 61,651
Pixel size, Å 1.108 1.108
Defocus range, μm 1.0–2.4 0.7–2.4
Voltage, kV 300 300
Electron dose, e−/Å-2 28 20
Map sharpening B factor, Å2 −234.20 −126.14
Resolution, Å (0.143 FSC) 3.9 3.6
Model composition
Nonhydrogen atoms 149,026 145,176
Protein residues 6,664 5,626
RNA bases 4,645 4,696
Validation (proteins)
Poor rotamers, % 0.00 0.08
Ramachandran outliers, % 2.61 1.68
Ramachandran favored, % 88.98 92.36
Bad backbone bonds, % 0.00 0.12
Bad backbone angles 0.00 0.01
MolProbity score 2.02 (74th percentile) 2.16 (100th percentile)
Validation (nucleic acids)
Correct sugar puckers, % 97.71 99.46
Bad backbone conformations, % 12.89 13.86
Bad bonds, % 0.05 0.39
Bad angles 0.01 0.01
Clashscore, all atoms 8.29 (80th percentile) 15.25 (97th percentile)
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Movie S1. Binding site of AVI on the bacterial 70S ribosome. Overview of AVI (bright yellow) binding site on the 70S ribosome (small subunit, yellow; large
subunit, white and blue). The P-tRNA (blue) and mRNA (magenta) are highlighted, as well as 23S rRNA helices H89 (red) and H91 (green) and ribosomal protein
L16 (light blue). A morph between A/T-tRNA in complex with EF-Tu and an accommodated A-tRNA demonstrates that AVI allows delivery of the A/T-tRNA, but
sterically interferes with the accommodation of the A-tRNA on the large subunit.
Movie S1
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ABSTRACT
Ribosomes are the protein synthesizing machines
of the cell. Recent advances in cryo-EM have led
to the determination of structures from a variety of
species, including bacterial 70S and eukaryotic 80S
ribosomes as well as mitoribosomes from eukaryotic
mitochondria, however, to date high resolution struc-
tures of plastid 70S ribosomes have been lacking.
Here we present a cryo-EM structure of the spinach
chloroplast 70S ribosome, with an average resolu-
tion of 5.4 Å for the small 30S subunit and 3.6 Å for
the large 50S ribosomal subunit. The structure re-
veals the location of the plastid-specific ribosomal
proteins (RPs) PSRP1, PSRP4, PSRP5 and PSRP6
as well as the numerous plastid-specific extensions
of the RPs. We discover many features by which the
plastid-specific extensions stabilize the ribosome via
establishing additional interactions with surround-
ing ribosomal RNA and RPs. Moreover, we identify a
large conglomerate of plastid-specific protein mass
adjacent to the tunnel exit site that could facilitate
interaction of the chloroplast ribosome with the thy-
lakoid membrane and the protein-targeting machin-
ery. Comparing the Escherichia coli 70S ribosome
with that of the spinach chloroplast ribosome pro-
vides detailed insight into the co-evolution of RP and
rRNA.
INTRODUCTION
Chloroplasts are organelles found in plant and algal cells,
which are responsible for carrying out photosynthesis. The
origin of chloroplasts is thought to result from an endosym-
biotic event where an early eukaryotic cell engulfed a pho-
tosynthetic cyanobacterium (1). As such chloroplasts pos-
sess their own genome, as well as the transcription and
translation machinery to convert the genetic information
into polypeptides or proteins (2,3). Chloroplast ribosomes,
or chlororibosomes, are very specialized since they are
only involved in synthesizing the limited number of pro-
teins encoded in the chloroplast genome (2,3). For exam-
ple, the complete genome sequence of the Spinacea oler-
acea (spinach) chloroplast contains 146 genes encoding pro-
tein products and structural RNAs (4). The majority of
the chloroplast-encoded proteins are targeted to the chloro-
plast thylakoid membranes and encompass components of
the adenosine triphosphate (ATP) synthase, cytochrome
b/f and photosystem I and II complexes (4). In addition,
chlororibosomes translate NADH dehydrogenase, the large
subunit (LSU) of RuBisCO, RNA polymerase subunits and
a distinct subset of ribosomal proteins (RPs), 12 from the
small subunit (SSU) and 8 from the LSU. Other proteins
essential for chloroplast function are nuclear encoded and
must therefore be imported into the chloroplast. This in-
cludes the remaining 32 chloroplast RPs (cpRPs), which
bear N-terminal chloroplast-targeting sequences that are
cleaved off upon import (5,6).
Sequence comparisons indicate that the components
of the chloroplast translational machinery are similar to
those of eubacteria, especially cyanobacteria, but also ! -
proteobacteria, such as Escherichia coli. The chloroplast
16S rRNA (cp16S) of the SSU contains 1491 nucleotides
(nts) and is therefore only slightly smaller than the E. coli
16S rRNA (Ec16S), which has 1542 nts. The E. coli LSU
contains 2 rRNAs, the 5S (120 nts) and 23S (2904 nts)
rRNAs, totaling to 3024 nts. While the chloroplast LSU
comprises 3 rRNAs, 5S (121 nts), 4.8S (103 nts) and 23S
(2810 nts) rRNAs, the total length of 3034 nts is only slightly
larger (10 nts) than in E. coli. Similarly, chlororibosomes
contain a total of 52 cpRPs (25 in the SSU and 33 in the
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LSU) and with the exception of L25 and L30, have or-
thologs in E. coli (5,6). However, the cpRPs are generally
larger than their E. coli counterparts, predominantly due
to N- and C-terminal extensions (NTEs and CTEs) (5,6).
Proteomic studies also identified six non-orthologous pro-
teins, termed ‘plastid-specific RPs’ (or PSRPs) (5–7). Four
PSRPs (PSRP1-4) were found to be associatedwith the SSU
and two (PSRP5 and PSRP6) with the LSU (5–7). A cryo-
EM reconstruction of the spinach chlororibosome at 9.4 Å
provided first insights into the localization of the PSRPs
and cpRP extensions (8), however, higher resolution is re-
quired to accurately assign and describe the interactions of
the PSRPs and cpRP extensions within the chlororibosome.
Here we present a cryo-EM structure of the spinach
chlororibosome, with an average resolution of 5.4 Å for the
SSU and 3.6 Å for the LSU, revealing the binding site of
the PSRP1, PSRP4, PSRP5 and PSRP6 as well as the con-
formation of numerous cpRP extensions. The structure il-
lustrates how cpRP extensions and PSRPs wind their way
through the core of the chlororibosome establishing interac-
tions with neighboring rRNA and RPs. In many cases, the
cpRP extensions interact with RNA or protein features that
are specific to the chlororibosome, thus providing insight
into their co-evolution. We also identify a large conglomer-
ate of cpRPmass adjacent to the tunnel exit site that we sug-
gest facilitates interaction of the chlororibosome with the
thylakoid membrane and the protein-targeting machinery.
MATERIALS AND METHODS
Isolation of chloroplast 70S ribosomes
Chloroplast ribosome isolation was performed as described
previously (9). Briefly, 6 kg of spinach leaves were de-
veined and washed thoroughly. The leaves were homoge-
nized (2l/kg of leaves) using 0.7 M Sorbitol in buffer A
(10 mM Tris–HCl pH 7.6, 50 mM KCl, 10 mM MgOAc,
7 mM "-mercaptoethanol). The homogenate was filtered
through several layers of cheesecloth and one layer of Mir-
acloth (Calbiochem) before centrifugation at 1200 × g for
15 min. The pellet was resuspended in 0.4 M Sorbitol in
buffer A and re-centrifuged at 1200 × g for 15 min. The
washed chloroplast pellet was resuspended in buffer A sup-
plemented with 2 % (v/v) Triton-X100 and incubated on ice
for 30 min. The lysed suspension was clarified by centrifu-
gation at 26 000 × g for 30 min before isolation of crude
ribosomes by centrifugation at 50 000 × g for 24 h through
a 1M sucrose (in buffer B: buffer A with 10% glycerol). The
greenish pellet was washed and then resuspended in buffer
B with gentle agitation. The crude ribosomes were clarified
by centrifugation at 26 000 × g for 15 min before being ei-
ther snap frozen at−80◦C.Alternatively, the clarified super-
natant was applied directly onto a 10–30% sucrose gradient
(in buffer B) in order to obtain tight-coupled chloroplast
70S ribosomes.
Negative-stain electron microscopy
Ribosomal particles were diluted in buffer A to a final con-
centration of 5 A260/ml. One drop of each sample was de-
posited on a carbon-coated grid. After 30 s, grids were
washed with distilled water and then stained with 2% aque-
ous uranyl acetate for 15 s. The remaining liquid was re-
moved by touching the grid with filter paper. Micrographs
were taken using a Morgagni transmission electron micro-
scope (FEI), 80 kV, wide angle 8K CCD at direct magnifi-
cations of 110K.
Cryo-electron microscopy and single particle reconstruction
A total of 5 A260/ml chloroplast ribosome sample was
applied to 2 nm pre-coated Quantifoil R3/3 holey car-
bon supported grids and vitrified using a Vitrobot Mark
IV (FEI, Eindhoven). Data collection was performed us-
ing an FEI Titan Krios transmission electron microscope
equipped with a Falcon II direct electron detector (FEI,
Eindhoven), using a pixel size of 1.061 Å and an underfocus
range of 1.0–2.3 #m resulting in 2031 micrographs. Each
micrograph was recorded as a series of 7 frames (3.9 e−/Å2
pre-exposure; 5.2 e−/Å2 dose per frame). All seven frames
(accumulated dose of 40.3 e−/Å2) were motion-corrected
using the Unblur program (10) and power-spectra, defo-
cus values, astigmatism and estimation of micrograph reso-
lution were determined using CTFFIND4 (11). Five hun-
dred and forty-five micrographs showing Thon rings be-
yond 3.2 Å resolution were manually inspected further for
good areas and power-spectra quality. Three times deci-
mated data were pre-processed using the SPIDER software
package (12), in combination with an automated workflow
as described previously (13). After initial, automated par-
ticle selection based on the program SIGNATURE (14),
initial alignment was performed with 56 475 particles us-
ing E. coli LSU as a reference structure (15). The dataset
could be sorted into 37 626 (66.6%) ribosomal particles and
18 849 (33.3%) non-aligning particles using an incremen-
tal K-means-like method of unsupervised 3D sorting (16)
(Supplementary Figure S2). Undecimated ribosomal par-
ticles were again initially aligned against an E. coli LSU
and subsequently refined using FREALIGN (17). Since the
SSU of the chlororibosome was flexible, focused alignment
and refinement was performed by applying masks either on
the SSU or LSU. Due to inherent flexibility, the SSU of the
chlororibosome could be refined to an average resolution
of 5.4 Å (0.143 FSC) and a local resolution extending to
5.0 Å for the core, whereas the LSU of the chlororibosome
could be refined to an average resolution of 3.6 Å (0.143
FSC) and a local resolution extending to <3.5 Å for the
core. The local resolution of the final maps was computed
using ResMap (18) (Supplementary Figure S2). The final
maps were sharpened by dividing the maps by the modula-
tion transfer function of the detector and by applying an au-
tomatically determined negative B-factor (−86 for the LSU
and −130 for the SSU) to the maps using RELION (19).
Molecular modeling and map-docking procedures
The molecular model of the chloroplast LSU was based on
the E. coli-70S-EF-Tu structure (20). The 23S rRNA sec-
ondary structure was initially generated by manual align-
ment of the chloroplast 23S rRNA sequence and the sec-
ondary structure map (21) to the E. coli 23S secondary
structure map, which shows high structural similarity. The
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16S, 5S and 4.8S rRNA sequences of the chloroplast ri-
bosome were aligned accordingly. The resulting rRNA ho-
mology models were rigid-body fitted into the respective
chloroplast EM-map using Chimera (22). Subsequently, the
models were manually adjusted and refined using Coot
(23). E. coli-based (20) homology models of the cpRPs
were built using SwissModel (24) and HHPred (25) and
rigid-body fitted into the map. cpRP-specific extensions
were modeled in Coot (23). PSRP5 and PSRP6 were mod-
eled de novo, using secondary structure predictions gener-
ated by PsiPred (26) as a reference. The complete atomic
model of the chloroplast LSU was subsequently refined us-
ing phenix.real space refine (27) with secondary structure
restraints calculated by PHENIX. In order to reduce the
clashscore, the model was additionally refined in reciprocal
space using REFMAC (28) in EM mode. Cross-validation
against overfitting was performed as described elsewhere
(29,30). The statistics of the refined model were obtained
using MolProbity (31).
Figure preparation
All figures showing electron densities and atomic mod-
els were generated using UCSF Chimera (22) and PyMol
Molecular Graphics Systems (version 1.8 Schrödinger).
RESULTS AND DISCUSSION
Cryo-EM structure of the chloroplast 70S ribosome
Chloroplast 70S ribosomes were isolated from S. oleracea
(spinach) leaves as described previously (8,9) and subjected
to single particle cryo-EM analysis. The cryo-EM data was
collected on a Titan Krios transmission electron micro-
scope with a Falcon II direct electron detector. From a total
of 56,475 ribosomal particles, in silico sorting revealed ex-
treme flexibility of the SSU with respect to the LSU (Sup-
plementary Figure S1). To overcome this conformational
heterogeneity, focused alignment was performed indepen-
dently for each ribosomal subunit using FREALIGN (17).
Subsequent refinement yielded cryo-EM reconstructions of
the chloroplast SSU and LSU (Figure 1A–D), with an aver-
age resolution of 5.4 Å and 3.6 Å, respectively (Supplemen-
tary Figure S2 and Table S1).
Analysis of the chloroplast SSU
The resolution of the SSU allowed a homologymodel of the
spinach chloroplast SSU to be rigid body fitted based on the
high sequence similarity between the E. coli and S. oleracea
rRNA and RPs (8). As already noted (8), the major differ-
ence with respect to the 16S rRNA is the shortening of he-
lices h6, h10 and h17 in the chlororibosome rRNA, leading
to a truncated spur (Figure 1A and B) when compared to
the E. coli SSU. In the previous chlororibosome cryo-EM
structure, additional protein density was observed, which
was tentatively assigned to PSRP2 and PSRP3, and pro-
posed to compensate for the truncated spur rRNA (8).
At higher resolution, this extra spur density was not well-
resolved (Figure 1A and B), however, filtering at lower reso-
lution indeed revealed extra density within this region (Sup-
plementary Figure S3). The mass of the extra spur density
could not account fully for either PSRP2 or PSRP3, sug-
gesting that if one of these PSRPs is bound there it is highly
flexible.
As mentioned, the S. oleracea cpRPs are larger than their
respective E. coli counterparts due to the presence of NTEs
and/or CTEs (6). To ascertain the location of the cpRP ex-
tensions, homology models for the S. oleracea cpRPs were
generated based on E. coli templates (20,32), which were
then fitted to the cryo-EMmap of the chloroplast SSU (Fig-
ure 1A andB). Inmany cases, additional density continuous
with the N- or C-termini of the cpRPs could be identified,
consistent with the presence of predicted S. oleracea cpRP-
extensions that are absent in the respective E. coliRPs (Fig-
ure 1A and B). For example, density was observed for the
NTE of cpS5, which is 86 aa longer than E. coli S5 (EcS5)
(6). In addition, density for the NTEs of cpS9, cpS10 and
cpS21 and the CTEs of cpS16 and cpS18 were observed, as
well as a rearrangement of the N-terminus of cpS4. The ex-
tensions of the cpRPs are located exclusively on the back
or cytosolic side of the SSU, but nevertheless encroach on
two functional regions related to the path of the mRNA.
Specifically, the CTE of cpS18 and the NTE of cpS21 are
located at the platform region in vicinity of where the Shine-
Dalgarno helix forms between the 5′ end of the mRNA and
the 3′ end of the 16S rRNA (Supplementary Figure S3). The
N-terminus of cpS4, and particularly the NTE of cpS5, sur-
round the mRNA entry channel (Figure 1A and B; Sup-
plementary Figure S3). Curiously, we also observed extra
density in this region that does not originate from any of
the neighboring cpRP extensions. The extra density con-
nects the head and body of the 30S subunit, namely, bridg-
ing the tip of helix h16 in the body with cpS3 of the head.
This connection is often referred to as the ‘latch’ because it
has been observed to open and close during translation ini-
tiation (33,34). Mass spectrometry analysis did not detect
additional non-orthologous proteins on the spinach chloro-
plast SSU (5–7), therefore, the additional density may actu-
ally be derived from part of PSRP2 or PSRP3, but we can-
not exclude that it is derived from unrelated proteins.
Finally, we identified two additional densities that we as-
signed to PSRP1 and PSRP4 (Supplementary Figure S4A
and B). In agreement with the previous localization (8), we
allocated the density within the head of the SSU to PSRP4
(Figure 1A and B) based on its similarity in sequence and
binding positionwithThx, a small RP identified in theTher-
mus thermophilus SSU (35). Similarly, we assigned the addi-
tional density located within the decoding site on the inter-
subunit side of the SSU to theN-terminal domain (NTD) of
PSRP1, as reported previously (8,36). Sequence alignments
indicated that PSRP1 is not a bone fide cpRP but rather
a homolog of a long form hibernation-promoting factor,
which is responsible for 100S formation (70S dimerization)
(37). The NTD of PSRP1 is homologous with YfiA and
the short form HPF, both of which have also been shown
to bind analogously to the SSU of bacterial 70S ribosomes
(38,39), overlapping the binding site of the mRNA and tR-
NAs in the A- and P-sites (Supplementary Figure S4C and
D). No density was observed for the C-terminal domain of
PSRP1, which has been shown to be responsible for 100S
formation in some bacteria (40,41).
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Figure 1. Cryo-EM structure of the chloroplast SSU and LSU. (A–D) Cryo-EM map (transparent gray) of the spinach chloroplast (A and B) SSU and
(C and D) LSU, illustrating the additional density for cpRPs (green) and extra density assigned to PSRPs (blue) and the ribosome recycling factor (RRF).
The molecular model for the SSU and LSU includes rRNA (gray) and cpRPs (yellow).
Molecular model for the chloroplast LSU
Consistent with the local resolution calculations (Supple-
mentary Figure S2), the electron density was particularly
well resolved within the core of the LSU, whereas the pe-
riphery of the subunit was less defined. We were able to
generate molecular models for 28 of the 33 cpRPs present
in the chlororibosome (Figure 2A–C; Supplementary Ta-
ble S2). cpRPs L1, L10, L11, L7/L12 and L31 were not
modeled due to poor density. The density for cpL5, cpL6
and cpL18 allowed only a rigid body fit of a homology
model based on EcL5 and EcL6, and only theNTDof cpL9
was included in the final model. As observed previously (8),
density was not observed for L25 and L30, consistent with
the absence of genes encoding these cpRPs in plant and
chloroplast genomes (4). We could also model domain I of
the chloroplast ribosome recycling factor (cpRRF) (Supple-
mentary Figure S4), which was bound analogously to that
reported previously on the chlororibosome at lower resolu-
tion (8) as well as on bacterial ribosomes (42,43). Together
with cpEF-G, cpRRF has been demonstrated to dissociate
PSRP1 from the chlororibosome (36). In addition, molec-
ular models are presented for the complete 5S and 2843
(97.6%) of the 2913 nucleotides that comprise the 4.8S and
23S rRNAs (Figure 3A and B; Supplementary Figure S5).
Features of the chloroplast LSU rRNAs
Unlike the mammalian mitoribosome where a tRNA
molecule substitutes for the lack of a 5S rRNA (44,45), the
chlororibosome contains a 5S rRNA (Figure 3A and B)
that is highly similar in sequence and structure to the bacte-
rial 5S rRNA. As mentioned, the chloroplast 23S rRNA is
present in the chlororibosome as two pieces, a 5′ fragment
representing H1-H97 of domains I-VI (hereafter referred to
as cp23S rRNA) and a 3′ fragment comprising H99-H101
of domain VII (termed 4.8S rRNA) (Figure 3A and Supple-
mentary Figure S5). This results in the loss ofH98 (!16 nts)
that links domains VI andVII within theE. coli 23S (Ec23S)
rRNA (Figure 3C). Together with reductions in helices H9
(!14 nts), H45, (!6 nts), H63 (!27 nts) (Figure 3A and
B), the cp23S rRNA has a total of 75 nts missing relative to
the Ec23S rRNA.While the reductions lead to a shortening
in the length of H9 and H45 (Figure 3D and E), the effect
on H98 and H63 results in the complete absence of these
helices in the chlororibosome (Figure 3C and F). Never-
theless, the combined length of the chloroplast LSU rRNA
(3034 nts) is similar to that for E. coli (3024 nts) because
the four rRNA reductions in the cp23S rRNA are compen-
sated by five rRNA additions (8). This includes additional
nucleotides within H15 (+30 nts), H38 (+20 nts), H58 (+23
nts) and H68 (+4 nts) of the cp23S rRNA, as well as +8
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Figure 2. Molecular model for the chloroplast LSU. (A–C) Three overviews of the chloroplast LSU with rRNA (gray ribbons) and modeled cpRPs and
PSRPs shown with a spacefill representation and colored and labeled individually.
Figure 3. Location of rRNA insertions and deletions in the chlororibo-
some. (A and B) Two overviews of the chloroplast LSU with 4.8S (teal),
5S (purple) and 23S (cyan) rRNA, highlighting insertions (green) on the
cp23S and deletions (red) relative to Ec23S. (C–F) Examples of deletions
in the cp23S (cyan) relative to the Ec23S (gray) include deletion of (C) 16
nts in H98, (D) 14 nts in H9, (E) 6 nts in H45 and (F) 27 nts in H63. (G and
H) Examples of additions in the cp23S (cyan) relative to the Ec23S (gray)
include insertion of (G) 30 nts in H15 and (H) 4 nts in H68.
nt insertion in the linker connecting H100 and H101 of the
4.8S rRNA (Figure 3A and B). The insertions within H15
(Figure 3G) and H68 (Figure 3H) are base-paired and well
resolved in the model, whereas the density for the non-base-
paired insertions within H38 and the H100–H101 linker are
poorly defined and therefore not included in the finalmodel.
Localization of cpRPs and extensions
In contrast to the SSU cpRPs, the LSU cpRPs are sig-
nificantly longer than their E. coli counterparts due to
the presence of NTEs and/or CTEs (5). As expected, ad-
ditional density continuous with the N- or C-termini of
the LSU cpRPs was observed (Figure 1C and D), allow-
ing 283 amino acids of the cpRP extensions to be mod-
eled (Figure 4A; Supplementary Table S2). In particular,
cpRPs L13, L15, L21, L22, L24, L27, L29 and L34 have
long NTEs and/or CTEs (Figure 4A). In addition, cpL33
has a "-hairpin with an internal expansion of 13 aa com-
pared to EcL33 (Figure 4A). There are four major excep-
tions of cpRPs (L2, L17, L19 and L23) that have signifi-
cant deletions (>2 aa) compared to their E. coli counter-
parts. In the chlororibosome, cpL17 is C-terminally trun-
cated by 11 aa, although only 4 aa of these are observed in
the E. coli 70S ribosome structures (20,32). The N-terminus
of cpL2 is shorter than EcL2 by only 6 aa, yet we observed
no density for the first 25 aa (Figure 4B). Similarly, the
CTE of cpL19 is not only 4 aa shorter than EcL19, but
the last 11 aa also adopt a distinct conformation (Figure
4B). Lastly, the "-hairpin of EcL23 that reaches into the
tunnel lumen in the E. coli ribosome (20,32) is significantly
shorter in the chlororibosome (Figure 4B), reminiscent of
the archaeal/eukaryotic L23 homologs (46,47). However,
unlike archaeal/eukaryotic ribosomes that compensate for
the truncated L23 with the presence of aeL38 (46,47), the
equivalent space remains vacant in the chlororibosome.
Binding sites of PSRP5 and PSRP6 on the LSU
Subsequent tomodeling of the LSU rRNAs aswell as all the
cpRPs and cpRP extensions, we noticed that two unmod-
eled regions of electron density were present in the cryo-EM
map, which we assigned to PSRP5 and PSRP6 (Figure 1C
and D). Due to their buried location within the chlororibo-
some, the electron density was well resolved (Figure 5A and
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Figure 4. Molecular models indicating cpRP extensions and deletions. (A) Structures of cpRPs showing the core region equivalent to the respective EcRPs
(gold) with N-terminal extensions (NTEs), C-terminal extensions (CTEs) or the internal expansion (ITE) highlighted (green). The numbers indicate the
modeled residues with the total expansion length indicated in parentheses. (B) Structures of cpRPs (gold) compared with the respective EcRPs (blue)
highlighting amino acid deletions (in parentheses) in cpRPs relative to EcRPs.
Figure 5. Localization of PSRP5 and PSRP6 on the chlororibosome. (A and B) Cryo-EM electron density (mesh) with molecular models for (A) PSRP5
and (B) PSRP6. (C and D) Cryo-EM electron density for (C) PSRP5 and (D) PSRP6 colored according to local resolution. (E and F) Molecular models
showing secondary structure for (E) PSRP5 and (F) PSRP6. (G) Binding site of PSRP5 (gold) on the LSU (cyan). (H and I) Interaction between PSRP5
(gold) and H58 and H60 of the cp23S rRNA (cyan), with (I) comparison of different conformation of H58 from the Ec23S rRNA (gray). (J) Binding site
of PSRP6 (gold) on the LSU (cyan). (K and L) Interaction between the N-terminus of PSRP6 (gold) and H40, H42 and H89 of the cp23S rRNA (cyan),
and (L) the C-terminus of PSRP6 (gold) with the cpL21 (green).
B), in agreement with local resolution calculations (Figure
5C and D), enabling unambiguous models for both PSRP5
and PSRP6 to be generated (Figure 5E and F; Supplemen-
tary Figure S4). Consistent with secondary structure pre-
dictions, PSRP5 consists of a short C-terminal $-helix con-
nected by a linker to a long central $-helix (Figure 5E). The
binding site of PSRP5 is located at the base of the LSU di-
rectly under the L1 stalk, with the N-terminus extending to-
ward the intersubunit interface (Figure 5G).We note that 38
aa are missing from the N-terminus in our model, presum-
ably due to flexibility outside of the ribosome. The surface
of the buried regions of PSRP5 is highly positively charged
(Supplementary Figure S4F and G), as would be expected
from the surrounding negatively charged rRNA environ-
ment. The short C-terminal $-helix of PSRP5 inserts into
the minor groove of H60, whereas the central $-helix es-
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tablishes interactions with H58 (Figure 5H). The specificity
of PSRP5 for the chlororibosome may be due to the in-
teraction with H58, since there are significant differences
in both the sequence and structural conformation of H58
when comparing with the E. coli 70S ribosome (Figure 5I).
We note that the position of PSRP5 was mis-assigned in the
previous structure of S. oleracea chloroplast 70S ribosome
(8), probably due to the small size of the protein and the
limited resolution of the reconstruction.
PSRP6 adopts a very extended conformation (Figure 5F)
that winds its way through the ribosome (Figure 5J–L).
The N-terminal half of PSRP6 is predominantly positively
charged (Supplementary Figure S4I–K), consistent with
the extensive interaction with the negatively charged rRNA
(Figure 5K). The N-terminus of PSRP6 interacts with the
minor grooves of H89, H40 and H42 as it winds its way out
of the ribosomal core (Figure 5K). The two short central $-
helices of PSRP6 are positioned within the minor grooves
of H40 and H42 and are separated by a linker region that
passes near to the 5S rRNA (Figure 5K). The C-terminal
half of PSRP6 is less charged (Supplementary Figure S4I),
consistent with an interaction with the globular domain of
cpL21, rather than with rRNA. The C-terminus of PSRP6
donates a "-strand to augment the "-sheet of cpL21 (Figure
5L) before extending into the solvent where the C-terminal
22 aa are not visualised. The conservation of this region be-
tweenS. oleracea chloroplast andE. coli 70S ribosomes sug-
gests that PSRP6 could in principal bind analogously to the
E. coli 70S ribosome.
cpRP extensions and rRNA stabilization
Generally, the NTE and CTE of cpRPs contain posi-
tively charged amino acids that establish additional interac-
tions with the surrounding rRNA, predominantly with the
phosphate-oxygens of the backbone. For example, the 10 aa
CTE of cpL34 interacts with the loop of helix H8 of the 23S
rRNA and forms a potential hydrogen bond from Lys148
with the backbone of U1638 within H51 (Figure 6A). In
many cases, the cpRP extensions interact with the minor
groove of rRNAhelices. Such an interaction is illustrated by
the 25 aaCTEof cpL15, which inserts into theminor groove
of a helix formed from the loops of H22 and H88 (Figure
6B). Lys243 comes within hydrogen bonding distance of the
ribose of A427 and Tyr241 stacks upon A213 that makes an
A-minor interaction within the H22/H88 helix (Figure 6B).
Similarly, the 18 aa NTE of cpL24 that penetrates deeper
into the ribosomal core, approaches the minor groove of an
rRNA helix formed from the loops of H6 and H7, before
the N-terminus emerges within the tunnel lumen (see later).
We also observed that the cpRP extensions often rein-
force interactions with rRNA elements that are already con-
tacted by the core of the cpRP, as illustrated by cpRPs L35
and L13 (Figure 6C and D). Arg140 in the core of cpL35
contacts the phosphate-oxygen of G966 in H38, an inter-
action also observed for EcL35 (Figure 6C). This contact
is reinforced in the chlororibosome by a potential hydrogen
bond from Arg157 within the 7 aa CTE of cpL35 to the
backbone of C966 within H38 (Figure 6C). Similarly, the
interaction from Arg126 in the core of cpL13 with A1170
in H41 is reinforced in the chlororibosome by an additional
hydrogen bond from Arg245 within the NTE of cpL13 to
the backbone of A1170 within H41 (Figure 6D).
Three of the cpRP extensions contain$-helical secondary
structure, namely within the NTE of cpL13 and the CTEs
of cpL15 and cpL27 (Figure 4A). The $-helix within the
CTE of cpL15 interacts with H68, which as mentioned is
extended in the chlororibosome compared to the E. coli
70S (Figure 3H). In the chlororibosome, the NTE of cpL13
forms an $-helix that interacts with the junction where the
5′ end of the 4.8S rRNAmeets the 3′ end of the cp23S rRNA
(Figure 6E). Comparison with the E. coli 70S ribosome re-
vealed that the N-terminal $-helix of cpL13 occupies the
position of H10 of the Ec23S rRNA (Figure 6F), which
is absent in the chlororibosome (Figure 6E). The $-helix
within the CTE of cpL27 appears to stabilize a three-way
junction formed by the insertion of 20 nts within H38 of
the cp23S rRNA (Figure 6G), which is lacking in the Ec23S
rRNA (Figure 6H). The site of insertion inH38 in the cp23S
rRNA correlates with the position of expansion segment 12
(ES12L) in eukaryotic 80S ribosomes (47,48). In the E. coli
ribosome, EcL30 contacts H38 in the vicinity of the inser-
tion site (Figure 6H). Such an L30-H38 interaction would
not be possible in the chlororibosome due to the presence of
the additional rRNAhelix inH38, thus providing a possible
explanation as to why L30 is missing in plant chloroplasts.
Intertwining of cpRP extensions at the tunnel exit
A number of differences with the E. coli 70S ribosome were
evident when examining the back or cytosolic side of the
LSU of the chlororibosome, in particular, the region sur-
rounding the tunnel exit site. Asmentioned, the"-hairpin of
cpL23 is shorter than EcL23 leading to an enlarged luminal
space near the exit site of the chlororibosome (Figure 7A–
C). In contrast, the opposite side of the tunnel from cpL23
has extramass due to the presence of theNTEof cpL24 that
penetrates into the ribosomal core from the surface located
globular domain (Figure 7B). The 27 aa CTE of cpL29 in-
tertwines with the NTE of cpL23 (Figure 7B), which to-
gether occupy the space where 23S rRNA helix H10 is sit-
uated in the E. coli 70S ribosome (Figure 7C). Comparison
with the binding site ofE. coli SRP on the ribosome (49,50),
suggests that the CTE of cpL29 could play a role in recruit-
ment cpSRP54 to the chlororibosome (Figure 7D).
By far the largest conglomerate of cpRP extensions is lo-
cated at the back of the LSU adjacent to the tunnel exit
site (Figure 7E). This conglomerate comprises the 45 aa (of
52 aa) NTE of cpL13, 22 aa (of 67 aa) from the NTE of
cpL21 and 37 aa (of 60 aa) CTE of cpL22, which reach
out from the respective globular domains to form multiple
protein–protein interactions with each other (Figure 7F).
The high flexibility of the extensions, and the poor quality
of the density at the periphery of the ribosome, enabled only
the backbone of the protein extensions to be traced. More-
over, the N-terminal 45 aa of the NTE of cpL21 could not
be modeled, although density was observed at lower thresh-
olds suggesting that these residues establish additional in-
teractions with the CTE of cpL22. Collectively, these cpRP
extensions expand the area of the LSU and could facilitate
interaction with the thylakoid membrane (Figure 7E).
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Figure 6. Interaction of cpRP extensions with rRNA. (A–D) Examples of interaction of cpRP extensions (gold) with cp23S rRNA (cyan) include the
(A) CTE of cpL34 with H51, (B) CTE of cpL15 with H22/H88, (C) CTE of cpL35 with H38 and (D) NTE of cpL13 with H41. (E) Interaction of NTE
of cpL13 (gold) with the 3′ end of the cp23S (cyan) and the 5′ end of the 4.8S (pink) in the chlororibosome, superimposed with the (F) Escherichia coli
70S ribosome showing that H10 of the Ec23S (gray) overlaps with the NTE of cpL13 (gold). (G) Interaction of CTE of cpL27 (gold) with the three-way
junction of H38 (cyan) of the chlororibosome, whereas in the (H) E. coli 70S ribosome, EcL27 (green) has no extension and H38 (gray) is bound by EcL30
(red).
Figure 7. Interaction of cpRP extensions with rRNA. (A) View onto the tunnel exit site of the chloroplast LSU with rRNA (cyan) and highlighting cpRPs
L23 (orange), L29 (purple), L24 (tan), L22 (green), L13 (blue) and L21 (yellow). (B) Zoom of (A) highlighting the NTE of cpL24 and cpL23, and the
CTE of cpL29 as well as the shorter "-hairpin of cpL23. (C) Equivalent view of (B) but for Escherichia coli 70S ribosome, highlighting the absence of
EcL24-NTE and the presence of the "-hairpin of EcL23 in the tunnel lumen, as well as H10 of Ec23S rRNA. (D) Superimposition of EcSRP (blue) on
chlororibosome illustrating overlap with the CTE of cpL29. (E) Chloroplast LSU, colored as in (A), illustrating additional cpRP protein mass that expands
the potential surface area of the LSU and facilitates its possible interaction with the thylakoid membrane (TM). (F) Zoom of boxed region in (E) without
rRNA to illustrate the contribution of the cpRP extensions (NTE/CTE) of L21 (yellow), L13 (blue) and L22 (green) to the thylakoid membrane interaction
surface.
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CONCLUSION
Here we present a near-complete molecular model for
the spinach chloroplast LSU, revealing the location of
rRNA insertions and deletions, cpRP extensions as well
as the binding site of two plastid-specific RPs, PSRP5 and
PSRP6. Prior to submission, a cryo-EM structure of the
spinach chloroplast 50S subunit was reported by Ahmed
and coworkers (51). Generally, the results appear to be in
good agreement with our structure, although a careful com-
parison cannot be undertaken as the cryo-EM map and
model were not yet available at the time of submission, nor
during the review process. In general, the differences of the
chlororibosome with respect to the eubacterial E. coli 70S
ribosome are localized to peripheral regions of the ribo-
some and not within core functional regions that would be
expected to influence translational activity, such as the sub-
unit interface, peptidyl-transferase center or translation fac-
tor binding site. One major exception is related to the ribo-
somal tunnel through which the nascent polypeptide chain
passes as it is synthesized. In the chlororibosome, we ob-
served that the lower region of the tunnel differs from bac-
teria due to a shorter "-hairpin of cpL23 and the additional
presence of the NTE of cpL24. Formation of $-helical sec-
ondary structure within nascent polypeptides chains has
been observed in this region of the ribosomal tunnel (52).
Structural changes within this region of the chlororibosome
may facilitate targeting and insertion of transmembrane-
containing proteins into the thylakoid membrane. In this
respect, we also note that the CTE of cpL29 could play a
role in recruitment of cpSRP54 to the chlororibosome. Un-
like bacterial SRPs, the cpSRP lacks the 4.5SRNA (termed,
SRP RNA) and comprises only the SRP54 protein, and
therefore the CTE of cpL29 may contribute to stabilization
of SRP54 interaction with the chlororibosome. Finally, we
observed a large conglomerate of cpRP extensions that ex-
pand the surface area at the back of the LSU. We suggest
that this may facilitate interaction of the chlororibosome
directly with the thylakoid membrane and/or membrane-
bound components of the targeting machinery, and thereby
increase the efficiency of membrane protein insertion. As
mentioned, the majority of the chloroplast-encoded pro-
teins is targeted to the thylakoid membranes, including
components of the ATP synthase, cytochrome b/f and es-
pecially photosystem I and II complexes (4).
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SUPPLEMENTARY FIGURES 
 
 
Figure S1: In silico sorting and refinement of the chloroplast SSU and LSU. (A) 
In silico sorting was performed using SPIDER (2), starting with an initial 56,475 
particles that yielded after removal of non-aligning particles (18,849), a dataset of 
37,626 ribosomal particles. (B) Subsequently, focused alignment and refinement of 
the SSU and LSU was performed in FREALIGN (3). 
 
 
Figure S2: Resolution of the cryo-EM reconstruction of the chloroplast SSU 
and LSU. (A,B) Fourier-shell correlation curve (FSC) of the refined final map of the 
chloroplast (A) SSU and (B) LSU, indicating the average resolution is 5.4 Å and 
3.6 Å, respectively. (C) Fit of models to maps. FSC curves calculated between the 
refined model and the final map (blue), with the self- and cross-validated correlations 
in orange and black, respectively. Information beyond 3.6 Å was not used during 
refinement and preserved for validation. (D) Overview and (E) transverse section 
through the chloroplast LSU colored according to the local resolution as calculated 
using ResMap (1). 
 
Figure S3: Localization of extra density on the SSU. (A) Overview of the back of 
the cryo-EM map (grey) of the chloroplast SSU with molecular model (rRNA, grey; 
RPs, yellow), and with (B) zoom onto the spur region, showing extra density (blue). 
(C) Overview of the back of the cryo-EM map (grey) of the chloroplast SSU from 
Sharma and coworkers (4) with molecular model (rRNA, grey; RPs, yellow), and with 
(D) zoom onto the spur region, showing additional density that was assigned to 
PSRP2/3. (E) Overview and (F) zoom onto the back of the cryo-EM map (grey) of 
the chloroplast SSU with molecular model (rRNA, grey; RPs, yellow), with cpRP 
densities (green) and unassigned extra density (blue) shown relative to the position 
of mRNA (yellow; superimposed from PDB ID 3I8G (5)). (G) Overview and (H) zoom 
onto the platform of the cryo-EM map (grey) of the chloroplast SSU with molecular 
model (rRNA, grey; RPs, yellow) and cpRP densities (green) shown relative to the 
position of SD-aSD helix (yellow/red; superimposed from PDB ID 3I8G (5)). 
 
Figure S4: Localization of PSRPs on the chlororibosome. (A,B) Cryo-EM 
electron density (grey mesh) for (A) PSRP4 and (B) PSRP1. (C,D) Superimposition 
of the binding site of PSRP1 (blue) on the chlororibosome relative to (C) E. coli HPF 
(orange) bound to the Thermus thermophilus 70S ribosome (PDB ID 4V8H, (6))!and 
(D) mRNA (yellow) and A-site (pink), P-site (green) and E-site (cyan) tRNAs (PDB ID 
3I8G, (5)). (E) Cryo-EM electron density (grey mesh) for domain I of the cpRRF 
(blue, cpRRF-DI). (F-H) Molecular model for PSRP5 shown as (F) surface charge 
(blue, positive) and (G) with electron density (grey mesh) and (H) zoom of the boxed 
region in (G). (I-K) Molecular model for PSRP6 shown as (I) surface charge (blue, 
positive, white neutral, red, negative) and (J) with electron density (grey mesh) and 
(K) zoom of the boxed region in (J). 
 
Figure S5: Modelled nucleotides of the chloroplast 4.8S and 23S rRNAs. (A) 
Secondary structure of the 5’ portion of the cp23S rRNA, with nucleotides highlighted 
in red that were not modelled. The secondary structure diagram was taken from the 
Comparative RNA Web (CRW) Site (www.rna.ccbb.utexas.edu) (7). 
!
Figure S5: Modelled nucleotides of the chloroplast 4.8S and 23S rRNAs. (B) 
Secondary structure of the 3’ portion of the cp23S rRNA and 4.8S rRNA, with 
nucleotides highlighted in red that were not modelled. The secondary structure 
diagram was taken from the Comparative RNA Web (CRW) Site 
(www.rna.ccbb.utexas.edu) (7). 
SUPPLEMENTARY TABLES 
Supplementary Table S1. Data collection and refinement statistics 
Data Collection and Refinement Cp50S 
Particles  37,636!
Pixel size (Å) 1.061!
Defocus range (µm)  )1.0)2.3!
Voltage (kV) 300!
Electron dose (e-/Å-2) 40.3!
Map sharpening B factor (Å2) )84.98!
Resolution (Å, 0.143 FSC) 3.6!
FSCAverage 0.88!
Model Composition !
Protein residues 3,392!
RNA bases 2,963!
Validation (proteins) !
Poor rotamers (%) 7.11!
Ramachandran outliers (%) 2.94!
Ramachandran favored (%) 85.51!
Bad backbone bonds (%) 0.04!
Bad backbone angles 0.01!
MolProbity score 2.48!(99th!percentile)!
Validation (nucleic acids) !
Correct sugar puckers (%) 96.39!
Good backbone conformations (%) 69.83!
Bad bonds (%) 0.01!
Bad angles 0.21!
Clash score, all atoms 3.96!(100th!percentile)!
 
Supplementary Table S2 Modeled proteins of the chloroplast LSU  
Protein( UniProtKB( (((((((((Preprotein( (((((Mature(Length( (((Modeled(Residues(
uL01c! Q9LE95! !!!!!!1)352! 73)352! !
uL02c! P06509! ! 2)272! 26)271!
uL03c! A0A0K9QEC7! !!!!!!1)305! 85)305! 85)303!
uL04c! O49937! !!!!!!1)293! 51)293! 56)260!
uL05c! P82192! ! 1)220! 16)194!
uL06c! A0A0K9R4N9! !!!!!!1)220! 39)220! 40)217!
bL09c! A0A0K9RQ91! !!!!!!1)196! 42)196! 43)87!
uL10c! A0A0K9R3N5! !!!!!!1)232! 53)232! !
uL11c! P31164! !!!!!!1)224! 67)224! !
bL12c! P02398! !!!!!!1)189! 57)189! !
uL13c! P12629! !!!!!!1)250! 48)250! 55)250!
uL14c! P09596! ! 1)121! 1)120!
uL15c! A0A0K9QHT0! !!!!!!1)271! 61)271! 78)259!
uL16c! P17353! ! 1)135! 1)135!
bL17c! A0A0K9RLJ4! !!!!!!1)126! 11)126! 11)126!
uL18c! A0A0K9QQ60! !!!!!!1)166! 45)166! 49)166!
bL19c! P82413! !!!!!!1)233! 78)233! 117)230!
bL20c! P28803! ! 2)128! 2)117!
bL21c! P24613! !!!!!!1)256! 56)256! 101)234!
uL22c! P09594! ! 2)199! 25)176!
uL23c! Q9LWB5! !!!!!!1)198! 77)198! 104)194!
uL24c! P27683! !!!!!!1)191! 47)191! 47)175!
bL27c! A0A0K9R4I2! !!!!!!1)194! 57)194! 59)166!
bL28c! A0A0K9RD02! !!!!!!1)148! 72)148! 72)146!
uL29c! A0A0K9R7W8! !!!!!!1)168! 59)168! 59)152!
bL31c! A0A0K9R0R6! !!!!!!1)130! 37)130! !
bL32c! P28804! !!!!!!1)57! 2)57! 2)43!
bL33c! P28805! ! 1)66! 6)65!
bL34c! P82244! !!!!!!1)152! 92)152! 92)152!
bL35c! P23326! !!!!!!1)159! 87)159! 90)159!
bL36c! P12230! ! 1)37! 1)37!
PSRP5! P27684! !!!!!!1)142! 59)142! 97)142!
PSRP6! P82411! !!!!!!1)116! 48)116! 48)94!
RRF! P82231! ! 1)271! 89)114;191)271!
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Structural basis for ArfA–RF2-mediated translation 
termination on mRNAs lacking stop codons
Paul Huter1*, Claudia Müller1*, Bertrand Beckert1,2, Stefan Arenz1, Otto Berninghausen1, Roland Beckmann1 & 
Daniel N. Wilson1,2
In bacteria, ribosomes stalled on truncated mRNAs that lack a 
stop codon are rescued by the transfer-messenger RNA (tmRNA), 
alternative rescue factor A (ArfA) or ArfB systems1. Although 
tmRNA–ribosome and ArfB–ribosome structures have been 
determined2-7, how ArfA recognizes the presence of truncated 
mRNAs and recruits the canonical termination release factor RF2 
to rescue the stalled ribosomes is unclear. Here we present a cryo-
electron microscopy reconstruction of the Escherichia coli 70S 
ribosome stalled on a truncated mRNA in the presence of ArfA 
and RF2. The structure shows that the C terminus of ArfA binds 
within the mRNA entry channel on the small ribosomal subunit, 
and explains how ArfA distinguishes between ribosomes that bear 
truncated or full-length mRNAs. The N terminus of ArfA establishes 
several interactions with the decoding domain of RF2, and this 
finding illustrates how ArfA recruits RF2 to the stalled ribosome. 
Furthermore, ArfA is shown to stabilize a unique conformation 
of the switch loop of RF2, which mimics the canonical translation 
termination state by directing the catalytically important GGQ 
motif within domain 3 of RF2 towards the peptidyl-transferase 
centre of the ribosome. Thus, our structure reveals not only how 
ArfA recruits RF2 to the ribosome but also how it promotes an 
active conformation of RF2 to enable translation termination in 
the absence of a stop codon.
Premature transcription termination or truncation of a full-length 
mRNA can lead to mRNAs lacking a stop codon. Ribosomes translating 
these truncated mRNAs become trapped at the 3′ end of the mRNA 
because translation elongation or termination cannot occur. In bacteria, 
these stalled ribosomes are recognized and recycled by the tmRNA 
rescue system (reviewed in ref. 1). A subset of bacteria, such as E. coli, 
can survive without the tmRNA system owing to the presence ArfA8. 
The synthetic lethality arising from inactivation of both the tmRNA 
and ArfA rescue systems can be alleviated by overexpression of ArfB9. 
Collectively, these studies illustrate the physiological importance that 
the rescue of stalled ribosomes has for cell viability. Structural studies 
have revealed how ribosomes stalled on truncated mRNA are recog-
nized and recycled by the tmRNA–SmpB complex6,7 or ArfB5. In the 
case of ArfB, the empty mRNA channel of the ribosome is probed 
by the C-terminal helix, positioning the N-terminal catalytic GGQ-
containing domain at the peptidyl-transferase centre (PTC) to trigger 
peptidyl-tRNA hydrolysis5. Similarly, in the tmRNA–SmpB complex, 
the C-terminal helix of SmpB recognizes the empty mRNA channel 
and positions the tRNA-like domain of tmRNA at the PTC to enable 
peptidyltransfer6,7. Translation then continues on the mRNA-like 
domain of tmRNA, which encodes a short peptide targeting the 
incompletely translated nascent polypeptide chain for degradation1. 
Biochemical studies have demonstrated that ArfA represents a back-up 
system for tmRNA10,11. The arfA mRNA contains a stem–loop that 
acts as a transcription terminator as well as a substrate for RNase III 
cleavage10-12. In the presence of tmRNA, the short ArfA product pro-
duced from the truncated arfA mRNA is tagged by tmRNA and tar-
geted for degradation. However, in the absence of tmRNA, the short 
ArfA product is not degraded and assumes the role of recycling ribo-
somes stalled on truncated mRNAs10,11. The full-length E. coli ArfA 
protein is 72 amino acids long and contains a C-terminal hydrophobic 
region that leads to aggregation of the protein in vivo10. Shorter 
forms of ArfA that result from truncated arfA mRNAs and lack the 
terminal 17–18 amino acids retain full recycling activity10,11. ArfA 
alone is insufficient to recycle ribosomes stalled on truncated mRNAs 
and requires the assistance of the canonical termination release factor 
RF2 to hydrolyse the peptidyl-tRNA on the ribosome13,14 (Fig. 1a–c). 
A mechanistic understanding of how ArfA recognizes ribosomes 
stalled on truncated mRNAs, recruits RF2 and stabilizes the active 
conformation of RF2 has so far been hampered by the lack of an 
ArfA–RF2–ribosome structure.
To generate a suitable complex for structural analysis, in vitro trans-
lation reactions were performed with a truncated mRNA in the pres-
ence and absence of ArfA∆17 (lacking residues 56–72) and/or RF2. 
As reported previously13,14, the presence of both ArfA and RF2 was 
required for efficient recycling of the peptidyl-tRNA (Extended Data 
Fig. 1). By contrast, replacing wild-type RF2 with the catalytically 
inactive RF2-GAQ mutant (in which the tripeptide Gly-Gly-Gln is 
converted to Gly-Ala-Gln) prevented peptidyl-tRNA hydrolysis and 
recycling (Extended Data Fig. 1), as described previously13. Cryo-
electron microscopy (cryo-EM) analysis of the ArfA∆17–RF2-GAQ–
stalled ribosomal complex (hereafter referred to as ArfA-RF2-SRC) 
and in silico sorting of this dataset yielded a major subpopulation 
of ribosomal particles that contained stoichiometric occupancy of 
P-tRNA, ArfA and RF2 (Extended Data Fig. 2). Subsequent refine-
ment resulted in a final reconstruction of ArfA-RF2-SRC (Fig. 1d) 
with an average resolution of 3.1 Å (Extended Data Fig. 3 and 
Extended Data Table 1). The electron density for most of ArfA was 
well-resolved with local resolution mostly within the range of 3.0 to 
3.5 Å (Fig. 1e), enabling a molecular model to be built de novo for resi-
dues 2–46 of ArfA (Fig. 1f, g). The lack of density for the C-terminal 
9 amino acids of ArfA prevented these residues from being included 
in the final model.
The ArfA-binding site is located on the 30S subunit within the decoding 
A-site, where it is sandwiched between helices 18 (h18), h34 and h44 of 
the 16S rRNA and ribosomal protein S12 (Fig. 2a). ArfA establishes two 
contact sites with the β-hairpin of S12, namely, from the N terminus 
in which potential hydrogen bonds are possible between Thr38 of S12 
and the backbone of Arg3 of ArfA, and between two highly conserved 
arginines (Arg26 and Arg28) of ArfA and Lys43 and Ser46 of S12 
(Fig. 2b and Extended Data Fig. 3f). The large interaction surface that 
ArfA establishes with the 30S subunit may explain how ArfA can interact 
with the ribosome in the absence of RF2 (ref. 15). The C terminus of 
1Gene Center, Department of Biochemistry and Center for integrated Protein Science Munich (CiPSM), Ludwig-Maximilians-Universität München, Feodor-Lynen-Strasse 25, 81377 Munich, 
Germany. 2Institute for Biochemistry and Molecular Biology, University of Hamburg, Martin-Luther-King-Pl. 6, 20146 Hamburg, Germany.
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ArfA extends from the decoding A-site into the mRNA entry channel, 
where it occupies the space that would be normally house the 3′ end 
of a full-length mRNA (Fig. 2c). The lack of density for the C-terminal 
residues of ArfA suggests that they are less important for binding, 
which is consistent with their poor conservation across ArfA from 
different species8,12. By contrast, two positively charged motifs, KKGK 
(residues 33–36) and RKGK (residues 41–44), are highly conserved 
and provide multiple interaction opportunities with the surrounding 
negatively charged rRNA forming the mRNA channel (Fig. 2d). 
We note that mutation of any single residue in ArfA, including within 
the K(R)KGK motifs, to cysteine is reported to have little effect on the 
recycling activity of ArfA15, suggesting a redundancy in the impor-
tance of the interactions of ArfA with the ribosome. Biochemical 
studies have demonstrated that the efficiency of ArfA–RF2-mediated 
ribosome recycling decreases with increasing length of the 3′ end of the 
mRNA extending into the A-site14-16. Specifically, recycling occurred, 
albeit with reduced efficiency, when the mRNA was extended by up 
to 3–4 A-site nucleotides, whereas almost no recycling was observed 
on artificially stalled ribosomes with mRNAs extended by six or more 
A-site nucleotides14-16. Consistently, superimposition of a full-length 
mRNA and the ArfA binding position suggests that only three nucleo-
tides can be accommodated in the A-site without notable clashes with 
ArfA (Fig. 2e).
The location of the C terminus of ArfA within the mRNA channel 
of the 30S subunit observed in the Arf-RF2-SRC structure is also com-
patible with hydroxyl-radical probing experiments performed in the 
absence of RF2 (ref. 15; Extended Data Fig. 4), suggesting that ArfA 
initially uses a similar conformation to monitor the vacant mRNA 
channel. By contrast, 16S rRNA cleavages indicate that the N terminus 
of ArfA is flexible and only adopts a defined conformation contacting 
h18 upon binding of RF2 (ref. 15), as observed in the Arf-RF2-SRC 
structure (Extended Data Fig. 4). The ArfA-RF2-SRC structure also 
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Figure 1 | Cryo-EM structure of ArfA-RF2-SRC. a–c, Schematic 
representation of ArfA–RF2-mediated rescue of ribosomes stalled on 
truncated mRNA (TR-mRNA). d, Transverse section of the cryo-EM 
map of ArfA-RF2-SRC, highlighting the 30S (yellow) and 50S (grey) 
subunits, P-tRNA (green), TR-mRNA (blue), RF2 (orange) and ArfA 
(red). e, Electron density for ArfA, coloured according to local resolution. 
f, Electron density (mesh) with molecular model for ArfA (red). g, Model 
for ArfA with features highlighted corresponding to the schematic of the 
ArfA protein, including helical region (green), β-strand (blue) and KKGK 
(orange) and RKGK (yellow) motifs.
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Figure 2 | Interaction of ArfA with the small subunit. a, Overview of 
ArfA (red) and 30S (16S rRNA, grey) interaction partners; h18 (tan), 
h34 (olive), h44 (dark grey), S12 (blue) and P-tRNA (green). b, Contacts 
between ArfA (red) and S12 (blue). c, Superimposition of ArfA (red) and 
truncated mRNA (TR-mRNA, blue), with full-length mRNA (FL-mRNA;  
cyan, PDB code 4V6F)25 within the mRNA entry channel (grey). 
d, Interaction of the KKGK (orange) and RKGK (yellow) motifs of ArfA 
with surrounding rRNA (grey ribbons). e, As in c, but highlighting the 
relative position of ArfA (red) with the A-site codon of the FL-mRNA 
(cyan).
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
LETTERRESEARCH
5 4 8  |  N A T U R E  |  V O L  5 4 1  |  2 6  J A N U A R Y  2 0 1 7
provides insight into how ArfA recruits RF2 despite the absence of a 
stop codon in the mRNA. ArfA has a large interaction interface with 
RF2, encompassing the central portion (residues 15–31) of ArfA that 
contacts the distal end of α-helix α7 of domain 3 as well as the β4–β5 
strands of domain 2 of RF2 (Fig. 3a, b and Extended Data Fig. 3g). The 
nature of the backbone interactions between ArfA and RF2 suggest 
that residues 27–30 of ArfA donate a small β-strand to the β-sheet of 
domain 2/4 (Fig. 3b, c). The overall position of RF2 in ArfA-RF2-SRC 
is similar to that observed during canonical translation termination17,18 
(Fig. 3d), although a slight shift in the position of the decoding domain 
2/4 is observed. The shift affects the loop between the β4–β5 strands of 
domain 2 bearing the SPF (E. coli 205-Ser-Pro-Phe-207) motif, which 
is involved in the specificity of recognition of the first and second posi-
tions of the UGA/UAA stop codons17,18,19 (Fig. 3e, f). Importantly, the 
structure illustrates that ArfA does not interact with the SPF motif and 
therefore does not directly mimic the presence of a stop codon (Fig. 3f). 
This observation is consistent with a previous report that demonstrates 
that mutations in the SPF motif impairing RF2 termination activity do 
not affect ArfA–RF2-mediated recycling activity13. Furthermore, RF1 
mutants bearing the SPF instead of PAT motif, conferring termination 
activity at UGA, are inactive in the ArfA-mediated recycling system13. 
An analysis of the ArfA–RF2 interaction network, together with E. coli 
RF1/RF2 sequence alignments (Extended Data Fig. 5) and models for 
E. coli RF1–ArfA on the ribosome (Extended Data Fig. 6), identified 
several regions in domain 2 of RF2 (Q133, V198 and G210–F221) and 
within the switch loop (K307–S321) that could potentially explain the 
specificity of ArfA for RF2.
During canonical termination, recognition of the stop codon by 
RF1 and RF2 is proposed to stabilize a rearranged conformation of 
the switch loop, which directs domain 3 into the PTC20,21. The switch 
loop conformation is stabilized by specific interactions with A1492 
and A1493, which, in the case of RF2, involves stacking interactions 
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of W319 (E. coli numbering) of RF2 with A1492 of the 16S rRNA17,18 
(Fig. 4a). In the ArfA-RF2-SRC structure, the conformation of A1492 
and A1493 are distinct from those observed during canonical transla-
tion termination, and the presence of ArfA precludes the interaction 
between the switch loop and A1492 (Fig. 4a, b). Instead, ArfA itself 
appears to stabilize a distinct conformation of the switch loop in RF2 
that extends the α-helix α7 of domain 3 of RF2 by three helical turns 
when compared to the crystal structure of the free (closed) form of RF2 
(ref. 22) (Fig. 4c, d, Supplementary Video 1). The extension of helix α7 
is analogous to that observed during canonical translation termination 
with RF2 (refs 17, 18) (Fig. 4e, Supplementary Video 2). As observed 
for canonical termination17,18, the open conformation of RF2 on the 
ribosome in the presence of ArfA also directs the GGQ motif of domain 
3 into the PTC (Fig. 4f), although the density for the GAQ motif is 
poorly resolved, possibly owing to the inactivity of the mutation. The 
A18T mutation that led to the discovery of ArfA does not interfere with 
ribosome binding8 or RF2 recruitment, but prevents peptidyl-tRNA 
hydrolysis14. This can be rationalized on the basis of the ArfA-RF2-SRC 
structure since the A18T mutation is not located at the ArfA–ribosome 
or ArfA–RF2 interfaces, but would rather perturb the conformation of 
the N terminus of ArfA and thereby interfere indirectly with the correct 
placement of domain 3 of RF2 at the PTC (Extended Data Fig. 7).
In conclusion, our findings indicate that ArfA not only provides an 
interface to recruit RF2 to the ribosome in the absence of a stop codon, 
but also, by interacting with the switch loop of RF2, induces confor-
mational changes that lead to the accurate placement of domain 3 at 
the PTC. Structurally, the bacterial recycling systems are similar in 
that they use tmRNA–SmpB6,7, ArfB5 or ArfA (Extended Data Fig. 8) 
to monitor the mRNA channel and release the nascent polypeptide 
before ribosome splitting. This contrasts with the eukaryotic recycling 
of ribosomes stalled on truncated mRNAs, in which ribosome splitting 
by Dom34–Hbs1 and ABCE1 occurs before nascent polypeptide chain 
release23,24.
Online Content Methods, along with any additional Extended Data display items and 
Source Data, are available in the online version of the paper; references unique to 
these sections appear only in the online paper.
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METHODS
No statistical methods were used to predetermine sample size. The experiments 
were not randomized and investigators were not blinded to allocation during 
experiments and outcome assessment.
Protein expression and purification. Escherichia coli RF2 was expressed from a 
pET11a vector incorporting a C-terminal hexa-histidine tag (His6) for purification 
and detection purposes. An inactive RF2-GAQ mutant was generated by site- 
directed mutagenesis. E. coli ArfA without 17 C-terminal amino acids (ArfA∆17) 
was cloned into pBAD vector with a N-terminal His6 and 3C protease cleavage 
site. The wild-type RF2, RF2-GAQ and ArfA∆17 proteins were over-expressed 
in E. coli BL21 (DE3) at 37 °C for 1.5 h after induction with 1 mM IPTG or 0.2% 
arabinose as required. Cells were collected and the pellet was re-suspended in lysis 
buffer (50 mM NaH2PO4·2H2O, 300 mM NaCl, 5 mM imidazole, pH 7.5). Lysis was 
performed using a microfluidizer (Microfluidics M-110L) by passing cells three 
times at 18,000 p.s.i. The cell debris was removed upon centrifugation and the pro-
teins were purified from the supernatant by His-tag affinity chromatography using 
Ni-NTA agarose beads (Clontech). The bound proteins were washed with lysis 
buffer containing 10 mM imidazole and then eluted with lysis buffer containing 
250 mM imidazole. The proteins were purified by size-exclusion chromatography 
using HiLoad 16/600 Superdex 75 (GE Life Sciences) in gel filtration buffer (50 mM 
HEPES, pH 7.4, 50 mM KCl, 100 mM NaCl, 2% glycerol, 5 mM β-mercaptoethanol). 
The proteins were concentrated using Amicon Ultra-4 Centrifugal Filter Units 
(Merck Millipore), Ultracel-3 for ArfA∆17 and Ultracel-30 for wild-type RF2 and 
RF2-GAQ.
Template preparation for in vitro translation. Truncated nlpD template 
containing an N-terminal His6 and a HA tag was amplified from pET21b-R1nlpD26  
using primers binding to pET21b upstream of the T7-promotor (GATCGAGA 
TCTCGATCCCGCG) and to nucleotides 133–159 of nlpD (AATCAACA 
TACCAGAATTAGTATTTGC). PCR products were purified via spin columns 
(Qiagen).
ArfA peptidyl-tRNA recycling assays. The recycling activity of the purified 
ArfA∆17 and RF2 (wild-type and GAQ mutant) was monitored by independent 
triplicate experiments using PURExpress ∆RF123 In Vitro Protein Synthesis Kit 
(NEB E6850S) (Extended Data Fig. 1). Reactions of 6 µl were performed according 
to the manual protocol by mixing 250 ng of truncated nlpD PCR template, 5 µM of 
anti-ssrA oligo, 2 µM of ArfA∆17 and/or wild-type RF2 or RF2-GAQ. The reac-
tions were incubated at 37 °C for 15 min with shaking at 1,000 r.p.m. The translation 
reactions were stopped by adding 6 µl of tricine sample buffer (200 mM Tris-HCl 
pH 6.8, 40% glycerol, 2% SDS, 0.04% Coomasssie Blue G-250) and then applied 
to 16.5% tricine-SDS–PAGE gels. The products were detected by western blotting 
using anti-haemagglutinin-peroxidase (Roche 11667475001) at 1:1,000 in 2.5% 
milk/TBS (2.5% (w/v) skim milk powder, 20 mM Tris, pH 7.5, 150 mM NaCl).
Generation of ArfA-RF2-SRC. In vitro translation was carried out using 
PURExpress In Vitro Protein Synthesis Kit (NEB 6800). The translation reaction 
(750 µl in total) was prepared according to the protocol of the PURExpress In Vitro 
Protein Synthesis Kit supplemented with 5 µM anti-ssrA oligo. Translation was 
started by adding the truncated nlpD PCR product at 37 °C for 20 min, shaking 
at 1,000 r.p.m. The ribosomes were first isolated from the in vitro reaction mix by 
centrifugation through a sucrose cushion (50 mM HEPES KOH pH 7.2, 250 mM 
potassium acetate, 25 mM magnesium acetate, 750 mM sucrose, 0.1% DDM) for 
180 min at 72,000g using a TLA120.2 rotor (Beckman Coulter). The pellet was 
resuspended in buffer B250 (50 mM HEPES KOH pH 7.2, 250 mM potassium 
acetate, 25 mM magnesium acetate, 0.1% DDM) and the stalled ribosomal com-
plexes (SRC) were isolated using Talon cobalt-chelate affinity resin (Clontech). 
SRCs bound to the Talon matrix by the N-terminal His6 tag of NlpD were washed 
with buffer B500 (50 mM HEPES KOH pH 7.2, 500 mM potassium acetate, 25 mM 
magnesium acetate2, 0.1% DDM) and eluted using buffer B250i (50 mM HEPES 
KOH pH 7.2, 250 mM potassium acetate, 25 mM magnesium acetate, 250 mM 
imidazole, 0.1% DDM). The eluted SRC was loaded onto a linear sucrose gradient 
(10–40% (w/v) sucrose in B250 buffer) for 18 h at 43,000g in a SW28 rotor 
(Beckman Coulter). The isolated 70S peak was pelleted by centrifugation for 3 h 
at 139,000g using a Ti70.1 rotor (Beckman Coulter). The pellet was re-suspended 
in SRC buffer (50 mM HEPES pH 7.2, 250 mM potassium acetate, 10 mM magne-
sium acetate, 0.05% DDM). The purified SRC was then incubated together with 
a 2.5×  excess of ArfA∆17 and RF2-GAQ mutant for 5 min at 37 °C before being 
applied to EM grids.
Cryo-electron microscopy and single particle reconstruction. Five microlitres 
(4.5 OD) of E. coli ArfA-RF2-SRC at OD260 nm was applied to 2 nm pre-coated 
Quantifoil R3/3 holey carbon supported grids and vitrified using the Vitrobot 
Mark IV (FEI, Holland). Data collection was performed using EM-TOOLS (TVIPS 
GmbH) on a Titan Krios transmission electron microscope equipped with a Falcon 
II direct electron detector (FEI, Holland) at 302 kV at a pixel size of 1.084 Å and a 
defocus range of 0.7–2.2 µm. Ten frames (dose per frame of 2.5 e−  Å−2) were aligned 
using Motion Correction Software27. Power-spectra, defocus values and astigma-
tism were determined with CTFIND4 software28. Micrographs showing Thon 
rings beyond 3.5 Å were manually inspected for good areas and power-spectra 
quality. Automatic particle picking was performed using SIGNATURE29 and single 
particles were processed using RELION 1.4 (ref. 30). 227,608 particles were first 
subjected to 3D refinement using E. coli 70S ribosome as reference structure31  
and movie particle extraction was performed as described before30 (Extended Data 
Fig. 2). The 227,608 polished particles were finally subjected to 3D classification 
and refinement using FREALIGN resulting in a final reconstruction of 3.11 Å 
(0.143 FSC) average resolution containing 69,089 particles (Extended Data Figs 2 
and 3). Local resolution was finally calculated using ResMap32.
Molecular modelling and refinement of the ArfA-RF2-SRC. The molecular 
model for the ribosomal proteins and rRNA of the 70S ribosome of the ArfA-RF2-
SRC was based on the molecular model from the recent cryo-EM reconstruction 
of the E. coli 70S ribosome (PDB code 5AFI)33. The molecular model was initially 
fitted as a rigid body into the cryo-EM density map of the corresponding stalled 
complex using UCSF Chimera34. Owing to flexibility and poor density, the L1, L10, 
L11 protein and the L7/L12 stalk were not included in the final model. For E. coli 
RF2, a homology model was generated using HHPred35 based on a template from 
T. thermophilus RF2 (PDB code 4V5E)18. Owing to flexibility and poor density, 
the GAQ motif, domain I, and the linker between domains 3 and 4 of RF2 were 
based on PDB code 2WH1. Residues 2–46 of ArfA∆17 were built de novo using 
an HHPred model as an initial starting point in terms of placement of the central 
helical region. The complete atomic model of the ArfA-RF2-SRC was manually 
adjusted using Coot36 and refined using phenix.real_space_refine37, with restraints 
obtained by phenix.secondary_structure_restraints37. The model and refinement 
statistics are presented in Extended Data Table 1. To reduce the clash score the 
model was refined using REFMAC38. The statistics of the refined model were 
calculated using Molprobity39 and the validation of the model was performed as 
previously described40.
Figure preparation. Figures showing electron densities and atomic models were 
generated using either UCSF Chimera34 or PyMol Molecular Graphic Systems 
(version 1.8 Schrödinger).
Data availability. The cryo-electron microscopy map for the ArfA-RF2-SRC has 
been deposited in the Electron Microscopy Data Bank (EMDB) with the accession 
code EMD-3508. The respective coordinates for electron-microscopy-based model 
of the ArfA-RF2-SRC are deposited in the Protein Data Bank (PDB) under the 
accession code 5MGP. All other data are available from the corresponding author 
upon reasonable request.
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Extended Data Figure 1 | Recycling of ribosomes stalled on truncated 
mRNA by ArfA and RF2. In vitro translation assay of the truncated 
nlpD template was performed in the presence of ArfA, RF2 or RF2-GAQ, 
revealing a peptidyl-tRNA band (nlpD_ns*P-tRNA), whereas the peptidyl-
tRNA was absent and free nlpD peptide (nlpD_ns) was observed when the 
reaction was performed with ArfA and RF2. Replacing wild-type RF2 with 
the inactive RF2-GAQ mutant led to the reappearance of the peptidyl-
tRNA band and loss of the free nlpD peptide.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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Extended Data Figure 2 | Classification of the ArfA-RF2-SRC. The 
complete dataset of 227,608 particles was initially aligned against a vacant 
E. coli 70S ribosome, refined with RELION using 3D auto-refine and the 
movie particles were extracted. The polished particles were then subjected 
to a 3D refinement and 3D classification using FREALIGN. The class 
2 (138,582 particles) resulting from the 100 rounds of 3D classification 
with 3×  binned images using a ribosomal mask was then further refined 
and classified with 2×  binned images. The remaining 69,089 particles 
containing ArfA-RF2-SRC were then 3D-refined, resulting in a final 
reconstruction of 3.1 Å (0.143 Fourier shell correlation (FSC)) average 
resolution.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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Extended Data Figure 3 | Resolution of the ArfA-RF2-SRC. a, Overview 
of the final refined cryo-EM map of the ArfA-RF2-SRC with separated 
densities for small (yellow) and large (grey) ribosomal subunit, as well as 
ArfA (red), RF2 (orange) and P-tRNA (green). b, Same view as in a but 
coloured according to local resolution. c, Transverse section of b showing 
local resolution in the core of the ribosomal subunits. d, FSC curve of the 
refined final map, indicating that the average resolution of the ArfA-RF2-SRC 
is 3.1 Å (at 0.143). e, Fit of models to maps. FSC curves calculated between 
the refined model and the final map (blue), with the self- and cross-
validated correlations in orange and black, respectively. Information 
beyond 3.2 Å was not used during refinement and preserved for validation. 
f, g, Selected examples illustrating the quality of fit of the molecular 
models to the unsegmented cryo-EM map (grey mesh) for the ArfA (red) 
interaction with S12 (blue), related to Fig. 2b (f), and with RF2 (orange), 
related to Fig. 3c (g).
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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Extended Data Figure 4 | Hydroxyl radical probing of ArfA on the 
ribosome. a–d, Hydroxyl-radical probing data15 of ArfA in complex with 
RF2 on the ribosome reveal that tethers linked to the N-terminal region 
of ArfA, for example, residues S2 and R3 (magenta), cleave the 16S rRNA 
within the vicinity of helices h18, whereas tethers linked to the C-terminal 
region of ArfA, such as residues 33–34/38–39 and 46 (teal), cleave the 
16S rRNA within the vicinity of helices h34 (ref. 15). These findings are 
in excellent agreement with the position of ArfA (red) within the ArfA-
RF2-SRC structure reported here. In the overview panels a and c, P-tRNA 
(green) is shown for reference.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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Extended Data Figure 5 | Sequence alignment of E. coli RF1 and RF2 
with secondary structure assignments. Sequence alignment of E. coli RF1 
and RF2 generated using ClustalX with secondary structure (helices and 
strands) and domain (I–IV) assignments based on the crystal structures 
of E. coli RF2 (ref. 22), except for the switch loop (yellow) and extension 
to helix α7 (purple), which was based on the ArfA-RF2-SRC structure. 
The pink boxes indicate regions of RF2 that form an interface with ArfA, 
with residues in bold predicted to prevent interaction of RF1 with ArfA. 
Asterisk (*) or colon (:) and full stop (.) indicate a single, fully conserved 
residue or residues with strong (>0.5 in the Gonnet PAM 250 matrix) and 
weakly (>0.5) similar properties, respectively.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
LETTERRESEARCH
Extended Data Figure 6 | Potential specificity determinants for ArfA-
mediated ribosome recycling. a, b, ArfA (red) and E. coli RF2 (orange) 
compared to homology model of E. coli RF1 (blue) aligned to RF2 in the 
ArfA-RF2-SRC. a, The ArfA interface with β4 and β5 strands of E. coli RF2 
(orange) consists of hydrophobic residues V198, F217 and F221, which 
are mutated to Gly, Ala and Ala, respectively, in RF1 (blue). b, The ArfA 
interface with α-helix α7 of RF2 (orange). Replacing negatively charged 
residues such as E311 and D312 in RF2 with Arg in RF1 is also likely 
to disrupt the interaction with ArfA. c, d, Sequence alignments for the 
regions of RF1 and RF2 corresponding to a and b, respectively. The pink 
boxes indicate regions of RF2 that form an interface with ArfA, including 
residues in bold predicted to prevent interaction of RF1 with ArfA and 
therefore could provide the basis for RF2-specificity of ArfA action. 
Organisms in bold contain ArfA, whereas others have no detectable ArfA 
homologue. Asterisk (*), colon (:) or full stop (.) indicate a single, fully 
conserved residue or residues with strong (>0.5 in the Gonnet PAM 250 
matrix) and weakly (>0.5) similar properties, respectively.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
LETTER RESEARCH
Extended Data Figure 7 | Location of the ArfA-A18T mutation relative to RF2. a, Overview of ArfA (red) and RF2 (gold) on the ribosome (30S, grey; 
50S, slate). b, c, Zoom of boxed region in a showing the environment of A18 (teal) of ArfA in close proximity to I11 and K8 in the N terminus of ArfA 
(red) (b), and A18T (teal) of ArfA in sterically clashing with I11 and K8 in the N terminus of ArfA (red) (c).
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
LETTERRESEARCH
Extended Data Figure 8 | Comparison of ArfA with other ribosome rescue systems. a–c, Relative orientation on the ribosome with truncated mRNAs 
and ArfA (red) and RF2 (orange) (a), ArfB (purple, PDB code 4V95)5 (b) or tmRNA (brown) and SmpB (yellow) (PDB code 4V8Q)6 (c). In all cases, the 
mRNA and P-tRNA are coloured cyan and green, respectively.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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Extended Data Table 1 | Data collection and refinement statistics
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Structural Basis for Ribosome
Rescue in Bacteria
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Ribosomes that translate mRNAs lacking stop codons become stalled at the 30
end of the mRNA. Recycling of these stalled ribosomes is essential for cell
viability. In bacteria three ribosome rescue systems have been identified so far,
with the most ubiquitous and best characterized being the trans-translation
system mediated by transfer–messenger RNA (tmRNA) and small protein B
(SmpB). The two additional rescue systems present in some bacteria employ
alternative rescue factor (Arf) A and release factor (RF) 2 or ArfB. Recent
structures have revealed how ArfA mediates ribosome rescue by recruiting
the canonical termination factor RF2 to ribosomes stalled on truncated mRNAs.
This now provides us with the opportunity to compare and contrast the avail-
able structures of all three bacterial ribosome rescue systems.
Bacterial Ribosome Rescue Systems
Ribosome rescue systems are necessary to recycle ribosomes that have become stalled at the
30 end of mRNAs, so-called non-stop ribosome complexes [1,2]. Translation on these non-stop
mRNAs is blocked due to the absence of a sense or stop codon (see Glossary) in the ribosomal
A site, which is crucial for elongation or termination to continue. These truncated or non-stop
mRNAs can arise in the cell due to premature transcription termination or mRNA damage; for
example, by the action of RNases. Additionally, non-programmed frameshifting events or
nonsense suppression (readthrough of a stop codon) can also lead to accumulation of non-
stop complexes. Ribosome rescue systems that deal with non-stop complexes are present in
all species of life. In archaea and eukaryotes, non-stop complexes are rescued by the
combined action of Dom34 and Hbs1, which are homologs of eukaryotic RF (eRF) 1 and
eRF3 [2]. Bacteria have evolved completely unrelated pathways to deal with rescue of non-stop
complexes (reviewed in [2–7]). These include the trans-translation system mediated by the
tmRNA and SmpB as well as two more recently identified Arf systems involving ArfA and ArfB
(formerly known in Escherichia coli as YhdL and YaeJ, respectively). The occurrence of non-
stop complexes appears to be a frequent event in bacteria. Experiments in E. coli indicate that
0.4% of all transcripts undergo trans-translation [8] and that 2–4% of peptidyl-tRNAs remain
non-hydrolyzed when ribosome rescue pathways are inactivated [9]. This explains why the
presence of at least one of the bacterial ribosome rescue pathways is essential for cell viability
[10]. While structural studies have provided much insight into the mechanism of tmRNA–
SmpB- and ArfB-mediated rescue of non-stop ribosome complexes, structural insight into
ArfA-mediated ribosome rescue has been lacking. Recently, five cryoelectron microscopy
(cryo-EM) structures of ArfA–RF2–non-stop ribosome complexes were reported [11–15],
providing the opportunity to not only compare the similarities and differences of the structures
with one another, but also to contrast the findings with the structures of the other bacterial
ribosome rescue systems.
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Trans-translation Mediated by tmRNA and SmpB
Genes encoding tmRNA (ssrA) and SmpB have been found in most if not all sequenced
bacterial genomes, including the smallest genomes of Mycoplasma species as well as endo-
symbionts such as Carsonella rudii [16]. Moreover, tmRNA is essential in many bacteria,
including many pathogenic bacteria such as Neisseria gonorrhoeae, Mycobacterium tubercu-
losis, and Legionella pneumophila [6,17]. ArfB, and particularly ArfA, have more limited
phylogenetic distributions, with ArfB being present in 34% of representatively sequenced
bacterial genomes and ArfA limited to a subset of b- and g-proteobacteria [18,19]. In many
bacteria trans-translation is not essential, presumably due to the presence of redundant
alternative rescue pathways. Nevertheless, the loss of trans-translation usually leads to reduc-
tion in fitness, particularly under various stress conditions, such as high or low temperature,
ethanol or acid treatment, or nutrient deprivation, or in the presence of antibiotics [6,17]. Such
stress conditions can lead to an increase in truncated mRNAs and stalled ribosomes, explain-
ing the higher levels and importance of trans-translation under these circumstances. These
findings also highlight that, although the presence of alternative rescue pathways is sufficient to
maintain cell viability, they appear to be insufficient to optimally cope with the cellular demands
for ribosome rescue in the absence of trans-translation.
In most bacteria, tmRNA comprises a single RNA molecule containing a tRNA-like domain
(TLD), which resembles the acceptor stem of an alanyl-tRNA, and a messenger-like domain
(MLD) encoding a short, 8–35-aa peptide [20]. The TLD and MLD are linked together by a series
of pseudoknots (see inset in Figure 1) [20]. The TLD of tmRNAs can be charged with alanine by
the canonical alanine tRNA synthetase (AlaRS), a reaction that is enhanced by the presence of
SmpB, which interacts with AlaRS and stabilizes the tmRNA structure [20]. The alanine-
charged TLD of the tmRNA is recognized by elongation factor (EF)-Tu, which delivers tmRNA
to the A site of a non-stop ribosome (Figure 1A,B) [20]. The structure of the TLD of a tmRNA in
complex with SmpB and EF-Tu–GDP stabilized on a 70S ribosome using the antibiotic
kirromycin [21] (Figure 1C) reveals that the TLD of tmRNA interacts with EF-Tu on the
ribosome, analogous to the acceptor arm of an aminoacyl-tRNA (aa-tRNA) being delivered
to the ribosome by EF-Tu [22]. During canonical translation the complementarity between the
codon in the A site and the anticodon stem–loop (ASL) of the aa-tRNA dictates which aa-tRNA
is delivered by EF-Tu [23,24]. On non-stop ribosomes there is no codon in the A site, explaining
why the TLD of tmRNA does not require an ASL. Instead, the globular domain of SmpB mimics
the ASL of a tRNA and occupies the decoding site of the ribosome [21] (Figure 1B,C), as
predicted based on previous X-ray [25,26] and cryo-EM [27,28] studies. The C-terminal tail of
SmpB, which is unstructured in solution, adopts an a-helical conformation on the ribosome that
probes the mRNA channel (Figure 1B,C) [21], explaining how the tmRNA–SmpB complex can
distinguish actively translating ribosomes with mRNA in the channel from ribosomes stalled on
truncated mRNAs with a vacant channel [29]. Accommodation of the TLD at the A site of the
peptidyltransferase center (PTC) of the large ribosomal subunit allows peptide bond
formation between the truncated nascent polypeptide chain and the alanine of the TLD of
the tmRNA (Figure 1D). Binding of EF-G translocates the TLD of the tmRNA from the A site to
the P site, which together with SmpB places the first (resume) codon of the MLD into the A site
ready to be decoded by the next aa-tRNA (Figure 1E,F) [30]. A cryo-EM structure of the
translocated state reveals that the TLD and SmpB occupy a hybrid A/P site of the ribosome
and the linking pseudoknots wrap around the swiveled head of the small subunit to facilitate
positioning of the MLD for decoding (Figure 1E) [31]. Translation then continues on the MLD of
the tmRNA incorporating a degradation tag into the C terminus of the truncated polypeptide,
which targets it for proteolysis by Clp and other proteases (Figure 1G). Importantly, the MLD of
the tmRNA contains a stop codon, such as UAA, which allows canonical translation termination
via recruitment of RF1 or RF2 (Figure 1G). The glycine–glycine–glutamine (GGQ) motif of
RF1 or RF2 then catalyzes the hydrolysis of the tagged polypeptide chain, allowing the
Glossary
Aminoacyl-tRNA (aa-tRNA): tRNA
charged at the 30 end with an amino
acid.
Anticodon: the region of the tRNA
that is complementary to the codon
of the mRNA.
Anti conformation: nucleotide
conformation where the ring of the
nucleobase is nearly perpendicular to
the furanose ring but projecting away
from the furanose; contrasts with the
syn conformation where the
nucleobase ring is rotated around
the glycosidic bond.
A site: the tRNA-binding site on the
ribosome where aa-tRNAs are
delivered by EF-Tu during translation.
Codon: a sequence of three RNA (or
DNA) nucleotides that corresponds
to a specific amino acid (or stop
signal) during protein synthesis.
Deacylated tRNA: tRNA that is not
charged with an amino acid.
E site: the tRNA-binding site on the
ribosome where uncharged or
deacylated tRNAs exit from the
ribosome during translation.
Glycine–glycine–glutamine (GGQ)
motif: conserved motif found in
protein factors that catalyze PTH on
the ribosome.
Hybrid A/P site: when the tRNA is
in the A site on the small subunit and
in the P site on the large subunit.
Hydroxyl radical probing: chemical
probing method that relies on the
cleavage of RNA (or DNA) molecules
by hydroxyl radicals, which can be
generated from site-specific tethers
located on neighboring proteins or
factors.
Kirromycin: an antibiotic that binds
and traps EF-Tu on the ribosome.
Peptidyltransferase center (PTC):
the highly conserved region in the
large subunit of the ribosome where
peptide bond formation occurs.
Peptidyl-tRNA: a tRNA bearing the
growing nascent polypeptide chain.
Peptidyl-tRNA hydrolysis (PTH):
the activity of hydrolyzing and
thereby breaking the ester linkage
between the polypeptide chain and
the tRNA to which it is attached.
Proline–alanine–threonine (PAT)
motif: motif in Escherichia coli RF1
that is involved in recognition of the
stop codon of the mRNA.
Pseudoknot: a nucleic acid
secondary structure containing at
least two stem–loop structures in
which half of one stem is intercalated
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between the two halves of another
stem.
P site: the tRNA-binding site for the
peptidyl-tRNA on the ribosome.
RNase: a type of nuclease that
catalyzes the degradation of RNA;
for example, RNase III is an
endonuclease that cleaves dsRNA.
Serine–proline–phenylalanine
(SPF) motif: motif in E. coli RF2 that
is involved in recognition of the stop
codon of the mRNA.
Translocation: the process of
moving the A and P site tRNAs as
well as the associated mRNA
through the ribosome into the P and
E sites, respectively. This reaction is
catalyzed by EF-G in bacteria.
ribosome to be subsequently recycled for the next round of translation. It has been demon-
strated that it is the recycling of the stalled ribosomes, rather than tagging of the truncated
polypeptide chains for degradation, that makes trans-translation essential for bacterial survival
[20,32]. This is consistent with the observation that inactivation of trans-translation in bacteria
such as E. coli is not lethal, due to the presence of back-up systems such as ArfA [33].
Interplay between the Trans-translation, ArfA, and ArfB Rescue Systems
While the deletion of either the ssrA or the arfA gene in E. coli does not significantly affect
viability, deletion of both genes (DssrADarfA) is synthetic lethal [33], illustrating the importance of
having at least one ribosome rescue for bacterial survival [5,10]. Biochemical studies have
demonstrated that ArfA represents a back-up system for trans-translation [34,35]. The arfA
mRNA contains a stem–loop structure that acts as a transcription terminator and/or a substrate
for RNase III cleavage [18,34,35] (Figure 2A). In the presence of tmRNA, the short ArfA protein
produced from the truncated arfA mRNA is tagged by tmRNA and targeted for degradation
(Figure 2A). However, in the absence of tmRNA the short ArfA protein product is not degraded
and assumes the role of recycling ribosomes stalled on truncated mRNAs [34,35] (Figure 2B).
The full-length E. coli ArfA protein is 72 aa in length and contains a C-terminal hydrophobic
region that leads to aggregation of the protein in vivo [34] (Figure 2A). By contrast, shorter forms
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Figure 1. Rescue of Non-stop Ribosomal Complexes by Trans-translation. (A) Ribosomes stall on truncated mRNAs (cyan) with vacant A sites. (B) The tRNA-
like domain (TLD) (yellow) of transfer–messenger RNA (tmRNA) (brown) is recognized by elongation factor (EF)-Tu (pale green) and delivered together with small protein
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of ArfA resulting from truncated arfA mRNA lack the terminal 17–18 aa but retain full rescue
activity [34,35].
Curiously, ssrA is essential in Neisseria gonorrhoeae, despite the presence of an arfA gene [32],
although N. gonorrhoeae ArfA is active when expressed in E. coli [18]. By contrast, tmRNA is
not essential in Bacillus subtilis [36] despite the apparent absence of both the ArfA and ArfB
systems, raising the question of additional alternative rescue systems existing in some bacteria
[10]. The synthetic lethality of E. coli due to the DssrADarfA double deletion occurs despite the
presence of arfB, but overexpression of ArfB can rescue the lethality of the DssrADarfA strain
[37]. This finding indicates that endogenous levels of ArfB are insufficient to cope with the level
of ribosome rescue needed when tmRNA and ArfA are both absent [7]. It also raises the
question of whether there are specific growth or stress conditions where ArfB is more important
or whether ArfB is simply less important in E. coli than in other species due to the additional
presence of ArfA.
Ribosome Rescue by ArfB
The globular N-terminal domain (NTD) of ArfB is evolutionarily related to domain 3 of RF1 and
RF2 [38,39], which contain a conserved GGQ motif that is critical for peptidyl-tRNA hydro-
lysis (PTH) activity [40]. In contrast to RF1 and RF2, ArfB lacks the domain 2/4 responsible for
stop codon recognition and instead has an extended C-terminal tail (Figure 3A–C). In agree-
ment with the finding that overexpression of ArfB can rescue E. coli lacking tmRNA and ArfA
rescue systems [37], ArfB can efficiently catalyze PTH on ribosomes stalled at the 30 ends of
non-stop mRNAs in vivo [19,37,41,42] (Figure 3A,B). The crystal structure of ArfB on the
ribosome reveals that the NTD interacts with the large subunit such that the GGQ motif is
positioned at the PTC (Figure 3C) [43], consistent with the reports that mutations of the GGQ
(A) (B)tmRNA ac!ve tmRNA inac!ve
Tr ArfA
mRNA
Tr ArfA
mRNA
RNase II cleavage
Premature TC termina!on
FI ArfA
mRNA
Transla!onal stalling
tnRNA rescues
ArfA protein ArfA protein Hydrophobic
Transla!on of
FI ArfA mRNA
Transla!on of
Tr ArfA mRNA
tmRNA tag
tmRNA tagging Degrada!on Aggrega!on
Transla!onal stalling
ArfA
ArfA
ArfA rescue?
ArfB rescue?
Ac!ve ArfA
ArfA
RNase III cleavage
Premature TC termina!on
50S
P
30S
3ʹ
5ʹ
E  P  A
mRNA
Figure 2. Alternative Rescue Factor A (ArfA) Is a Back-Up System for Trans-translation. (A) Full-length (Fl) ArfA mRNA (gray) forms a stem–loop structure that
acts as a transcription terminator and/or is recognized and cleaved by RNase III, generating a truncated (Tr) mRNA. Ribosomes stall on the truncated mRNAs, inducing
trans-translation, leading to tmRNA tagging (purple) and degradation of the ArfA protein (red). In the case that full-length ArfA protein is translated, the C-terminal region
contains a hydrophobic stretch (cyan) that leads to aggregation and degradation of the full-length ArfA. (B) If trans-translation is impaired (or overwhelmed), the short
ArfA protein is not tagged or degraded and the active ArfA assumes the role of rescuing non-stop ribosome complexes.
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motif of ArfB impair the rescue activity of ArfB both in vitro [19,37] and in vivo [37]. The C-
terminal tail of ArfB, which was disordered in previous unbound ArfB structures [38,39,44],
adopts a a-helical conformation that reaches into the mRNA channel of the small subunit
(Figure 3B,C) [43]. This suggests that, like SmpB, ArfB also utilizes the C-terminal tail to
distinguish actively translating ribosomes from those stalled on truncated mRNAs. Truncation
of ten residues or more from the C terminus of ArfB leads to a severe reduction in ribosome
binding and PTH activity as well as the ability to rescue the DssrADarfA strain [19,37,39]. The
NTD and C-terminal helix are connected by a flexible linker of !12 aa that adopts an extended
conformation on the ribosome (Figure 3B,C). Deletion of one or two residues within the linker of
ArfB led to progressive loss of PTH activity although the ribosome interaction remained
unaffected [39], suggesting that the linker is important for positioning of the NTD at the
PTC of the ribosome.
While ArfB rescue is most efficient on non-stop ribosomes, it maintains some rescue activity on
longer mRNAs that extend into the A site [19,42]. The ArfB rescue activity decreases with
increasing length of the 30 end, such that little activity is observed when the 30 end extends >14
nucleotides from the P site [42]. This suggests that the C-terminal tail of ArfB can efficiently
compete and may even displace short mRNA 30 ends from the channel and that longer mRNAs
encompassing the entire mRNA channel are resilient to displacement by ArfB, explaining why
ArfB does not interfere with canonical translation elongation.
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ArfB homologs are present in most, if not all, eukaryotes, where they are targeted to mito-
chondria [45]. In addition, some plants also encode ArfB homologs with chloroplast-targeting
signals. By contrast, there is no evidence for ArfA genes in eukaryotes and tmRNA/SmpB
genes are found only in some protist mitochondria [46]. The best-characterized organellar ArfB
homolog is the human mitochondrial immature colon carcinoma transcript-1 (ICT1) (reviewed in
[47]). Like other ArfB homologs, ICT1 displays excellent rescue activity on non-stop ribosomal
complexes from either E. coli [39,42,48] or mammalian mitochondria [49]. The rescue activity is
dependent on an intact GGQ motif and the presence of a C-terminal tail [39,48,49]. Loss or
knockdown of ICT1 leads to a loss of cell viability [38,48], which can be rescued by the
expression of a bacterial ArfB homolog [42]. Likewise, ICT1 supported the viability of a bacterial
DssrADarfA strain, suggesting that ICT1 and ArfB are functionally interchangeable [42]. How-
ever, unlike bacterial ArfB, ICT1 was shown to be an integral component of the mitochondrial
large subunit [48], where it is located at the base of the central protuberance [50]. Subsequent
in vitro experiments demonstrated that the integrated ICT1 does not appear to display any
rescue activity on non-stop complexes, but rather exogenous ICT1 is required [49]. So far,
ribosome-free ICT1 has not been detected in mitochondria [48], raising the question of whether
ICT1 is released from the mitoribosome to rescue stalled ribosomes or whether ICT1 expres-
sion is upregulated under specific stress conditions.
Ribosome Rescue by ArfA and RF2
ArfA was originally identified in a screen for factors that are essential for viability of E. coli when
the ssrA gene is disabled [33]. The loss-of-function mutation identified had an Ala-to-Thr
substitution at position 18 (A18T) in ArfA [33]. ArfA, as well as the ArfA-A18T mutant, were both
shown to co-localize with ribosomes in vivo, but only the wild-type ArfA could rescue non-stop
ribosomes [33]. Interestingly, recombinant ArfA was effective at rescuing non-stop ribosomes
in vitro when an E. coli-extract-based system was used [33] but displayed no rescue activity
with purified non-stop ribosome complexes [37]. This indicated that ArfA requires an additional
cellular factor present in the E. coli extract to mediate ribosome rescue [37]. Subsequent in vitro
studies using a reconstituted cell-free translation system revealed that RF2, but not RF1,
cooperates with ArfA to hydrolyze the peptidyl-tRNA and rescue non-stop ribosomes [41,51]
(Figure 3D,E). ArfA does not interact with RF2 in solution [51,52] but rather interacts with non-
stop ribosomes [52] (Figure 3D) before recruiting RF2 to the complex (Figure 3E). Initial binding
assays observed interaction of ArfA with the large ribosomal subunit [33], whereas subsequent
hydroxyl radical probing experiments indicated a binding site located on the 30S subunit in
the vicinity of the mRNA channel [52]. The five cryo-EM structures of ArfA–RF2–non-stop
ribosome complexes [11–15] (Figure 3F) revealed that ArfA interacts almost exclusively with the
small subunit. Overall, the structures are in excellent agreement with each other and enable
most of the available biochemical data to be rationalized. The structures provide much-needed
structural insight into the mechanisms of action of ArfA and RF2 in rescuing non-stop ribosome
complexes, which are discussed in detail in the following sections.
Monitoring the mRNA Channel of the Non-stop Ribosome
Full-length E. coli ArfA is 72 aa in length but is aggregation prone; therefore, C-terminally
truncated ArfA variants were used for the structural analysis that lacked either 12 [11,15] or 17
residues [12–14]. In each case, however, the flexibility of the C terminus permitted only 46–48 of
the 55–60 aa of ArfA to be modeled. The absence of electron density for the very-C terminus of
ArfA suggests that these residues are less important for binding, which is consistent with their
poor conservation across ArfA from different species [18,33]. In all five cryo-EM structures [11–
15], the C-terminal part of ArfA extends from the decoding A site into the mRNA entry channel
(Figure 4A), analogous to the C-terminal tails of SmpB [21] (Figure 4B) and ArfB [43] (Figure 4C)
as well as the 30 end of a full-length mRNA [53] (Figure 4D). The location of the C terminus of
ArfA within the mRNA channel is also compatible with hydroxyl radical probing experiments
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performed in the absence of RF2 [52], suggesting that ArfA initially uses a similar conformation
to monitor the vacant mRNA channel.
Like SmpB and ArfB, the C terminus of ArfA also contains several highly conserved positively
charged arginine and lysine residues that establish interactions with the negatively charged 16S
rRNA comprising the walls of the mRNA channel [11–15] (Figure 4A–C). There appears to be
(A) (B)
(C) (D)
ArfA
ArfB FI mRNA
SmpB
Amino acid Amino acid
Amino acid
Tr mRNA Tr mRNA
Tr mRNATr mRNA
Figure 4. Monitoring of the mRNA Channel by Ribosome Rescue Factors. The mRNA channel of the ribosome is probed by the C-terminal tail of (A) alternative
rescue factor (Arf) A (PDB ID: 5MGP) [12], (B) small protein B (SmpB) (PDB ID: 4V8Q) [70], or (C) ArfB (PDB ID: 4V95) [43]. The interaction is mediated via positively
charged amino acids (red), the conservation of which is presented as a WebLogo [71] below the respective panels. (D) For comparison, the path of a full-length (Fl)
mRNA is indicated (PDB ID: 4V6F) [53].
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some redundancy in the interaction of these conserved residues of ArfA, since individual point
mutations had little to no effect on the recycling activity of ArfA [13,52], although some reduction
was reported for K34C and R41C mutations in a recent study [14]. The C-terminal tail of SmpB
is also rich in positively charged residues and includes several highly conserved stretches, such
as 131KGKK134 and 137DKR139 (Figure 4B). Although single mutations within the 137DKR139
motif had little effect, a triple alanine substitution abolished SmpB’s ability to support tmRNA
activity in vivo [54,55]. Similar loss of activity was observed when the C-terminal helix of SmpB
was truncated [56]. Single mutations within the C-terminal tail of E. coli ArfB, such as K122A,
K129A, and R132A, as well as the equivalent residues in ICT1, dramatically decreased the
rescue activity of the respective factors [39] (Figure 4C). Similar to ArfB [19,37,39], C-terminal
truncations in human ICT1 that remove these residues also abolished rescue activity [39,49].
Biochemical studies have demonstrated that the efficiency of ArfA–RF2-mediated ribosome
rescue decreases with increasing length of the 30 end of the mRNA that extends into the A site
[41,57]. Specifically, rescue was observed, although with reduced efficiency, when mRNA
extended by up to three or four A-site nucleotides was used [41,57]. Almost no rescue occurred
on artificially stalled ribosomes with mRNAs extended by six or more A-site nucleotides [41,57].
This is consistent with the overlap in the binding position of ArfA [11–15] (Figure 4A) and a full-
length mRNA (Figure 4D), which indicates that three nucleotides (but not more) can be
accommodated in the A site without significant clashes with ArfA. By contrast, the tmRNA–
SmpB trans-translation system is less sensitive to mRNA length, with the most dramatic
reductions in trans-translation activity being observed when mRNAs with 12 or more A-site
nucleotides were used [29,58,59]. mRNA length dependence for the rescue activity of ArfB has
also been reported and appears to be intermediate to the ArfA and trans-translation systems
[41]. It remains to be determined whether the length dependencies of the different rescue
systems correlate with the ability of C-terminal extensions of the respective rescue factors to
displace the 30 portion of the mRNA from the mRNA channel, or whether the factors utilize
different binding modes when the mRNA channel is occupied.
Recruitment of RF2 to the Ribosome by ArfA
The recent cryo-EM structures also provide insight into how ArfA recruits RF2 to the ribosome
despite the absence of a stop codon in the mRNA [11–15]. ArfA establishes a large interaction
interface with RF2 encompassing the central portion (residues 15–31) of ArfA and the distal end
of a helix a7 of domain 3 as well as the b4–b5 strands of domain 2 of RF2 (Figure 5A). Residues
27–30 of ArfA form a small b strand that complements the b sheet of RF2 domain 2/4
(Figure 5B). The overall position of RF2 in the ArfA–RF2–non-stop complex is similar to that
observed during canonical translation termination [60,61], although the decoding domain 2/4 is
slightly shifted. The shift affects the loop between the b4–b5 strand of domain 2 of RF2 bearing
the serine–proline–phenylalanine (SPF) motif (E. coli Ser205–Pro206–Phe207), which is
involved in the specificity of recognition of the first and second positions of the UGA and UAA
stop codons [60–62] (Figure 5C,D). Importantly, the structures illustrate that ArfA does not
interact with the SPF motif and therefore does not directly mimic the presence of a stop codon
(Figure 5D). Consistently, mutations in the SPF motif that impair RF2 termination activity do not
affect ArfA–RF2-mediated rescue activity [51] whereas RF1 mutants bearing the SPF motif
instead of the proline–alanine–threonine (PAT) motif (which confers termination activity at
UGA) remain inactive in the ArfA-mediated rescue system [51].
Distinct Conformations of the Decoding Site during Ribosome Rescue
During canonical termination G530 of the 16S rRNA adopts an anti conformation that stacks
on the A3 nucleotide of a stop codon [40]. The same flipped anti conformation of G530 is also
stabilized during ribosome rescue via interaction with E30 of ArfA [11–15] or by stacking
interactions with Y126 of SmpB [21] and Arg118 of ArfB [43]. G530, together with A1492 and
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A1493, is critical for monitoring the interaction between the codon of the mRNA and the
anticodon of the A-site tRNA [23,63]. While both A1492 and A1493 are flipped out of helix 44
(h44) during decoding of sense codons [23,63], only A1492 is flipped during termination by RFs
while A1493 stacks on A1913 in H69 of the 23S rRNA (Figure 5E) [40]. In the presence of ArfB,
A1492 is only partially flipped out and A1493 is stacked with A1913 (Figure 5E) and Pro110 of
ArfB [43]. The opposite occurs with ArfA or SmpB; namely, A1493 is flipped out of h44 whereas
A1492 stacks on A1913 [11–15,21] (Figure 5F). This is similar to the conformation observed
when tRNA is bound at the P site but the A site is vacant [64] (Figure 5F). Thus, the flexibility of
the decoding site is manipulated in various ways to accommodate binding of the rescue factors
on the ribosome. While mutations with the decoding center of the ribosome (G530A, A1492G,
or A1493G) have a dramatic effect (1000-fold reduction) on aa-tRNA accommodation at the
PTC, only a twofold reduction was observed on peptidyl-transfer to Ala-tmRNA [55]. It remains
to be determined to what extent such mutants influence factor binding and accommodation at
the PTC during ArfA- and ArfB-mediated ribosome rescue.
ArfA Induces the Active Open Conformation of RF2 on the Ribosome
During canonical termination, recognition of the stop codon by RF1 and RF2 stabilizes a
rearranged conformation of the switch loop that directs domain 3 into the PTC [40,65]. The
switch loop conformation is stabilized via specific interactions with A1492 and A1493 that, in
the case of RF2, involve stacking interactions of W319 of RF2 with A1492 [60,61] (Figure 6A). In
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Figure 5. Recruitment of Release Factor 2 (RF2) to Non-stop Ribosomes by Alternative Rescue Factor A (ArfA). (A) Interaction surface between ArfA (red)
and RF2 (orange). (B) ArfA donates a b strand to the b sheet of domain 2/4 of RF2 (orange). (C) Interaction of the serine–proline–phenylalanine (SPF) motif of RF2 with the
A-site UGA stop codon of an mRNA (mRNAStop, cyan; PDB ID: 4V5E) [60]. (D) Same view as (C) but superimposed with the ArfA–RF2–non-stop ribosome complex
containing ArfA (red), RF2 (orange), and the truncated (Tr) mRNA (cyan; PDB ID: 5MGP) [12]. (E,F) Superimposition of decoding center showing 16S rRNA nucleotides
G530, A1492, and A1493 as well as the 23S rRNA nucleotide A1913 from ribosomes bound with (E) A-tRNA (grey; PDB ID: 4V6F) [53], RF2Stop with a UGA codon
(marine blue; PDB ID: 4V5E) [60], ArfB (purple; PDB ID: 4V95) [43], (F) P-tRNA (green; PDB ID: 4V9B) [64], ArfA (red; PDB ID: 5MGP) [12], or small protein B (SmpB) (blue;
PDB ID: 4V8Q) [70].
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the cryo-EM structures, ArfA precludes the interaction between the switch loop and A1492
[11–15] (Figure 6B). Instead, ArfA itself appears to stabilize a distinct conformation of the switch
loop in RF2 that extends the a helix a7 of domain 3 of RF2 by two to three helical turns,
analogous to that observed during canonical translation termination with RF2 [60,61]. As
observed for canonical termination [60,61], the open conformation of RF2 on the ribosome
in the presence of ArfA also directs the GGQ motif of domain 3 into the PTC (Figure 6C). The
A18T mutation that led to the discovery of ArfA does not interfere with ribosome binding [33] or
with RF2 recruitment, but prevents PTH [41]. Consistently, the cryo-EM structure of the ArfA–
A18T non-stop complex reveals that RF2 is recruited to the ribosome but adopts a closed
rather than an open conformation [11] (Figure 6D). The A18T mutation appears to destabilize
the interaction of the N terminus of ArfA and the switch loop of RF2, preventing the transition
from the closed to the open conformation [11]. A closed conformation of RF2 was also
observed when Thermus thermophilus RF2 replaced E. coli RF2 [11] (Figure 6E), suggesting
an incompatibility between T. thermophilus RF2 and E. coli ArfA (note: T. thermophilus does not
have an ArfA homolog). The ribosome-bound closed conformations resemble the closed
conformation observed previously in the structures of the unbound form of RF2 [66,67]
(Figure 6F). The closed conformation may reflect a bona fide intermediate during ribosome
rescue, since this state represented a major population in the cryo-EM analysis of Demo et al.
[15], where wild-type RF2 was employed. The open conformation and positioning of domain 3
of RF2 at the PTC observed in the different cryo-EM structures are very similar despite two of
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Figure 6. Alternative Rescue Factor A (ArfA) Induces a Closed-to-Open Transition in Release Factor 2 (RF2). (A) Interaction between Trp319 (W307 in
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the structures reflecting pre-hydrolysis states (obtained using either a GAQ mutant or a non-
hydrolyzable P-tRNA) [11,12] and the other three representing post-hydrolysis states (assem-
bled with deacylated tRNA in the P site) [13–15].
Concluding Remarks
The availability of structures of ArfA and RF2 on the non-stop ribosome has provided much
needed mechanistic insight into this bacterial ribosome rescue system and enabled
comparisons with the tmRNA/SmpB and ArfB systems to be made. The structures have
also provided initial insights into specificity determinants in ArfA and RF2 that allow ArfA to
cooperate with RF2 but not RF1; however, this needs to be validated biochemically
(see Outstanding Questions). Similarly, the species specificity of ArfA–RF2 action has so
far not been addressed systematically. The apparent absence of Arfs in some species where
trans-translation is not essential raises the possibility of other novel, unidentified Arf systems.
Will novel ArfA or ArfA-like systems emerge in bacteria where RF1, rather than RF2, is
recruited to the stalled ribosomes? Perhaps bacteria exist where entirely different GGQ-
containing factors (ArfB-like?) or even non-GGQ factors are recruited to non-stop ribosomes
to mediate PTH. The wider distribution of ArfB/ICT1 compared with ArfA suggests that it may
play a more important role in other bacteria and organelles than it does in E. coli. Distinguish-
ing the division of labor of alternative rescue systems in different bacteria will provide much
needed insight into their importance under different environmental and stress conditions. The
importance of ribosome rescue in bacteria, coupled with the distinct pathways used by
eukaryotic ribosomes, suggests that ribosome rescue may be a possible target for the
development of novel antimicrobial agents. Small molecules have already been discovered
that specifically target trans-translation [68,69]. Can similar approaches be used to identify
lead compounds that selectively target the Arf systems?
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SUMMARY
Ribosomes synthesizing proteins containing
consecutive proline residues become stalled and
require rescue via the action of uniquely modified
translation elongation factors, EF-P in bacteria, or
archaeal/eukaryotic a/eIF5A. To date, no structures
exist of EF-P or eIF5A in complex with translating
ribosomes stalled at polyproline stretches, and thus
structural insight into how EF-P/eIF5A rescue these
arrested ribosomes has been lacking. Here we
present cryo-EM structures of ribosomes stalled on
proline stretches, without and with modified EF-P.
The structures suggest that the favored conforma-
tion of the polyproline-containing nascent chain is
incompatible with the peptide exit tunnel of the ribo-
some and leads to destabilization of the peptidyl-
tRNA. Binding of EF-P stabilizes the P-site tRNA,
particularly via interactions between its modification
and the CCA end, thereby enforcing an alternative
conformation of the polyproline-containing nascent
chain, which allows a favorable substrate geometry
for peptide bond formation.
INTRODUCTION
Ribosomes catalyze the synthesis of proteins in cells by
providing a platform for the binding of tRNAs. There are three
tRNA binding sites on the ribosome, the A, P, and E sites. During
translation elongation, aminoacyl-tRNAs (aa-tRNAs) binding at
the A site undergo peptide bond formation with the peptidyl-
tRNA located at the P site. The rate of peptide bond formation
is influenced by the chemical nature of the amino acid substrates
in both the A and P sites. Among other amino acids, proline is a
particularly poor substrate both as donor and acceptor during
peptide bond formation (Pavlov et al., 2009; Johansson et al.,
2011; Muto and Ito, 2008; Wohlgemuth et al., 2008; Doerfel
et al., 2013, 2015). In fact, ribosomes become stalled when syn-
thesizing proteins containing consecutive proline residues
(Doerfel et al., 2013; Ude et al., 2013; Woolstenhulme et al.,
2013). To alleviate the ribosome stalling and allow translation
to continue, a specialized translation factor is required, elonga-
tion factor P (EF-P) in bacteria or initiation factor 5A (IF5A) in
archaea and eukaryotes (Doerfel et al., 2013; Ude et al., 2013;
Gutierrez et al., 2013). IF5A has been shown to be essential in eu-
karyotes (Dever et al., 2014), and deletion of efp in some bacteria
leads to growth defects and avirulence (Lassak et al., 2016).
Both EF-P and IF5A bear post-translational modifications that
are essential for their rescue activity (Doerfel et al., 2013; Ude
et al., 2013; Gutierrez et al., 2013; Peil et al., 2013). In Escherichia
coli, lysine 34 (K34) of EF-P is post-translationally modified by
the combined action of EpmA (YjeA), EpmB (YjeK), and EpmC
(YfcM). EpmB converts (S)-a-lysine to (R)-b-lysine (Behshad
et al., 2006), and EpmA ligates the (R)-b-lysine to the ε-amino
group of K34 (Yanagisawa et al., 2010; Navarre et al., 2010).
EpmC recognizes the modified form of EF-P and hydroxylates
the C5(d) of K34 (Peil et al., 2012); however, the hydroxylation
is not required for the rescue activity of EF-P (Doerfel et al.,
2013; Ude et al., 2013). Surprisingly, the resulting ε(R)-b-lysyl-
hydroxylysine modification of E. coli EF-P and the enzymes
associated with this modification are not conserved across all
bacteria (Bailly and de Crécy-Lagard, 2010; Lassak et al.,
2015). Instead, unrelated enzymes and/or modifications have
been identified in other bacteria. In Pseudomonas aeruginosa
and Shewanella oneidensis, EarP catalyzes the addition of
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rhamnose to arginine 32 (R32) of EF-P (Lassak et al., 2015; Raj-
kovic et al., 2015), whereas Bacillus subtilis is reported to bear a
5-aminopentanol moiety attached to K32 (Rajkovic et al., 2016).
In eukaryotes, a conserved lysine residue is post-translationally
modified to hypusine by the action of deoxyhypusine synthase
(DHS) and deoxyhypusine hydroxylase (DOHH) (Dever et al.,
2014; Lassak et al., 2016).
The structure of bacterial EF-P revealed a three-domain archi-
tecture, with the modified residue located at the tip of domain 1
(Hanawa-Suetsugu et al., 2004). aIF5A and eIF5A are homolo-
gous to bacterial EF-P domains 1 and 2 but lack the bacterial-
specific domain 3 (Dever et al., 2014; Lassak et al., 2016). The
X-ray structure of unmodified Thermus thermophilus EF-P in
complex with T. thermophilus 70S ribosome bearing a deacy-
lated tRNAfMet at the P site revealed that EF-P binds within the
E site of the ribosome with the unmodified arginine 32 (R32) of
EF-P interacting with the CCA end of the P-site tRNA (Blaha
et al., 2009). Similarly, structures of modified eIF5A on the yeast
ribosome also visualized the hypusine modification extending
into the peptidyltransferase center (PTC) of the ribosome (Melni-
kov et al., 2016b; Schmidt et al., 2016), where it interacts with the
CCA end of the P-site tRNA (Schmidt et al., 2016). However, to
date, no structures exist of EF-P or eIF5A in complex with poly-
proline-stalled ribosomes; therefore, it remains unclear how the
proline residues stall translation and how EF-P/IF5A alleviates
these stalled ribosomes.
RESULTS
Structure of a Polyproline-Stalled Ribosome Complex
To investigate how polyproline stretches cause translational
arrest, we employed a previously used reporter mRNA coding
for NlpD-PPP protein bearing three consecutive proline
(71PPP73) residues (Starosta et al., 2014) (Figure 1A), which was
translated in an E. coli lysate-based translation system derived
from an E. coli efp deletion strain (see STAR Methods). As ex-
pected (Starosta et al., 2014), ribosomes with peptidyl-tRNA
stalled at the PPP stretch could be alleviated by the exogenous
addition of purified modified EF-P protein (Figure 1A). Previous
biochemical studies (Doerfel et al., 2013; Ude et al., 2013; Wool-
stenhulme et al., 2013), as well as toeprinting assays using the
same NlpD-PPP template (Starosta et al., 2014), indicate that
Figure 1. Cryo-EM Structures of Polyproline-Stalled Ribosomes in the Absence of EF-P
(A) Schematic representation of NlpD-PPP reporter protein (brown) with the site of the PPP-motif indicated. Western blot using an anti-HA-tag antibody of in vitro
translation reactions of NlpD-PPP reporter in the absence (–) and presence (+) of EF-P. Full-length (FL), peptidyl-tRNA, and free peptide, as well as loading control
(LC), are indicated.
(B–D) Schematic representation (B) and cryo-EM reconstructions (C andD) of PPP-stalled ribosome complexes formed in the absence of EF-P containing P-tRNA
(C) or A- and P-tRNAs (D). The nascent chain (NC) has an N-terminal histidine tag (His-tag).
(E and F) Cryo-EM density at high threshold (7s), colored according to the local resolution, for the P-site tRNA (gray ribbon) from cryo-EM maps in (C) containing
P-tRNA (E) and in (D) containing A- and P-tRNAs (F), respectively.
(G) Cryo-EM density (mesh) of the CCA end of the P-site tRNA (green) from (C), with aligned fMet (cyan, PDB: 1VY4) (Polikanov et al., 2014) illustrating lack of
density for nascent chain even at low thresholds (4s).
(H) Cryo-EM density (mesh) of the CCA end of the A-site tRNA (orange) and P-site tRNA (green) from (D), with aligned Phe (green) and fMet (cyan, PDB: 1VY4)
(Polikanov et al., 2014).
See also Figures S1 and S2.
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ribosomes stall in the absence of EF-P because of slow peptide
bond formation between the peptidyl-Pro-Pro-tRNA in the P site
and the incoming Pro-tRNA in the A site (Figure 1B). These PPP-
stalled ribosomeswere purified using the 6x-Histidine tag located
at the N terminus of the nascent peptide (Figure 1B) and sub-
jected to cryo-electron microscopy (cryo-EM) analysis (see
STAR Methods). In silico sorting of the cryo-EM images yielded
two subpopulations of non-rotated ribosomes bearing a P-site
tRNA but differing by the absence or presence of A-site tRNA
(44% and 17%, respectively; Figure S1A). The cryo-EM struc-
tures were refined to yield average resolutions of 3.6 Å and
3.9 Å, respectively (Figures 1C and 1D; Figures S1B–S1E;
Table 1). In addition, a large population (30%) of vacant ribo-
somes was observed, as well as a small population (9%) of 70S
ribosomes in a rotated state lacking EF-P but containing hybrid
A/P-site and P/E-site tRNAs (Figure S1A), the latter presumably
representing a post-peptide bond formation state.
The density quality and resolution for the A-site and P-site
tRNAs were generally poorer and less uniform than observed
in previous ribosomal complexes (Arenz et al., 2014a, 2014b,
2016a). In particular, the density was well resolved for the anti-
codon stem loop (ASL) of the tRNA on the 30S subunit and
progressively deteriorated toward the elbow and acceptor arm
of the tRNAs on the 50S subunit (Figures 1E and 1F; Figures
S2A–S2G). In fact, density for the CCA end of the P- and A-site
tRNAs at the PTC was only present at low thresholds (Figures
1G and 1H). Local resolution calculations also confirmed the
flexible nature of the CCA end, particularly with respect to the
terminal A76 nucleotide (Figures S2H–S2J). In the structure con-
taining only P-site tRNA, no significant density was observed for
the nascent polypeptide chain (Figure 1G), whereas in the struc-
ture with both A- and P-site tRNAs, the density attributable to the
nascent chain was fragmented and disconnected from the
tRNAs (Figure 1H). The density for the CCA end of the A-site
tRNA was worse than the one of the P-site tRNA (Figure 1D; Fig-
ures S2D–S2G), suggesting that the Pro-tRNA had severe prob-
lems to accommodate at the A site of the PTC. Consistent with
this notion, the N terminus of ribosomal protein L27, which
Table 1. Cryo-EM Data Collection, Refinement, and Validation Statistics
#1 P-site tRNA only
(EMDB: 3898, PDB: 6ENF)
#2 A- and P-site tRNA + EF-P
(EMDB: 3899, PDB: 6ENJ)
#3 P-site tRNA + EF-P
(EMDB: 3903, PDB: 6ENU)
Data Collection
Microscope FEI Titan Krios FEI Titan Krios FEI Titan Krios
Camera Falcon II Falcon II Falcon II
Magnification 129,151 129,151 129,151
Voltage (kV) 300 300 300
Electron dose (e–/Ǻ2) 28 28 28
Defocus range (mm) !0.8 to !2.5 !0.8 to !2.5 !0.8 to !2.5
Pixel size (Ǻ) 1.084 1.084 1.084
Initial particles (no.) 229,613 229,613 229,455
Final particles (no.) 75,089 21,655 69,761
Model Composition
Protein residues 5,531 5,951 5,944
RNA bases 4,547 4,693 4,613
Refinement
Resolution range (Å) 3.3 3.9 3.2
Map CC (around atoms) 0.78 0.72 0.80
Map CC (whole unit cell) 0.76 0.75 0.75
FSCaverage 0.85 0.85 0.85
Map sharpening B factor (Ǻ2) !62,88 !66,61 !60,10
RMS Deviations
Bond lengths (Å) 0.011 0.003 0.007
Bond angles (") 0.729 0.594 0.932
Validation
MolProbity score 1.77 1.64 1.77
Clashscore 4.29 3.44 4.11
Poor rotamers (%) 0 0.04 0.41
Ramachandran Plot
Favored (%) 92.06 91.33 88.83
Allowed (%) 7.76 8.37 10.74
Disallowed (%) 0.18 0.31 0.43
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becomes stabilized upon A-site tRNA accommodation (Polika-
nov et al., 2014; Voorhees et al., 2009), remained disordered
(Figure S2K). Collectively, our findings suggest that the presence
of the polyproline stretch within the nascent polypeptide chain
leads to destabilization of the peptidyl-tRNA and prevents
accommodation of the aa-tRNA at the A site, thereby causing
translational stalling.
EF-P in Complex with PPP-Stalled Ribosomes
To investigate structurally how EF-P relieves the translation ar-
rest caused by polyproline stretches, we incubated PPP-stalled
ribosomes with fully modified E. coli EF-P (Figure 2A) and
analyzed the resulting complexes by cryo-EM. In silico sorting
of the cryo-EM data yielded two major subpopulations of ribo-
somes bearing P-site tRNA, distinguished by the presence
(30%) or absence (33%) of EF-P (Figure S1F). The EF-P-contain-
ing subpopulation was extremely heterogeneous, and only a
stable subpopulation containing A- and P-site tRNAs with EF-P
bound in the E site (Figure 2B) could be refined further, yielding
an average resolution of 3.7 Å (Figures S1G and S1H; Table 1).
Despite multiple attempts, wewere unable to obtain a clean sub-
population containing P-site tRNA and EF-P but lacking A-site
tRNA. For completeness, we also refined the major P-site
tRNA subpopulation lacking EF-P (Figure 2C) to an average
resolution of 3.2 Å (Figures S1I and S1J; Table 1). As before (Fig-
ure 1G), little density was observed for the nascent polypeptide
chain attached to the P-site tRNA in the EF-P-lacking structure
(Figure 2D) despite the improved quality of the density for the
CCA end of the P-site tRNA. By contrast, additional nascent
chain density was observed when EF-P was present (Figure 2E);
however, this density fused directly to the A-site tRNA rather
than the P-site tRNA (Figure 2F). Therefore, we concluded that
the EF-P-containing subpopulation represents a post-peptide
bond formation state with deacylated tRNA in the P site and pep-
tidyl-tRNA in the A site. We also observe that the N terminus of
L27 was ordered (Figure 2G), which, as mentioned, is diagnostic
for accommodation of the aa-tRNA at the A site (Polikanov et al.,
2014; Voorhees et al., 2009).
EF-P in Complex with PP-Stalled Ribosomes without the
A-Site tRNA
In order to capture EF-P bound to polyproline-stalled ribosomes
in a pre-peptide bond formation state, we employed a modified
version of the NlpD-PPP mRNA that was truncated directly after
the codon for the second proline of the PPP motif (Figure 3A).
Ribosomes translating the truncated NlpD-PP mRNA become
stalled after the PP motif because the absence of an A-site
codon precludes binding of the next aa-tRNA; thus, the
Figure 2. Cryo-EM Structures of Polyproline-Stalled Ribosomes in the Presence of EF-P
(A–C) Schematic representation (A) and cryo-EM reconstructions (B and C) of PPP-stalled ribosome complexes with (B) or without (C) of EF-P (salmon) bound in
the E site.
(D and E) Cryo-EM density (mesh) of the CCA end of the P-site tRNA (green) from cryo-EMmaps in (C) without EF-P (D) and in (B) with EF-P (E), respectively, with
aligned fMet (cyan, PDB: 1VY4) (Polikanov et al., 2014).
(F) Cryo-EM density (mesh) of the CCA end of the A-site tRNA (orange) and P-site tRNA (green) from (B), with aligned fMet-Phe dipeptide (green, PDB: 1VY5)
(Polikanov et al., 2014).
(G) Cryo-EM density (mesh) for the N-terminal residues of L27 (purple) showing possible interactions with residues G2251 and G2252 of the P loop (gray) and
A-site tRNA (orange).
See also Figure S1.
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ribosomes cannot catalyze peptide bond formation even when
EF-P is present (Figure 3A). The purified truncated NlpD-PP-
stalled ribosomes were then incubated with active modified
E. coli EF-P (Figure 3A), and the resulting complexes were
analyzed by cryo-EM. In silico sorting of the cryo-EM data
yielded two major subpopulations of ribosomes bearing either
P- and E-site tRNAs (22%) or P-site tRNA with EF-P bound in
the E site (74%) (Figure S1K). The EF-P-containing subpopula-
tion could be further segregated into ribosome populations
that differed with respect to the L1 stalk adopting an ‘‘in’’
(30%) or ‘‘out’’ (44%) conformation. The ‘‘in’’ position of the L1
stalk significantly improved the quality of the EF-P density, and
therefore this population was further refined, yielding a final
cryo-EM structure (Figure 3B) with an average resolution of
3.1 Å (Figures S1L and S1M; Table 1). Similarly, we could also
refine the major P- and E-site tRNA-containing ribosome
subpopulation that lacked EF-P (Figure 3C) to a final average
resolution of 3.2 Å (Figures S1N and S1O). Local resolution cal-
culations indicate less flexibility of the P-site tRNA in the pres-
ence of EF-P (Figure 3D) when compared to ribosomes bound
with E-site tRNA (Figure 3E) or having a vacant E site (Figure 3F),
thus supporting the hypothesis that EF-P stabilizes the P-site
peptidyl-tRNA on the ribosome.
EF-P Residues Critical for P-Site tRNA Interaction
The well-resolved density for E. coli EF-P bound to the ribosome
population with the L1 ‘‘in’’ conformation enabled a complete
molecular model to be generated (Figure 4A; Figure S3A). The
overall conformation of E. coli EF-P on a polyproline-stalled ribo-
some is very similar to that observed by X-ray crystallography for
T. thermophilus EF-P bound to a T. thermophilus 70S ribosome
with a deacylated-tRNAfMet in the P site (Blaha et al., 2009),
whereas it deviates more significantly from the binding position
observed for the yeast homolog eIF5A bound to the 80S ribo-
some (Schmidt et al., 2016; Melnikov et al., 2016b) (Figures
S3B and S3C). We observe that the backbone of Asp69 of
E. coli EF-P is within hydrogen bonding distance of U17a within
the D-loop of the peptidyl-tRNAPro in the P site (Figure S3D). This
interaction is also observed in the T. thermophilus EF-P-ribo-
some structure (Blaha et al., 2009) (Figure S3E) but is not
possible for tRNAs containing shorter D-loops (Figure S3F),
thus providing a specificity determinant for EF-P to recognize
tRNAfMet and tRNAPro (Katoh et al., 2016) (Figures S3D and
S3E). By contrast, such a specific interaction between yeast
eIF5A and the P-site tRNA was not observed (Schmidt et al.,
2016; Melnikov et al., 2016b), consistent with the diverse range
of non-proline-containing stalling motifs that are recognized
and rescued by eIF5A (Schuller et al., 2017; Pelechano and Ale-
puz, 2017).
Unlike eIF5A, bacterial EF-P has an additional domain 3 that
contacts the small ribosomal subunit and the ASL of the P-site
tRNA (Figure 4B). In particular, two conserved residues Tyr183
and Arg186 are within hydrogen bonding distance of A42 of
the P-site tRNA and G1338 within helix h29 of the 16S rRNA
Figure 3. Stabilization of the P-Site Peptidyl-tRNA by EF-P
(A–C) Schematic representation (A) and cryo-EM reconstructions (B and C) of truncated NlpD-PP-stalled ribosomes in the presence (B) or absence (C) of EF-P
(salmon).
(D–F) Cryo-EM densities colored according to local resolution for the P-site tRNAs from reconstructions illustrated in (B) and (C), respectively, (D and E) as well as
from the reconstruction from Figure 2C (F).
See also Figure S1.
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(Blaha et al., 2009) (Figure 4B). To investigate the importance of
these interactions, we generated modified EF-P variants bearing
Y183A or R186A substitutions and monitored their ability to pro-
mote translation of a polyproline-containing firefly luciferase
(Fluc) reporter protein (Ude et al., 2013) (Figure 4C). In the
absence of EF-P, ribosomes stall at the polyproline motif and lit-
tle or no luminescence is observed because translation of full-
length Fluc is prevented. As expected, addition of modified
wild-type EF-P rescues the polyproline-stalled ribosomes, lead-
ing to production of full-length Fluc and a corresponding in-
crease in luminescence (Figure 4C). By contrast, the EF-P-
Y183A and EF-P-R186A variants were both completely inactive,
as was the previously reported inactive EF-P-K34A variant (Ude
et al., 2013). These findings demonstrate that the Tyr183 and
Arg186 residues are critical for the rescue activity of EF-P and
explain their high conservation among bacterial EF-P proteins.
Interaction of EF-P with the mRNA Codon in the E Site
In the X-ray structure of T. thermophilus EF-P-ribosome struc-
ture, loop I of domain 3 of EF-P is disordered (Blaha et al.,
2009) (Figure 4D). By contrast, loop I is well resolved in the
cryo-EM structure of E. coli EF-P in complex with the PP-stalled
ribosome (Figure 4A; Figures S4A and S4B), where it interacts
with the ribosomal protein S7 and E-site codon of the mRNA
(Figures 4D and 4E). Binding of EF-P to the ribosome leads to
a shift in conformation of the b-hairpin of S7 by 7.4 Å (Figure 4D),
which is stabilized via potential hydrogen bond interactions
between the sidechain of Arg78 of S7 and the backbone of
Gly144 aswell as the sidechain of T146 of EF-P (Figure 4E). Addi-
tional interactions are formed between S7 (Thr83 and Ser82) and
EF-P (the backbone of Leu142 and the side chain of Asp139)
(Figure 4E; Figures S4C and S4D). Loop I of domain 3 of EF-P
contains a highly conservedGly144-Asp145-Thr146 (GDT)motif,
which establishes contact with the nucleobase of the first and
second positions of the E-site codon of the mRNA (Figures 4D
and 4E; Figures S4E and S4F). To assess the importance of
the GDT motif for EF-P activity, we generated modified EF-P
bearing a triple substitution of GDT to AAA (EF-P-144AAA146).
Since most of the interactions involve the backbone of the
GDT motif, we also generated EF-P variants where 1, 2, or 4
residues within loop I were deleted (EF-P-loopID1, -loopID2,
and -loopID4, respectively). The activity of the EF-P variants
was assessed by monitoring the formation of fMPPPF peptide
on the ribosome, as described previously (Doerfel et al., 2013,
2015). As seen in Figure 4F, no fMPPPF peptide was synthesized
when the inactive EF-P-K34A variant was used (or when EF-P
was absent, see legend to Figure 4), whereas the presence of
wild-type EF-P led to efficient fMPPPF peptide formation.
Figure 4. Interaction of EF-P with the P-Site tRNA
(A) Cryo-EM density (mesh) with molecular model for EF-P (salmon ribbon) with domains 1–3 (d1–d3) indicated.
(B) Overview of EF-P relative to P-site-bound tRNAPro (green) with a zoom on the interactions between Y183 and R186 of EF-P and their respective interaction
partners of tRNAPro and h29 (blue) of the 30S subunit.
(C) Luminescence resulting from in vitro translated Fluc-3xPro wasmonitored over time and quantified in the absence of EF-P (red) or in the presence of wild-type
EF-P (pink) or indicated EF-P variants. 100% luminescence is defined as the luminescence produced by Fluc-3xPro after a 30-min incubation in the presence of
wild-type EF-P. Error bars represent the standard deviation of three independent experiments.
(D) Location of EF-P d3 loop I relative to peptidyl-tRNAPro (green) in the P site,mRNA (light blue), and ribosomal protein S7 (cyan), with the position of the loop of S7
in the absence of EF-P (tan) indicated for reference. The relative position of T. thermophilus EF-P (Blaha et al., 2009) (gray) is shown with the disordered region of
d3 loop of EF-P indicated (dashed line). The positions of the conserved residues within the 144GDT146 motif within loop I of EF-P are indicated by spheres.
(E) Potential hydrogen-bond interactions (dashed yellow lines) between Loop I of EF-P (salmon), the E-site codon (blue), and S7 (cyan).
(F) Synthesis of the fMPPPF peptide as a function of EF-P concentration in the presence of wild-type EF-P (pink) or various EF-P variants. In the absence of EF-P,
0.06 ± 0.01 fMPPPF peptide were formed per ribosome. Error bars represent the standard deviation of three independent experiments.
See also Figures S3–S5.
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While the EF-P-loopID1 retained wild-type-like activity, the
EF-P-144AAA146 and EF-P-loopID2 variants displayed reduced
activity, and the EF-P-loopID4 variant was completely inactive
(Figure 4F). Furthermore, an EF-P variant with the complete
domain 3 deleted (EF-P-DDomain 3) was also inactive
(Figure 4F).
These results suggest that the conserved loop I of domain 3 of
EF-P is critical for the rescue activity of EF-P and raises the pos-
sibility that EF-P recognizes the nature of the E-site codon, anal-
ogous to stop codon recognition by the SPF and PXT containing
loops of termination factors RF2 and RF1, respectively (Zhou
et al., 2012). Modeling on the basis of our structure suggests
that purines in the first and second position, such as AAA or
GGG codons, in the E site lead to clashes with EF-P, whereas
UUU could be accommodated but in a less stable manner (Fig-
ures S5A–S5D). In the X-ray structure of T. thermophilus EF-P-
ribosome structure, the E-site codon was AAA (Blaha et al.,
2009) (Figures S5E and S5F), possibly explaining why loop I of
domain 3 of EF-P was disordered. Moreover, the !3 nucleotide
was also not visualized, supporting the suggestion that EF-P is
critical for positioning and stabilization of the E-site codon (Fig-
ures S5E and S5F). Further biochemical experiments will be
necessary to assess whether loop I of EF-P can really distinguish
CCN proline codons in the E site from other sense codons. The
absence of domain 3 in eIF5A does, however, preclude recogni-
tion of the nature of the E-site codon, whichmay contribute to the
relaxed specificity of eIF5A, allowing eIF5A to also act on a
diverse range of non-proline containing stalling motifs (Schuller
et al., 2017; Pelechano and Alepuz, 2017).
Stabilization of the CCA End of the P-Site tRNA by the
EF-P Modification
Clear electron density is observed at the tip of domain 1 of EF-P
that corresponds to the ε(R)-b-lysylhydroxylysine located at
position K34 of EF-P (Figures 5A and 5B). The post-translational
modification extends into a crevice located adjacent to the CCA
end of the P-site tRNA (Figures 5A and 5B), similar but distinct
from that observed previously for the unmodified R32 residues
of T. thermophilus EF-P (Blaha et al., 2009), and the hypusine
modification located at position K51 of yeast eIF5A (Schmidt
et al., 2016; Melnikov et al., 2016b) (Figures S3G–S3I). The struc-
ture reveals how the EF-P modification can stabilize the P-site
tRNA (Figure 5C) by forming interactions with the backbone of
the CCA end (Figure 5B). Specifically, hydrogen bonds are
possible between the ε-amino group of the (R)-lysyl moiety of
EF-P and the 20 OH of the ribose of C75 and the bridging oxygen
Figure 5. EF-P Stabilizes the PP-Containing Nascent Chain
(A) Cryo-EM density (gray mesh) for the CCA end of the P-site tRNA (green) and ε(R)-b-lysyl-hydroxylysine modification of EF-P (salmon).
(B) Same as (A), but without cryo-EM density, and potential hydrogen bond interactions (dashed lines) between the ε(R)-b-lysyl-hydroxylysinemodification, P-site
tRNA (green), and A2439 (gray) are indicated.
(C) Cryo-EM density colored according to the local resolution for the CCA end of the P-site tRNA, ε(R)-b-lysyl-hydroxylysine modification of EF-P, and the
modeled nascent chain (Pro1-Pro2-Ala3-Ala4).
(D–G) Cryo-EM density (mesh) for the P-site tRNA with the first four residues of the modeled nascent chain (NC) Pro1-Pro2-Ala3-Ala4 (cyan) (D), all-trans Pro-Pro
conformation of CCA-Pro-Pro tRNAmimic in complex with yeast 80S ribosome (PDB: 5DGV) (Melnikov et al., 2016a) (E), three prolines of a polyproline type II (PII)
helix (PP-trans) modeled onto the CCA end of the P-site tRNA, with G2061 shown as a surface to better illustrate the steric clash with the PP-trans nascent chain
(F), and three prolines of a polyproline type I (PI) helix (PP-cis) modeled onto CCA end of the P-site tRNA (G), showing a potential clash with a Pro residue (light
green surface) attached to the A-site tRNA (orange).
See also Figure S6.
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of A76 (Figure 5B). Furthermore, the hydroxyl group that is post-
translationally added to K34 of EF-P by EpmC (Peil et al., 2012)
comes within hydrogen binding distance of the 20 OH of C74,
but this interaction is unlikely to be critical since EF-P lacking
the hydroxylation retains rescue activity (Doerfel et al., 2013;
Ude et al., 2013; Peil et al., 2013). In addition, the EF-P modifica-
tion can form hydrogen bonds with the conserved nucleotide
A2439 of the 23S rRNA (Figure 5B), analogous to those formedbe-
tween eIF5A and A2808 (Schmidt et al., 2016; Melnikov et al.,
2016b), the equivalent residue in the yeast 28S rRNA (Figure S3I).
Figure 6. MD Simulations of Polyproline-
Stalled Ribosomes in the Presence and
Absence of EF-P
(A–C) Conformational landscape explored by MD
simulations with EF-P (A), without EF-P (B), or with
unmodified EF-P (C). The logarithm of the proba-
bility density r is shown along the two most
dominant conformational modes of the CCA end
and the C-terminal proline backbone atoms.
Probability density maxima are indicated by
crosses, green (simulations with EF-P, additionally
markedwith a square), red (without EF-P), and blue
(unmodified EF-P). For comparison, plus signs (+)
indicate the projections of our cryo-EM derived
structure (black), the pre-attack state (Polikanov
et al., 2014) (gray), and the uninduced and the
induced states (Schmeing et al., 2005) (cyan and
magenta, respectively).
(D–F) Conformations of P-site tRNA with peptide
and EF-P corresponding to the density maxima
obtained from MD simulations with EF-P
(D; green), without EF-P (E; red) and with unmodi-
fied EF-P (F; blue). The cryo-EM structure with
EF-P (black) and the pre-attack (Polikanov et al.,
2014) (gray) conformation are shown for compari-
son. Distance between the ester carbonyl carbon
of the peptidyl-tRNA and the a-amino group of the
aa-tRNA is indicated in orange.
See also Figure S7.
By contrast, the overall position and inter-
actions of the modified K34 residue of
E. coli EF-P differs dramatically from that
of the unmodified R32 residues of
T. thermophilus EF-P (Blaha et al., 2009),
which is significantly shorter and interacts
only with the nucleobase of C75 of the P-
site tRNA (Figure S3H).
The Conformation of the Nascent
Chain in the Presence of EF-P
The presence of additional density for the
nascent polypeptide chain attached to
the P-site tRNA (Figures 5C and 5D) sug-
gests that by stabilizing the P-site tRNA,
EF-P also indirectly stabilizes the nascent
chain. Nevertheless, local resolution cal-
culations indicate that the nascent chain
is still relatively flexible (Figure 5C), permit-
ting only the four C-terminal residues to be
tentatively modeled into the density (Figure 5D). To compare the
C-terminal Pro-Pro residues in our structure to other known con-
formations of Pro-Propeptides, we initially aligned theX-ray struc-
ture of a short CCA-Pro-Pro tRNA mimic bound to the yeast 80S
ribosome (Melnikov et al., 2016a) (Figure 5E). These two proline
residues adopt an all-trans conformation, which is present in
type II polyproline helices (Figure 5F) and also observed in other
diprolyl-containing proteins, such as ribosomal proteins S11
and L11 (Fischer et al., 2015), and the ribosome-bound antimicro-
bial peptide Onc112 (Seefeldt et al., 2015; Roy et al., 2015)
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(Figures S6A–S6C). However, this conformation cannot occur on
the ribosome because it would produce a steric clash between
the !2 residue of the nascent chain and nucleotide G2061 of the
23S rRNA that comprises part of the ribosomal exit tunnel (Fig-
ure 5F; Figures S6A–S6C). Similarly, an all-cis conformation of
the two prolyl residues is compatible neither with the density nor
with translation, since it directs the nascent chain into the
ribosomal A site (Figure 5G). Instead, the diprolyl moiety appears
to adopt an alternative trans-conformation, allowing the !2 resi-
due of the nascent chain to bypass G2061 and extend into the
lumenof the ribosomal exit tunnel (Figure5D). Althoughhigher res-
olutionwill be required to accurately describe the trans-conforma-
tion in detail, our model suggests that the backbone Psi angle of
#120" is identical with the all-trans conformation, but thePhi angle
of approximately!90" differs by#30" from the all-trans Phi angle
(!60"). Although the structure represents a ‘‘rescued state,’’ the
alternative conformation appears to be similar to that observed
on a ribosome stalled by the diprolyl-containing, CMV-stalling
peptidyl-tRNA (Matheisl et al., 2015) (Figure S6D), and the overall
path of the nascent chain is similar to that observed for other stall-
ingnascentpolypeptidechainsobservedonthe ribosome,suchas
TnaC (Bischoff et al., 2014), VemP (Su et al., 2017), MifM (Sohmen
et al., 2015), and SecM (Zhang et al., 2015) (Figures S6E and S6F).
Wenote thatwhen the rigid five-memberedproline ring is replaced
with a more flexible four-membered ring, such as in azetidine-2-
carboxylic, ribosome stalling was reduced (Doerfel et al., 2015;
Shin et al., 2017), possibly indicating that the additional freedom
of the azetidine-2-carboxylic allows alternative conformations to
be adopted more easily that do not sterically clash with G2061.
In summary, we suggest that the incompatibility between the
preferred diprolyl conformation of the nascent chain and the ribo-
some induces a strained conformation that can be relieved either
by (1) destabilization of the P-site peptidyl-tRNA and therefore ri-
bosomal stalling ensues or (2) binding of EF-P that stabilizes the
P-site peptidyl-tRNA and forces the nascent chain to adopt an
alternative conformation, with the outcome that peptide bond for-
mation can occur.
EF-P Stabilizes the P-Site tRNA in a Pre-attack
Conformation
To assess the dynamics of the region surrounding the PTC in the
presence of modified EF-P or unmodified EF-P or the absence of
EF-P, we carried out all-atom explicit-solvent molecular dy-
namics (MD) simulations. The first MD simulation was initiated
using the model of the cryo-EM structure of the NlpD-PP-EF-
P-ribosome, and two subsequent simulations were performed
Figure 7. Mechanism of Action of EF-P on Polyproline-Stalled Ribosomes
(A andB) Ribosomes stall during translation of proteins containing three consecutive prolines (Doerfel et al., 2013; Ude et al., 2013) leading to destabilization of the
peptidyl-tRNA in the P site (A), which leads to peptidyl-tRNA drop-off, particular with short peptidyl-tRNAs (Doerfel et al., 2013) (B).
(C) The all-trans or all-cis conformation of polyprolines (red stars) of the nascent chain is not possible because of a steric clash with G2061 (gray) within the tunnel
wall, leading to peptidyl-tRNA destabilization and thus preventing accommodation of the A-site tRNA and peptide bond formation.
(D) Ribosomes stalled on polyproline stretches are recognized by EF-P, which binds within the E-site region and stabilizes the peptidyl-tRNA. EF-P binding is
facilitated via contacts with the L1 stalk (Blaha et al., 2009) and the P-site tRNA (Katoh et al., 2016) as well as E-site codon.
(E) Interaction of the ε(R)-b-lysyl-hydroxylysine with the CCA end of P-site tRNAPro stabilizes the P-site tRNA, as well as the nascent chain, by forcing the prolines
to adopt an alternative conformation that passes into the ribosomal exit tunnel.
(F) Thus, an optimal geometry between the nascent chain and the aminoacyl-tRNA in the A site is achieved and peptide bond formation can occur.
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where either the b-lysine part of modification on K34 or the entire
EF-P protein were computationally removed. A total of 15 simu-
lations, 2 ms each, accumulating to a total simulation run time of
30 ms were performed using a reduced system encompassing a
35 Å radius from the PTC. Principal-component analysis (PCA)
(Amadei et al., 1993) was used to extract the two most dominant
conformational modes of motion. As shown in Figure 6A, in the
presence of modified EF-P, the major conformations are stable
and remain close to the cryo-EM structure, which is similar to
that observed in the X-ray structures of the T. thermophilus
pre-attack conformation (Polikanov et al., 2014) as well as
uninduced and induced conformations from H. marismortui
(Schmeing et al., 2005). By contrast, after the b-lysine modifica-
tion of EF-P or the complete EF-P protein was removed from the
simulation, the system explored new conformations, moving
away from the conformations observed in presence of EF-P,
particularly with respect to conformational mode 2 (Figure 6C).
Since conformational mode 2 reflects the relative distance
between the a-amino group of an aminoacyl-tRNA in the A site
and the carbonyl-carbon of the aminoacyl ester linkage in the
peptidyl-Pro-Pro-tRNA (Figure S7), the MD simulations suggest
that when the EF-P modification or the entire EF-P protein was
absent, the peptidyl-tRNA moved away from the A-site tRNA,
generating a geometry that is incompatible with peptide bond
formation (Figures 6E and 6F). By contrast, the presence of the
EF-P modification stabilized the pre-attack conformation of the
P-site tRNA, thus promoting peptide bond formation (Figure 6D).
DISCUSSION
Collectively, our biochemical and structural findings, together
with the available literature, lead us to propose a model for poly-
proline-mediated translational stalling and rescue by EF-P
(Figure 7). Ribosomes translating proteins containing polypro-
line-stretches become stalled because of slow peptide bond
formation between the peptidyl-Pro-Pro-tRNA in the P site and
the incoming Pro-tRNA in the A site (Doerfel et al., 2013) (Fig-
ure 7A). The favorable all-trans conformation of the Pro-Pro pep-
tide is not possible within the context of the ribosomal tunnel,
which leads to destabilization of the P-site tRNA and nascent
chain (Figure 7B). For short oligo-peptidyl-tRNAs, this results in
high levels of peptidyl-tRNA drop-off (Doerfel et al., 2013,
2015). For longer peptidyl-tRNAs that are more refractory to
drop-off, the destabilized peptidyl-tRNA results in suboptimal
positioning for peptide bond formation and may also disfavor
accommodation of the aminoacyl-tRNA at the A site (Figure 7B).
Additionally, the destabilized peptidyl-tRNAs may be more sus-
ceptible to peptide release and/or ribosome rescue systems (Fig-
ures 7A and 7B), whichmay explain the unusually high proportion
(30%) of vacant 70S ribosomes that were present in the PPP-
stalled ribosome sample following purification (Figure S1A). Pol-
yproline-stalled ribosomesare recognizedbyEF-P,whichutilizes
features of the E site codon of themRNA, aswell as specific inter-
actionswithD-loopof theP-sitePro-tRNA (Katohet al., 2016), the
L1 stalk, and the 30S subunit to promote binding (Blaha et al.,
2009) (Figure 7C).While the presence of EF-P generally stabilizes
the binding of the P-site tRNA, the ε(R)-b-lysylhydroxylysine is
necessary to specifically interact and stabilize the CCA end at
the PTC (Figure 7D). Stabilization of theCCA end by the ε(R)-b-ly-
sylhydroxylysine modification of EF-P also positions the nascent
polypeptide chain such that it extends into the lumenof the tunnel
(Figure 7E), thus allowing theCCA ends of the tRNAs to adopt the
conformation that favors peptide bond formation (Figure 7F).
These findings provide a structural rationale for the entropic
steering effect of EF-P on peptide bond formation (Doerfel
et al., 2015). It will be interesting to see how the distinct modifica-
tions found on EF-P in other bacteria, such as the rhamnosylation
found in P. aeurignosa EF-P (Lassak et al., 2015; Rajkovic et al.,
2015) or the 5-aminopentanol moiety ofB. subtilis EF-P (Rajkovic
et al., 2016), stabilize the CCA end of the P-site tRNA to promote
an optimal geometry for peptide bond formation. Moreover,
although it remains to be determined as to what promotes EF-P
dissociation from the ribosome following peptide bond
formation, our structure suggests that subunit rotation and open-
ing of the L1 stalk are good candidates for destabilization of EF-P
binding.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Bacterial and Virus Strains
E. coli BL21(DE3)pLysS Merck 69450
E. coli Defp KEIO Collection BW25113
Biological Samples
tRNA from E.coli MRE600 Roche 10109550001
Chemicals, Peptides, and Recombinant Proteins
Ampicillin Sigma A9518
Complete, EDTA-free Roche 05056489001
Dpn 1 NEB R0176S
GTP Sigma G8877
Isopropyl-b-D-1-thiogalactopyranoside Roth 2316
Kanamycin Sigma 60615
KOD Xtreme Hot Start Polymerase Merck 71975
LiCl precipitation solution Thermo Fisher Scientific AM9480
n-Dodecyl b-D-maltoside (DDM) Sigma D4641
PEG-8000 Sigma 1546605
Phosphoenol pyruvate Sigma 10108294001
Pyruvate kinase (PK) Sigma 10109045001
Rnasin Promega N2511
rNTPs Sigma 27-2025-01
Triton X-100 Sigma T8787
Critical Commercial Assays
Luciferase Assay System Promega E1500
PURExpress In Vitro Protein Synthesis Kit New England Biolabs E6800
Talon Purification kit Clontech 635501
Deposited Data
Dataset 1: Cryo-EM map of PPP stalled 70S with P-site tRNA This paper EMDB: 3900
Dataset 1: Cryo-EM map of PPP-stalled 70S with A+P-site tRNA This paper EMDB: 3901
Dataset 2: Cryo-EM map of EF-P/PPP-stalled 70S with P-site tRNA
(no EF-P bound) and associated structural model
This paper EMDB: 3898;
PDB: 6ENF
Dataset 2: Cryo-EM map of EF-P/PPP-stalled 70S with A+P-site tRNA and
EF-P and associated structural model
This paper EMDB: 3899;
PDB: 6ENJ
Dataset 3: Cryo-EM map of EF-P/PP stalled 70S with P-site tRNA and EF-P
and associated structural model
This paper EMDB: 3903;
PDB: 6ENU
Dataset 3: Cryo-EM map of EF-P/PP stalled 70S with P+E-site tRNA
(no EF-P bound)
This paper EMDB: 3902
Oligonucleotides
EF-P-R186A_FOR: 50-GGTGAATACGTCTCTGCGGTGAAGTAATGGATC-30 Eurofins Genomics N/A
EF-P-R186A_REV: 50-GATCCATTACTTCACCGCAGAGACGTATTCACC-30 Eurofins Genomics N/A
EF-P-Y183A_FOR: 50-CCCGCTCTGGTGAAGCGGTCTCTCGCGTGAAG-30 Eurofins Genomics N/A
EF-P-Y183A_REV: 50-CTTCACGCGAGAGACCGCTTCACCAGAGCGGG-30 Eurofins Genomics N/A
EF-P-loopID1_FOR: 50-CTGAAAGGTGATACCGCAACTGGCGGCAAACCGGC-30 Eurofins Genomics N/A
EF-P-loopID1_REV: 50-GCCGGTTTGCCGCCAGTTGCGGTATCACCTTTCAG-30 Eurofins Genomics N/A
EF-P-loopID2_FOR: 50-GGCCTGAAAGGTGATACCACTGGCGGCAAACCGGC-30 Eurofins Genomics N/A
EF-P-loopID2_REV: 50-GCCGGTTTGCCGCCAGTGGTATCACCTTTCAGGCC-30 Eurofins Genomics N/A
(Continued on next page)
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CONTACT FOR REAGENT AND RESOURCE SHARING
Please direct any requests for further information or reagents to the Lead Contact, Daniel N. Wilson (daniel.wilson@chemie.
uni-hamburg.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
E. coli Strain and Growth Conditions
The E. coli Defp strain (Keio collection BW25113) was grown to OD600 = 5.8 in an ‘INFORCE HT minifors’ bench-top fermenter in
2xYPTG (16 g/l peptone, 10 g/l yeast extract, 5 g/l NaCl, 22 mM NaH2PO4, 40 mM Na2HPO4, 19.8 g/l glucose) at 37
"C while main-
taining pH 7.0 and oxygen level (60%).
METHODS DETAILS
Preparation of the E. coli Defp S12 Translation Extract
The E. coli Defp S12 translation extract was prepared as described for B. subtilis S12 translation extract (Sohmen et al., 2015) with
some minor modifications. E. coli Defp cells (Keio collection BW25113) were grown to OD600 = 5.8 in an ‘INFORCE HT minifors’
bench-top fermenter in 2xYPTG (16 g/l peptone, 10 g/l yeast extract, 5 g/l NaCl, 22mMNaH2PO4, 40mMNa2HPO4, 19.8 g/l glucose)
at 37"C while maintaining pH 7.0 and oxygen level (60%). Cells were collected at 5,000 x g at 4"C for 15 min. 22 g of cells were
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
EF-P-loopID3_FOR: 50-CCGGGCCTGAAAGGTGATGGCGGCAAACCGGCTACC-30 Eurofins Genomics N/A
EF-P-loopID3_REV: 50-GGTAGCCGGTTTGCCGCCATCACCTTTCAGGCCCGG-30 Eurofins Genomics N/A
EF-P-144AAA146_FOR: 50-GATCCGGGCCTGAAAGCGGCGGCGGCAGGTACTG
GCGGC-30
Eurofins Genomics N/A
EF-P-144AAA146_REV: 50-GCCGCCAGTACCTGCCGCCGCCGCTTTCAGGC
CCGGATC-30
Eurofins Genomics N/A
EF-P-K34A_FOR: 50-CGTAAAACCGGGTGCGGGCCAGGCATTTG-30 Eurofins Genomics N/A
EF-P-K34A_REV: 50-CAAATGCCTGGCCCGCACCCGGTTTTACG-30 Eurofins Genomics N/A
EF-P-DDomain3_FOR: 50-GTTACTCCGCCGAACTAAGTTGAACTGGAAATC-30 Eurofins Genomics N/A
EF-P-DDomain3_REV: 50-GATTTCCAGTTCAACTTAGTTCGGCGGAGTAAC-30 Eurofins Genomics N/A
Recombinant DNA
Plasmid pET21b-R1NlpD Starosta et al., 2014 N/A
pET46LIC_Ec_efp Starosta et al., 2014 N/A
pRSFDuet_Ec_yjeK/Ec_yjeA Starosta et al., 2014 N/A
Software and Algorithms
WHATIF Vriend, 1990 N/A
Gromacs 5, Solvate and GENION Pronk et al., 2013 N/A
LINCS Hess, 2008 N/A
SIGNATURE Chen and Grigorieff, 2007 N/A
RELION-2 Scheres, 2012 N/A
CTFFIND4 Rohou and Grigorieff, 2015 N/A
MotionCor2 Zheng et al., 2017 N/A
Chimera Pettersen et al., 2004 N/A
Coot Emsley and Cowtan, 2004 N/A
Chem3Dpro PerkinElmer N/A
MolProbity Chen et al., 2010 N/A
HHPred Hildebrand et al., 2009 N/A
PyMol Molecular Graphic Systems Version 1.8 Schrödinger; https://pymol.org/2/ N/A
Other
Protino Ni-NTA agarose beads Macherey-Nagel 745400
Superdex HiLoad S75 16/600 GE Healthcare 28989333
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resuspended in 14.6 mL of Buffer A (10 mM Tris-acetate, pH 8.2, 14 mM magnesium acetate, 60 mM potassium glutamate, 1 mM
dithiothreitol and 6 mM 2-mercaptoethanol) and broken open in an ‘microfluidics model 110I lab homogenizer’, 3x at 15,000 psi.
Subsequently, the lysate was cleared at 12,000 x g and incubated for 30 min at 37"C in a water bath. The cell extract was aliquoted,
snap frozen and stored at !80"C.
PCR and In Vitro Transcription
Full-length nlpD-PPP construct with a N-terminal 6 x His- andHA-tagwas amplified frompET-21b-R1nlpD (Starosta et al., 2014) using
T7 forward (50-TAATACGACTCACTATAGGG-30) and T7 terminator (50GCTAGTTATTGCTCAGCGG-30) primer. Truncated nlpD-PP
construct was amplified from nlpD-PPP PCR product using T7 forward and revPP (50-CGGCGGTCTAATCAACATAC-30) primer.
To avoid contamination with remaining full-length nlpD-PPP product, nlpD-PP was excised from the agarose gel and a second
PCR was performed using the excised product as a template with T7 forward and revPP as primers. PCR products were purified
and in vitro transcription reaction was performed using 2 mg of PCR product and 4ml of homemade T7 polymerase per 100 ml reaction
volume (40 mM Tris pH 7.9, 25mMSpermidine, 26 mMMgCl2, 0,01% Triton X-100, 5mMDTT and 6.25 mM rNTPs (Sigma)) (Sohmen
et al., 2015). The RNA was purified by LiCl/ethanol precipitation.
Preparation of Full-Length NlpD-PPP-SRC and Truncated NlpD-PP-SRC
Full-length NlpD-PPP-SRC was prepared using E. coli Defp S12 translation extract following the procedure described for the
B. subtilisMifM-SRC (Sohmen et al., 2015). In summary the translation reaction contained 240 mM HEPES pH 8.2, 1.5 mM glucose,
2% PEG-8000, 2 mMDTT, 90 mM potassium glutamate, 80 mM ammonium acetate, 7.5 mMMgAc, 20 mMKH2PO4, 35 mM of each
amino acid and 6.75 ml/25 ml of the S12 cell extract as well as 1.5 ml/25 ml reaction of in vitro transcribedmRNA. For the purifications of
the SRCs the reaction was scaled up to 2500 ml. In vitro translation was carried out for 20 min. Translation reaction was stopped by
adding ice cold Buffer B (50 mM HEPES pH 7.2 at 4"C, 250 mM KOAc, 10 mM MgOAc, 0,1% DDM, 1/1,000 complete protease
inhibitor (Roche), 0.2 U/ml RNasin). For the truncated NlpD-PP-SRC, the in vitro reaction was carried out using PURExpress
In vitro Protein Synthesis Kit (NEB). The translation reaction (750 ml in total) was prepared according to the protocol of the
PURExpress In vitro Protein Synthesis Kit but was supplemented with 5 mM anti-ssrA oligo (50TTAAGCTGCTAAAGCGTAGTTTTCG
TCGTTTGCGACTA-30). Translation was started by adding the truncated nlpD-PP PCR product and then the reaction was incubated
at 37"C for 20 min with shaking at 1,000 rpm.
Purification of the NlpD-PPP-SRC and Truncated NlpD-PP-SRC
Translation reactions were loaded onto 500 mL sucrose cushion (750 mM sucrose) in Buffer B and pelleted at a speed of 45.000 rpm
for 150min in a TLA 120.2 rotor (Sohmen et al., 2015). The SRCswere resuspended in Buffer B and bound via its N-terminal 6x His-tag
to a Talonmetal affinity chromatography column (Clontech) which was pre-equilibrated with Buffer B containing 10mg/ml bulk tRNA.
The column was washed with Buffer C (same as Buffer B, but with 500 mM KOAc). The SRCs were eluted by using Buffer B supple-
mented with 150 mM Imidazole. The eluates were loaded onto 10%–40% sucrose gradients (in Buffer B) and centrifuged for 13h in a
Beckman coulter SW40 swinging bucket rotor at 20.000 rpm. 70S peaks were collected, pelleted for 3h in a TLA 120.2 rotor
(45.000 rpm) and pellets were resuspended in Buffer B. Purification of the SRCs were confirmed by SDS-Page and western blotting
using an anti-HA-tag antibody.
Cryogrid Preparation for the NlpD-PPP-SRC and NlpD-PP-SRC
Dataset 1: For grid preparation 4.5 OD A260/ml monosomes of the full-length NlpD-PPP-SRC were used. Dataset 2: For grid prep-
aration 5.0 OD A260/ml monosomes of the full length NlpD-PPP-SRC were used and a 3x excess of modified EF-P over 70S was
added and incubated for 20 min at 37"C. Dataset 3 For grid preparation 4.5 OD A260/ml monosomes of the truncated NlpD-PP
SRC were used. A 5x excess of modified EF-P over 70S as well as 100 mM evernimicin (to ensure absence of A-site tRNA) (Arenz
et al., 2016b) were added and incubated for 5 min at 37"C. All samples were applied to 2 nm precoated Quantifoil R3/3 holey carbon
supported grids and vitrified using a Vitrobot Mark IV (FEI company).
Generation and Purification of Modified EF-P and Mutants
All EF-P variants were generated by site-directedmutagenesis PCR using the whole plasmid PCRmethod with pET46LIC_EC_efp as
a template (primers and plasmids are listed in the Key Resources Table). For the PCR reaction the KOD Xtreme Hot Start Polymerase
(Merck) was used with the following conditions: 94"C 2 min; 20x (98"C 10 s, 63"C 30 s, 68"C 2 min); 68"C 7 min. The product was
digested with Dpn1 (NEB) for 1h at 37"C and purified using a PCR Purification Kit (Qiaqen). The EF-P variants were coexpressed
together with EpmA and EpmB from pRSFDuet vector (to ensure modification of EF-P) in E. coli BL21 cells grown at 37"C from over-
night culture in lysogeny broth (LB) medium and in the presence of 100 mg/mL ampicillin and 50 mg/ml kanamycin. Protein expression
was induced at an OD600 of 0.4 with a final concentration of 1 mM isopropyl-b-D-1-thiogalactopyranoside (IPTG) (Roth). After 1 hour
of expression cells were lysed using a microfluidizer. The cell lysate was cleared using a SS34 rotor at 4"C and 44,100 x g for
30 minutes. Purification of His-tagged proteins was done with Protino Ni-NTA agarose beads (Macherey-Nagel). The final eluate
was applied onto a Superdex HiLoad S75 16/600 column (GE Healthcare) to yield the final concentrated protein in gel filtration buffer
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(50 mM HEPES pH 7.4, 50 mM KCl, 100 mM NaCl and 5 mM 2-mercaptoethanol). The post-translational modification of wild-type
EF-P and EF-P variants was confirmed by mass spectrometry as performed previously for EF-P (Peil et al., 2012).
Luminescence Determination of Firefly Luciferase
In vitro translation of the firefly luciferase was performed using the PURExpress in vitro translation kit. For template generation
Fluc3xPro was amplified via PCR using T7 forward and T7 reverse primer from plasmid pIVEX-Fluc3xPro (Ude et al., 2013). Samples
have been incubated at 37"C for defined time periods. 1 ml of each reaction were added on to white 96-well chimney flat bottom
microtiter plates. 40 ml of luminol substrate (Promega) was added, immediately before luminescence was detected using a Tecan
Infinite M1000.
Ribosome Complexes for Kinetic Experiments
The mRNA (GGGCAAGGAGGUAAAUAAUGCCGCCGCCGUUCAUU) coding for fMPPPF was synthesized by IBA Lifescience. Initi-
ation complexes were formed by incubating 70S ribosomes (1 mM)with IF 1, IF2, IF3 (1.5 mMeach), f[3H]Met-tRNAfMet (3 mM) andGTP
(1 mM) in buffer D (50 mM Tris-HCl, pH 7.5 at 37"C, 70 mM NH4Cl, 30 mM KCl and 7 mM MgCl2) for 30 min (Doerfel et al., 2013).
Initiation complexes were purified by centrifugation through a 400 ml sucrose cushion (40% sucrose in buffer D) at 260,000 g for
2 h at 4"C. Pellets were dissolved in buffer D, flash frozen and stored at !80"C. [14C]Phe-tRNAPhe was prepared from total tRNA
as described. tRNAPro in-vitro transcripts were prepared and aminoacylated as described (Doerfel et al., 2013). Ternary complexes
EF-Tu–GTP–aminoacyl-tRNA were prepared by incubating aminoacyl-tRNA (Pro-tRNAPro and Phe-tRNAPhe) with a 2.5-fold excess
of EF-Tu, GTP (1 mM), pyruvate kinase (0.1 mg/ml) and phosphoenolpyruvate (3 mM) for 15 min at 37"C.
In Vitro Translation of fMPPPF Model Peptide
Initiation complexes (0.2 mM), ternary complexes Pro and Phe (each 2 mM), EF-G (1 mM) and EF-P (varying concentrations) weremixed
in buffer E (50 mM Tris-HCl, pH 7.5 at 37"C, 70 mM NH4Cl, 30 mM KCl, 3.5 mM MgCl2, 0.5 mM spermidine, 8 mM putrescine and
2mMDTT) at 37"C. The reaction was quenched after 20 swith KOH (0.5M), hydrolyzed for 30min at 37"Cand neutralized with glacial
acetic acid. Amino acids and peptides were separated by reversed-phase HPLC (Chromolith Performance RP8e 100-4.6 column,
Merck) using a 0%–65% acetonitrile gradient in 0.1% TFA. Products and educts were quantified by double-label scintillation count-
ing (Doerfel et al., 2013).
Molecular Dynamics Simulations
To obtain the dynamics of the region surrounding the PTC in presence of EF-P, unmodified EF-P or without EF-P, we carried out
all-atom explicit-solvent molecular dynamics (MD) simulations. The simulations were started (i) from the cryo-EM structure, (ii)
from the cryo-EM structure after removal of the b-lysine modification of Lys34 (EF-P), and (iii) after removal of EF-P. Since the struc-
tural differences between the cryo-EM structures with and without EF-P are only found in the vicinity of the PTC, we used a reduced
simulation system that allowed us to increase the achievable simulation time. The simulation system (+EF-P) includes all residues of
the cryo-EM structure located within 35 Å of any atom of the P-site tRNA CCA tail, of the attached peptide, or of the b-lysine modified
Lys34 of EF-P. Nucleotides (amino acids) that are not within this radius, but whose 50- and 30- (n- and c-) neighbors are within the
radius, are also included in the simulation system. Nucleotides whose 50 (30) bound nucleotide neighbor is not in the simulation system
were treated as 50 (30) terminal nucleotides. Any amino acid i whose i!1 neighbor (i + 1 neighbor) is not in the simulation system was
capped by an uncharged N-terminal acetyl (C-terminal amide). Positions of residues in a 25 Å radius were not restrained (inner layer),
while heavy atom positions of the remaining residues (outer layer) were restrained by a harmonic potential. The harmonic force con-
stant k of each restrained atomwas chosen as k = 8RT p $ rmsf2 where rmsf is the root mean square fluctuation of the corresponding
atom obtained from a 2 ms-simulations of the full ribosome in complex with A- and P-site tRNAs and the ErmBL peptide (Arenz et al.,
2016a). For those heavy atoms without corresponding atoms in the full-ribsome simulations, the average of all other force constants
was used. Two more simulation systems were used, one after removal of the modification of EF-P Lys34 (+EF-P (unmod)) and the
other after removal of all EF-P atoms (–EF-P). To place initial Mg2+ ions, a cryo-EM structure of the ribosome (Fischer et al., 2015)
was aligned to each simulation system. Then, Mg2+ ions resolved in the cryo-EM structure that are located within 5 Å of the atoms
of the simulation system were extracted from the aligned structure and included in the simulations system. WHATIF (Vriend, 1990)
was used to determine the protonation states of the histidines. Each simulation systems was then solvated in a dodecahedron box of
water molecules with a minimum distance of 1.5 nm between the atoms of the simulation system and the box boundaries using the
program solvate (Pronk et al., 2013). To neutralize the overall charge of each system, first the Coulomb potential at the positions of all
water oxygen atoms was calculated based on the charges and positions of all other atoms. Iteratively, the water molecule with the
lowest Coulomb potential was replaced by a K+ ion and theCoulomb potential at all other water oxygens was updated until the overall
charge was neutral. Using the program GENION (Pronk et al., 2013), subsequently 7 mM MgCl2 and 150 mM KCl were added. All
simulations were carried out with Gromacs 5 (Pronk et al., 2013) using the amberff12sb force field (Lindorff-Larsen et al., 2010)
and the SPC/E water model (Berendsen et al., 1987). Force field parameters for modified nucleotides were taken from (Aduri
et al., 2007). Potassium and chloride ion parameters were taken from (Joung and Cheatham, 2008). Atom types for b-lysine modified
Lys were obtained with ANTECHAMBER (Wang et al., 2006) and partial charges were determined using DFT-B3LYP with a 6-31/G*
basis set. The ester bond between the C-terminal proline and A76 of the P-site tRNA was treated as described earlier (Bock et al.,
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2013). Lennard- Jones and short-range Coulomb interactions were calculated within a distance of 1 nm, while long-range Coulomb
interactions were calculated using particle-mesh Ewald summation (Essmann et al., 1995). The LINCS algorithm was used to
constrain bond lengths (Hess, 2008) and virtual site constraints (Feenstra et al., 1999) were used for hydrogens, allowing an integra-
tion time step of 4 fs. Solute and solvent temperatures were controlled independently at 300 K using velocity rescaling (Bussi et al.,
2007) with a coupling time constant of 0.1 ps. For each of the three simulation systems, the system was equilibrated in four steps.
First, the potential energy was minimized using steepest decent while restraining the positions of all solute heavy atoms (k = 1000 kJ
mol!1 nm!2). Second, for the first 50 ns, the pressure was coupled to a Berendsen barostat (1 ps coupling time) (Berendsen et al.,
1984) and position restraints were applied. Third, during the next 20 ns, the position restraint force constant was linearly decreased to
the values obtained from the full-ribosome simulations for the outer-layer atoms and to zero for the remaining atoms. Finally, for
production runs starting at 70 ns, the Parrinello-Rahman barostat was used (Parrinello and Rahman, 1981). At simulation times
170, 270, 370, and 470 ns coordinates were extracted from the trajectory, new velocities were assigned according to a Boltzmann
distribution, and subsequently new simulations were started, resulting in a total of 15 simulations, 2 ms each, accumulating to a total
production run simulation time of 30 ms.
Conformational Landscape of CCA End and C-Terminal Proline
To investigate how either the removal of the modification of EF-P or the removal of EF-P entirely changes the conformation of the
P-site CCA end and the C-terminal proline of the peptide, we carried out a Principal Component Analysis (PCA) (Amadei et al.,
1993). A PCA is used to extract the dominant modes of motion, here the first two eigenvectors. To that aim, we first aligned all
the trajectories using all 23S P atoms and, second, extracted backbone atoms of the CCA end (O30, C30, C4’, C50, O50, and P atoms)
and of the peptide (N, CA, C, and O atoms). The extracted trajectories were then concatenated and the atomic displacement covari-
ance matrix was calculated. The eigenvectors of this covariance matrix were sorted according to their eigenvalues. The eigenvectors
corresponding to the largest eigenvalues represent the most dominant conformational modes. To describe the structural ensembles
obtained from the three sets of simulations, first, the projection of all the frames onto the first two eigenvectors was calculated. For
each set of simulations, the projections were then sorted into 2-dimensional bins and the logarithm of the probability r = ci,j/ctotal of
each bin i,j was calculated, where ci,j is the number of the projections in the bin, ctotal is the total number of frames (Figures 6A–6C). For
comparison, our cryo-EM structure with EF-P as well the X-ray structures of the pre-attack conformation (Polikanov et al., 2014) and
the uninduced and induced conformations (Schmeing et al., 2005) were projected onto the two conformational modes (Figures 6A–
6C). For each set of simulations, all the structures sorted into the bin marked with a cross in the conformational landscape (Figures
6A–6C) were extracted. For each set, from the extracted structures the onewith themedian peptide bond distancewas chosen and is
shown in (Figures 6D–6F).
Cryo-electron Microscopy and Single Particle Reconstruction
Data collections were performed on FEI Titan Krios transmission electron microscopes equipped with a Falcon II direct electron
detector (FEI) at 300 kV at a pixel size of 1.064 Å (Dataset 1) or 1.084 Å (Dataset 2 and 3). Dataset 1: Defocus range was
from!1.0 to!2.5 mm (underfocus) resulting in 1156Micrographs aftermanual inspection and discardingmicrographswith resolution
worse than 4 Å. Eachmicrograph contained 16 frames (2.68 e-/ Å 2). Original image stacks weremotion-corrected and doseweighted
using MotionCor2 (Zheng et al., 2017). Dataset 2 and 3: Defocus range was from !0.8 to !2.5 mm (underfocus) resulting in 2109
micrographs for Dataset 2 and 1957 micrographs for Dataset 3 after manual inspection and discarding micrographs showing a res-
olution worse than 3.3 Å (Dataset 2) and 3.4 Å (Dataset 3), respectively. Each micrograph contained 17 frames in total (2.4 e-/ Å2 +
4 e-/ Å2 pre exposure) and frames 0-9 were used resulting in a total dose of 28 e-/ Å2. Original image stacks were motion-corrected
using MotionCor2 (Zheng et al., 2017). Power-spectra, defocus values, astigmatism and estimation of resolution were determined
using CTFFIND4 software (Rohou and Grigorieff, 2015). After automated particle picking using SIGNATURE (Chen and Grigorieff,
2007) single particles were processed using RELION-2 (Scheres, 2012). All particles from the three datasets (Dataset 1: 121,704 par-
ticles, Dataset 2: 229,613 particles, Dataset 3: 229,458 particles) were first subjected to 3D refinement using an E. coli 70S ribosome
as reference structure and subsequently a 3D classification was performed (Figure S1). Dataset 1 was classified into four classes and
dataset 2 and 3 into eight classes. For dataset 3 classes 2 and 3 were joined and a second classification was performed with a mask
focusing on EF-P. Final structures of all datasets were refined, corrected for the modulation transfer function of the Falcon 2 detector
and sharpened by applying a negative B-factor automatically estimated by RELION-2 (Figure S1). Resolution was estimated using
the ‘‘gold standard’’ criterion (FSC = 0.143).
Molecular Modeling and Map-Docking Procedures
Themolecular model for the ribosomal proteins and rRNA of either the PPP or PP stalled complexes is based on themolecular model
for the 70S subunit from the cryo-EM reconstruction of the E. coli 70S ribosome (PDB: 5AFI) (Fischer et al., 2015) and obtained by
performing a rigid body fit into the cryo-EM density map of the corresponding stalled complex using UCSF Chimera (Pettersen et al.,
2004) (fit in map function). For E. coli EF-P, a homology model was generated using HHPred (Hildebrand et al., 2009) based on a
template from T. thermophilus (PDB: 3HUW) (Blaha et al., 2009). The model was fitted to the density using Chimera (Pettersen
et al., 2004) and refined in Coot (Emsley and Cowtan, 2004). The post-translational modification of ε(R)!b!lysylhydroxylysine that
is positioned at K34 of EF-P was designed using Chem3DPro (PerkinElmer), manually placed into the cryo-EM density map at
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position 34 of EF-P and refined in Coot. P-site tRNA of the E. coli 70S ribosome (PDB: 5AFI) (Fischer et al., 2015) was manually
mutated to tRNAPro(CCG). In the case of the truncated PP-SRC in the presence of EF-P, the L1 stalk and L1 protein were taken
from the crystal structure of T. thermophilus (PDB: 3HUW), manually mutated and refined using Coot. Nucleotides of the PTC that
differ from the cryo-EM E. coli 70S ribosome (PDB: 5AFI) (Fischer et al., 2015) were manually refined into density using Coot.
Atomic coordinates were refined using phenix.real_space_refine (Adams et al., 2010), with restraints obtained by
phenix.secondary_structure_restraints (Adams et al., 2010). Cross-validation against overfitting was performed as described else-
where (Brown et al., 2015). Statistics of the refined models were obtained using MolProbity (Chen et al., 2010) and are presented
in Table 1.
Figure Preparation
Figures showing electron densities and atomic models were generated using either UCSF Chimera (Pettersen et al., 2004) or PyMol
Molecular Graphic Systems (Version 1.8 Schrödinger). Figure panels were assembled using Adobe Illustrator.
QUANTIFICATION AND STATISTICAL ANALYSIS
Cryo-EM Data Analysis
Bayesian selection using RELION software package was used to choose the cryo-EM data package (Scheres, 2012). Resolutions
were calculated according to gold standard and the estimation of variation within each group of data was performed using Bayesian
calculation within RELION (Scheres, 2012).
DATA AND SOFTWARE AVAILABILITY
Accession Numbers
The atomic coordinates and/or the associated maps have been deposited in the PDB and/or EMDB with the accession codes EMD:
3900 (Dataset 1, P-tRNA only), EMD: 3901 (Dataset 1, A+P-tRNA), EMD: 3898/PDB: 6ENF (Dataset 2, P-tRNA only), EMD: 3899/PDB:
6ENJ (Dataset 2, A+P-tRNA+EF-P), EMD: 3903/PDB: 6ENU (Dataset 3, P-tRNA+EF-P) and EMD: 3902 (Dataset 3, P+E-tRNA).
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Figure S1 - Related to Figure 1-3. Data processing of the cryo-EM structures of 
polyproline-stalled ribosomes ± EF-P. (A) In silico sorting procedure for Dataset 1 
derived from the PPP-stalled ribosome complexes prepared in the absence of EF-P. (B) 
Fourier-shell-correlation (FSC) curve (green) and (C) transverse section of the P-site 
tRNA only structure colored according to local resolution. (D) FSC curve (orange) and 
(E) transverse section of the A- and P-site tRNAs containing structure colored according 
to local resolution. In (B) and (D), the resolution at FSC=0.143 is indicated with a dashed 
line. (F) In silico sorting procedure for Dataset 2 derived from the PPP-SRC prepared in 
the presence of EF-P. (G) FSC curve (orange), as well as self and cross-validated 
correlations FSCwork (red) and FSCtest (purple), respectively. The resolutions at 
FSC=0.143 and FSC=0.5 (Cref) are indicated with dashed lines. (H) Transverse section of 
the A- and P-site tRNA- and EF-P-containing structure colored according to local 
resolution. (I) FSC curve (green), as well as self and cross-validated correlations as in (G) 
but for the P-site tRNA only structure. (J) as (H) but for P-site tRNA only structure. (K) 
In silico sorting procedure for Dataset 3 derived from the PP-SRC prepared in the 
presence of EF-P. (L) FSC curve (orange), as well as self and cross-validated correlations 
FSCwork (red) and FSCtest (purple), respectively. The resolutions at FSC=0.143 and 
FSC=0.5 (Cref) are indicated with dashed lines. (M) Transverse section of the P-site tRNA 
and EF-P structure colored according to local resolution. (N) FSC curve (green) for the P- 
and E-site tRNA containing structure. (O) as (M) but for P- and E-site tRNA containing 
structure.  
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Figure S2 - Related to Figure 1. Flexibility of tRNAPro in A- and P-sites in the 
absence of EF-P. (A-C) Cryo-EM densities coloured according to local resolution of the 
ASL of P-site tRNAPro (green) or A-site tRNAPro (orange) in comparison to nucleotides 
947-972 (purple) of the 16S rRNA at high threshold (7σ). (D-G) Cryo-EM densities of 
(D and E) P-site tRNAPro (green) and (F and G) tRNAPro (orange) coloured according to 
local resolution at (D-F) high (7σ) or (G) low threshold (3.5σ). (H-J) Cryo-EM densities 
of the CCA-ends of (H) P-site tRNA or (I and J) P- and A-site tRNAs including modeled 
fMet (cyan) and Phe (green) (from PDB: 1V4Y) (Polikanov et al., 2014), coloured 
according to local resolution. (K) Cryo-EM density colored according to local resolution 
for the N-terminus of ribosomal protein L27 (purple).  
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Figure S3 - Related to Figure 4. Comparison of E. coli EF-P, T. thermophilus EF-P 
and yeast eIF5A on the ribosome. (A) Cryo-EM density for EF-P coloured according to 
local resolution, with EF-P domains labeled (d1-d3). (B and C) Superimposition of 
ribosome-bound conformations of E. coli EF-P (salmon) with (B) T. thermophilus EF-P 
(grey) (PDB: 3HUX) (Blaha et al., 2009) and (C) yeast eIF5A (light blue) (PDB: 
5GAK)(Schmidt et al., 2016). Root mean square deviations (RMSD) for the individual 
domains are indicated. (D) Interaction of D69 of E. coli EF-P with nucleotide U17a of the 
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D-loop of P-site tRNAPro (green). (E) Interaction of N67 of T. thermophilus with 
nucleotide U17a of the D-loop of P-site tRNAfMet (grey)(PDB: 3HUX) (Blaha et al., 
2009). (F) Absence of interaction of D69 of E. coli EF-P with the D-loop of a tRNATyr 
(cyan, PDB: 4WQ1) modeled into the P-site of the ribosome. (G-I) Interaction of (G) 
E. coli EF-P, (H) T. thermophilus EF-P (grey)(PDB: 3HUX) (Blaha et al., 2009) and (I) 
yeast eIF5A (light blue) (PDB: 5GAK) (Schmidt et al., 2016), with the CCA-end of P-
site tRNA as well as A2439 (blue) of 23S rRNA (A2808 of 28S rRNA in yeast). 
 7 
 
 
Figure S4 - Related to Figure 4. Interactions of Loop I of domain 3 with S7 and the 
E-site codon. (A) Electron density (grey mesh) for loop I of domain 3 (salmon). (B) 
Same as (A) but coloured according to local resolution. (C) Potential hydrogen bonds 
between loop I of EF-P (salmon), S7 (cyan) and the E-site codon (light blue) are 
indicated as dashed lines. (D) as (C) but only focusing on interactions between S7 and 
loop I of EF-P. (E) as (C) but only focusing on the interactions between the E-site codon 
and loop I. In (C) and (E), -1, -2 and -3 nucleotides of the E-site codon are relative to the 
first position of the P-site codon. (F) Weblogo of residues of EF-P loop I (based on 12 
different bacterial EF-P sequences) and mutation scheme for EF-P variants.  
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Figure S5 - Related to Figure 4. Interaction of Loop I of EF-P with the E-site codon. 
(A and B) Modeling of an (A) AAA (magenta) or (B) GGG (blue) codon in the E-site 
suggests a steric clash with residues within loop I of EF-P (salmon). (C and D) 
Interaction of (C) UUU (olive) or (D) CCG (light blue) codon in the E-site with loop I of 
EF-P and S7 (cyan). Potential hydrogen bonds are indicated with dashed yellow lines. 
Note an additional interaction of loop I of EF-P with the -2 position of the (D) proline 
codon CCG, as compared with (C) phenylalanine UUU codon. (E) Lack of interaction of 
T. thermophilus (grey) loop I of EF-P with S7 and mRNA (PDB: 3HUX) (Blaha et al., 
2009). (F) Comparison of position of R78 of S7 (grey) from the T. thermophilus EF-P 
(grey) 70S structure (PDB: 3HUX) (Blaha et al., 2009) or S7 (cyan) from our E. coli EF-
P-PP-70S structure. 
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Figure S6 - Related to Figure 5. Conformation of polyproline nascent chain on the 
ribosome. (A-D) Comparison of cryo-EM density (mesh) and model for Pro-Pro nascent 
chain (cyan) compared with conformation of diprolyl residues found in (A) S11 (residues 
122-124, deep olive), (B) L11 (residues 73-75, yellow), (C) the antimicrobial peptide 
Onc112 (residues 3-5, olive, PDB: 4ZER) (Seefeldt et al., 2015), and (D) the CMV-
stalling peptidyl-tRNA (orange, PDB: 5A8L) (Matheisl et al., 2015). (E and F) 
Comparison of cryo-EM density (mesh) and model for Pro-Pro nascent chain (cyan 
ribbon) with (E) TnaC (yellow, PDB: 4UY8) (Bischoff et al., 2014), VemP (dark green, 
PDB: 5NWY) (Su et al., 2017) as well as (F) MifM (pink, PDB: 3J9W) (Sohmen et al., 
2015) and SecM (tan, PDB: 3JBV) (Zhang et al., 2015). The relative position of 
nucleotide G2061 (grey) of the 23S rRNA is shown for reference.  
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Figure S7 - Related to Figure 6. Conformation of polyproline nascent chain on the 
ribosome. Logarithm of the probability of finding a given peptide bond distance along 
the first (left panel) or the second (right) conformational mode of the CCA-end and the 
C-terminal proline backbone atoms obtained from all the simulations. Mode 2 highly 
correlates (cc=0.89) with the peptide bond distance, while mode 1 describes motions that 
are largely uncorrelated with the peptide bond distance (cc=0.23). 
 
